{"resourceType":"MedicationAdministration","id":"7598a2b1-fabb-0a73-0ef1-9f03ce7cf93c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"807283","display":"Mirena 52 MG Intrauterine System"}],"text":"Mirena 52 MG Intrauterine System"},"subject":{"reference":"Patient/e1646dc8-cd7f-3923-9cb6-d308fce05914"},"context":{"reference":"Encounter/d9dc64e1-006e-39fb-12b4-f1773f6f92b0"},"effectiveDateTime":"2014-11-12T08:21:42-08:00"}
{"resourceType":"MedicationAdministration","id":"abd09832-5200-0a7f-aa91-5db6d5e280c4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/7c2855fa-9abd-e121-1ffc-a590dae90c65"},"context":{"reference":"Encounter/2c070a71-a9b4-e5e2-99f1-159c0dcb1dd4"},"effectiveDateTime":"2015-10-14T07:01:24-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"bd3d748c-45bf-da47-6a20-7ec8f398ed73","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e1646dc8-cd7f-3923-9cb6-d308fce05914"},"context":{"reference":"Encounter/fe72259b-dba4-16a6-a37f-d120ac70ed98"},"effectiveDateTime":"2016-01-25T11:57:07-08:00","reasonReference":[{"reference":"Condition/b63f8172-697a-6d32-7989-0867dfc1df34","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"afbbc170-8ac2-6b7e-3ef0-4d44dc896713","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/826888f4-239d-5a0d-77ee-b7da06d0a553"},"context":{"reference":"Encounter/d04e5c10-c9d6-5c70-7aab-996271ca636a"},"effectiveDateTime":"2015-08-23T22:56:16-07:00","reasonReference":[{"reference":"Condition/ac181065-35fa-3252-6736-5a9208ff7253","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"58cfbbc7-b2d1-3fca-5935-0d14cd177329","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/54aa52a4-de75-af5b-3ddd-e0a4a25adfca"},"context":{"reference":"Encounter/2213cc6b-af73-d9cd-6325-becb4c246d0c"},"effectiveDateTime":"2015-12-03T07:18:44-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"9a01a7c2-0412-3b14-5f86-2ba82cace13b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/7c2855fa-9abd-e121-1ffc-a590dae90c65"},"context":{"reference":"Encounter/1d87e0ef-aff8-f072-c56b-b1348dcef15f"},"effectiveDateTime":"2017-10-18T07:58:43-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"212b8ba2-812c-f7fc-f3f1-7a6b1a8e1a44","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e1646dc8-cd7f-3923-9cb6-d308fce05914"},"context":{"reference":"Encounter/5ba3a8a5-f354-a35f-668d-34a9803eb4a4"},"effectiveDateTime":"2017-01-30T10:57:47-08:00","reasonReference":[{"reference":"Condition/b63f8172-697a-6d32-7989-0867dfc1df34","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fc82b03f-73e0-c805-5739-3973dcf9993d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/54aa52a4-de75-af5b-3ddd-e0a4a25adfca"},"context":{"reference":"Encounter/86dd86ac-53fb-850a-32e1-d2c274802377"},"effectiveDateTime":"2016-12-08T07:48:09-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"c90eb6a0-8efa-9b1e-b53a-cdf6c7354045","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/fbbd0a57-396a-7121-90b5-ee9e071ae723"},"context":{"reference":"Encounter/03217477-0616-4e04-00a3-f954f489c7a1"},"effectiveDateTime":"2015-10-09T02:16:16-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"9de8bb93-689c-479b-c235-d5d99da601f9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/54aa52a4-de75-af5b-3ddd-e0a4a25adfca"},"context":{"reference":"Encounter/46eed5f1-f67b-4833-7e88-a830f6a81db9"},"effectiveDateTime":"2017-09-26T05:49:39-07:00"}
{"resourceType":"MedicationAdministration","id":"92b25dc7-403f-3271-322d-35e07818f030","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0943da3a-df03-d699-4e25-2b976d4a70dd"},"context":{"reference":"Encounter/3f56ca93-4ad7-9486-a8a7-49afc70e4bc8"},"effectiveDateTime":"2017-11-21T19:24:56-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"1588e867-ad04-e607-3533-569c6736e8eb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/55653595-2836-20d7-17f3-8e05da83be69"},"context":{"reference":"Encounter/1116059d-78e0-f130-572d-f326d862d61d"},"effectiveDateTime":"2018-07-30T16:19:17-07:00","reasonReference":[{"reference":"Condition/1aa52527-765a-deb9-a72a-9c7eb9a4b0aa","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f5d76159-8b41-72b1-002f-d4db851f8a61","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/0e4b11f0-14d7-ca69-9578-954296bfaefe"},"effectiveDateTime":"2008-04-11T23:30:07-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"fe37c99a-ca3a-9f46-3ae1-59ed1754e57c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/54aa52a4-de75-af5b-3ddd-e0a4a25adfca"},"context":{"reference":"Encounter/a2537550-8333-f76c-efb6-1fd61975bd66"},"effectiveDateTime":"2017-12-14T07:47:53-08:00","reasonReference":[{"reference":"Condition/7387f4be-2432-09dc-5753-2c15dc8c225e","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"86ea7f64-25e0-dcd5-d138-7596fd2e8d4a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/fbbd0a57-396a-7121-90b5-ee9e071ae723"},"context":{"reference":"Encounter/1c6004c5-4b8c-61ce-ae47-30967aff0315"},"effectiveDateTime":"2016-10-14T02:36:50-07:00","reasonReference":[{"reference":"Condition/9cbe6015-3fc2-ce15-715d-9d996b153a6d","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"924d4661-e192-afd6-247d-2c12dec70094","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/dd04bd01-8147-0ded-3a30-0688a97fddad"},"context":{"reference":"Encounter/cde58841-b60c-d6fc-c5c6-edacd13e0351"},"effectiveDateTime":"2019-01-22T11:34:22-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"6d269578-adff-e43b-22e7-334aa709285a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8829dc8b-a55a-62c7-fd65-95b22c4ff59e"},"context":{"reference":"Encounter/ee114ae6-03e9-848c-6f7d-4c804ff86ddf"},"effectiveDateTime":"2019-02-15T02:20:20-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"a750203c-490f-64e2-3837-19b66119bd56","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/0cfa087d-bc21-32a9-22c9-416b60e6b634"},"effectiveDateTime":"2010-04-23T23:09:04-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"5e02473c-4a29-73c3-5ad6-41c35e012609","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/dd04bd01-8147-0ded-3a30-0688a97fddad"},"context":{"reference":"Encounter/912af448-27d0-e563-a8bd-b343eb1747bc"},"effectiveDateTime":"2020-01-28T12:10:12-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"d20e79ff-2fef-dffd-069a-e833c9bc3258","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/54aa52a4-de75-af5b-3ddd-e0a4a25adfca"},"context":{"reference":"Encounter/2ed00277-815f-15f6-633b-c2bd77d3f168"},"effectiveDateTime":"2019-12-26T07:26:04-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"6b3e92f0-1684-fde9-fbbc-83aa64ee9699","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/7c2855fa-9abd-e121-1ffc-a590dae90c65"},"context":{"reference":"Encounter/c47b4493-93b2-50a1-4aa8-c6e6459f413b"},"effectiveDateTime":"2022-11-23T06:21:38-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"4730d840-1eca-3509-f931-9dc4a2bb98a9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/7c2855fa-9abd-e121-1ffc-a590dae90c65"},"context":{"reference":"Encounter/35f07124-daf9-d20e-8f68-a31017ce5ac1"},"effectiveDateTime":"2023-11-29T09:18:12-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"79c2ef8d-c799-d5f1-543e-782747950da9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0943da3a-df03-d699-4e25-2b976d4a70dd"},"context":{"reference":"Encounter/f34a5616-fea3-4fa0-ce76-2cf4c33b5166"},"effectiveDateTime":"2025-01-07T15:51:49-08:00","reasonReference":[{"reference":"Condition/6bac6604-3362-3332-8fc9-7d673cb00895","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"276ebe8a-befd-c9de-8b3b-e180147e4fee","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/826888f4-239d-5a0d-77ee-b7da06d0a553"},"context":{"reference":"Encounter/b1b42fa6-030e-b895-4748-84b78bf19302"},"effectiveDateTime":"2020-01-26T22:23:00-08:00","reasonReference":[{"reference":"Condition/ac181065-35fa-3252-6736-5a9208ff7253","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f3324aec-c83f-be01-d712-17797174271a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/54aa52a4-de75-af5b-3ddd-e0a4a25adfca"},"context":{"reference":"Encounter/641f9275-5a90-ceba-bc1b-7000fe64c48a"},"effectiveDateTime":"2022-01-06T07:29:37-08:00","reasonReference":[{"reference":"Condition/7387f4be-2432-09dc-5753-2c15dc8c225e","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"854618d3-4be1-4959-3128-9ef0ea5aedb8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/826888f4-239d-5a0d-77ee-b7da06d0a553"},"context":{"reference":"Encounter/b9e6baf4-b4be-95e6-6ca1-840602b65eb8"},"effectiveDateTime":"2020-09-21T00:10:57-07:00","reasonReference":[{"reference":"Condition/ac181065-35fa-3252-6736-5a9208ff7253","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cc9df02e-9c6a-274b-d321-0d81300efd04","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1856546","display":"Kyleena 19.5 MG Intrauterine System"}],"text":"Kyleena 19.5 MG Intrauterine System"},"subject":{"reference":"Patient/fbbd0a57-396a-7121-90b5-ee9e071ae723"},"context":{"reference":"Encounter/4e5422e1-a5cc-4934-07fd-071168662071"},"effectiveDateTime":"2022-02-17T22:41:21-08:00"}
{"resourceType":"MedicationAdministration","id":"cf9adafa-c25f-d288-56d4-e80250a2d32e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/9de24a61-45ed-223a-b896-9e07fb35c86b"},"effectiveDateTime":"2012-06-22T23:01:35-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"3f873d7a-a48f-6e5f-c58f-829b349e575b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8829dc8b-a55a-62c7-fd65-95b22c4ff59e"},"context":{"reference":"Encounter/08e8b944-d517-04f0-4760-1bd24abfe1f2"},"effectiveDateTime":"2025-03-20T23:29:35-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"e5f64208-a1c5-89f6-02a1-bf48639ab332","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/fbbd0a57-396a-7121-90b5-ee9e071ae723"},"context":{"reference":"Encounter/9b5e7bca-d061-c454-3368-9165c35c076c"},"effectiveDateTime":"2023-11-24T01:00:28-08:00","reasonReference":[{"reference":"Condition/9cbe6015-3fc2-ce15-715d-9d996b153a6d","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"662f9a6d-e2c7-4907-289a-2d52aed3c90a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c608c578-b469-438b-bd5f-7096f595c808"},"context":{"reference":"Encounter/019bf14f-7103-063a-07bc-02719d8e8685"},"effectiveDateTime":"2016-03-30T11:14:58-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"9e52280e-5938-7601-2ed2-cd9593c3a0d0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1803932","display":"Leucovorin 100 MG Injection"}],"text":"Leucovorin 100 MG Injection"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/e9352049-babd-6456-9669-ab089f83e27f"},"effectiveDateTime":"2013-07-19T20:32:06-07:00","reasonReference":[{"reference":"Condition/e0a638b6-7492-267f-2165-90613668ac24","display":"Metastatic malignant neoplasm to colon (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fb1e1544-b979-882f-435e-680856bf1d97","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736776","display":"10 ML oxaliplatin 5 MG/ML Injection"}],"text":"10 ML oxaliplatin 5 MG/ML Injection"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/e9352049-babd-6456-9669-ab089f83e27f"},"effectiveDateTime":"2013-07-19T20:32:06-07:00","reasonReference":[{"reference":"Condition/e0a638b6-7492-267f-2165-90613668ac24","display":"Metastatic malignant neoplasm to colon (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"22a44631-322b-730d-d38b-98bcf2338321","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1803932","display":"Leucovorin 100 MG Injection"}],"text":"Leucovorin 100 MG Injection"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/fe4d4eef-7531-84fd-9a86-be8fcf2b817b"},"effectiveDateTime":"2013-08-17T10:32:06-07:00","reasonReference":[{"reference":"Condition/e0a638b6-7492-267f-2165-90613668ac24","display":"Metastatic malignant neoplasm to colon (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"532a503f-ea03-7d01-633f-01273c8f3d09","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736776","display":"10 ML oxaliplatin 5 MG/ML Injection"}],"text":"10 ML oxaliplatin 5 MG/ML Injection"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/fe4d4eef-7531-84fd-9a86-be8fcf2b817b"},"effectiveDateTime":"2013-08-17T10:32:06-07:00","reasonReference":[{"reference":"Condition/e0a638b6-7492-267f-2165-90613668ac24","display":"Metastatic malignant neoplasm to colon (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"adb5c54c-ebdd-f56d-1e06-6d6d153fc415","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1803932","display":"Leucovorin 100 MG Injection"}],"text":"Leucovorin 100 MG Injection"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/cabe7bcb-02a5-d807-c711-52cc67f396e1"},"effectiveDateTime":"2013-09-15T14:32:06-07:00","reasonReference":[{"reference":"Condition/e0a638b6-7492-267f-2165-90613668ac24","display":"Metastatic malignant neoplasm to colon (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d325661c-25e1-b6b2-1e33-db57a866f7b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736776","display":"10 ML oxaliplatin 5 MG/ML Injection"}],"text":"10 ML oxaliplatin 5 MG/ML Injection"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/cabe7bcb-02a5-d807-c711-52cc67f396e1"},"effectiveDateTime":"2013-09-15T14:32:06-07:00","reasonReference":[{"reference":"Condition/e0a638b6-7492-267f-2165-90613668ac24","display":"Metastatic malignant neoplasm to colon (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0527db54-4119-6eb9-bcc9-ddea5e040ec7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1803932","display":"Leucovorin 100 MG Injection"}],"text":"Leucovorin 100 MG Injection"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/19687268-c333-7f4a-759c-a25d35630a85"},"effectiveDateTime":"2013-10-17T11:32:06-07:00","reasonReference":[{"reference":"Condition/e0a638b6-7492-267f-2165-90613668ac24","display":"Metastatic malignant neoplasm to colon (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2e891365-5e43-9c24-a8a9-3cc72ced9d0f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736776","display":"10 ML oxaliplatin 5 MG/ML Injection"}],"text":"10 ML oxaliplatin 5 MG/ML Injection"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/19687268-c333-7f4a-759c-a25d35630a85"},"effectiveDateTime":"2013-10-17T11:32:06-07:00","reasonReference":[{"reference":"Condition/e0a638b6-7492-267f-2165-90613668ac24","display":"Metastatic malignant neoplasm to colon (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dd2cbd31-d517-13eb-dfc2-da1cbf04032d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1803932","display":"Leucovorin 100 MG Injection"}],"text":"Leucovorin 100 MG Injection"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/5bb01a2b-d3ce-7936-6927-066e13652a5f"},"effectiveDateTime":"2013-12-13T19:32:06-08:00","reasonReference":[{"reference":"Condition/e0a638b6-7492-267f-2165-90613668ac24","display":"Metastatic malignant neoplasm to colon (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d345da1e-5b99-dec2-53eb-615916151a93","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736776","display":"10 ML oxaliplatin 5 MG/ML Injection"}],"text":"10 ML oxaliplatin 5 MG/ML Injection"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/5bb01a2b-d3ce-7936-6927-066e13652a5f"},"effectiveDateTime":"2013-12-13T19:32:06-08:00","reasonReference":[{"reference":"Condition/e0a638b6-7492-267f-2165-90613668ac24","display":"Metastatic malignant neoplasm to colon (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ad4dc083-a648-fa49-0d77-225254ec965e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/01b4b0d6-f3be-b497-c1a7-5c25eb673b34"},"effectiveDateTime":"2013-12-14T01:07:44-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"a30dcf38-a63d-8575-528f-5e9b550cf323","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/6ad77d9d-4c7d-8d71-96c2-58fe3649570e"},"context":{"reference":"Encounter/859b4535-d03b-40bb-6624-c258d747d5ee"},"effectiveDateTime":"2022-04-17T20:56:33-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"054c9c50-fb60-7955-53f1-2a5805b8ed01","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1803932","display":"Leucovorin 100 MG Injection"}],"text":"Leucovorin 100 MG Injection"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/409f6468-4b8c-9d24-bc84-c437d5e61e15"},"effectiveDateTime":"2014-01-15T05:32:06-08:00","reasonReference":[{"reference":"Condition/e0a638b6-7492-267f-2165-90613668ac24","display":"Metastatic malignant neoplasm to colon (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6d9efcaf-4536-e91a-cf6d-ade9d76f0943","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736776","display":"10 ML oxaliplatin 5 MG/ML Injection"}],"text":"10 ML oxaliplatin 5 MG/ML Injection"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/409f6468-4b8c-9d24-bc84-c437d5e61e15"},"effectiveDateTime":"2014-01-15T05:32:06-08:00","reasonReference":[{"reference":"Condition/e0a638b6-7492-267f-2165-90613668ac24","display":"Metastatic malignant neoplasm to colon (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"38cd5af0-480f-3635-e5ba-1259f0198ea8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/5d02a25c-d2ea-2156-c20b-bd79dc8c8944"},"effectiveDateTime":"2014-02-14T22:12:42-08:00","reasonReference":[{"reference":"Condition/ae975a71-1e4f-e15b-67e3-c4e24ca53705","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"beb51eaa-8f57-7097-ac8f-592c7ff7f9b3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/798e19b7-03fe-2415-bdc7-7e4a738b693c"},"context":{"reference":"Encounter/ccc9579a-bad3-23e8-bc97-e732395c51e4"},"effectiveDateTime":"2016-09-16T12:25:50-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"4deb53b6-0be7-95bc-e418-0ce90f43daa9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1605257","display":"Liletta 52 MG Intrauterine System"}],"text":"Liletta 52 MG Intrauterine System"},"subject":{"reference":"Patient/c608c578-b469-438b-bd5f-7096f595c808"},"context":{"reference":"Encounter/2c86471b-adcb-fac1-cf8d-9bb10d3968c4"},"effectiveDateTime":"2024-06-12T08:03:03-07:00"}
{"resourceType":"MedicationAdministration","id":"fb954037-9638-3d95-91b2-2be7ebbcdd98","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/787049f2-9a45-202a-4ea1-580b04dcf70f"},"effectiveDateTime":"2014-05-16T23:08:17-07:00","reasonReference":[{"reference":"Condition/ae975a71-1e4f-e15b-67e3-c4e24ca53705","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8ac5ec3f-5e22-2a47-cdb5-8a77face49c8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/a0830037-86de-ea7f-4766-45bf8e8a106a"},"context":{"reference":"Encounter/399b3654-f8d9-05e2-eeee-327037f45e51"},"effectiveDateTime":"2019-05-09T01:58:12-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"01fe6dc8-4acb-847f-228a-1d1f0cba2c7a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/471d3c4a-eb00-0e0b-8811-317ca4eed732"},"context":{"reference":"Encounter/5d3e2d54-7dcb-3c44-dd7d-15540d7d9a83"},"effectiveDateTime":"2015-11-05T16:05:01-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f4cee825-9457-2f1e-79d6-70662718732e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/798e19b7-03fe-2415-bdc7-7e4a738b693c"},"context":{"reference":"Encounter/269c03fe-1b35-564d-7953-5e94c53f0f95"},"effectiveDateTime":"2023-10-13T12:34:33-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"406ceafa-98b7-22f0-fee5-cd74bf8180ab","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/a0830037-86de-ea7f-4766-45bf8e8a106a"},"context":{"reference":"Encounter/cd1958ee-860c-4b05-9025-81261b7340b5"},"effectiveDateTime":"2021-05-19T23:14:24-07:00"}
{"resourceType":"MedicationAdministration","id":"d0de1e1b-2d45-5329-d71c-d29096f5ced3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/471d3c4a-eb00-0e0b-8811-317ca4eed732"},"context":{"reference":"Encounter/0f9f0343-d072-5c0e-d6c7-664ec6409c22"},"effectiveDateTime":"2017-11-16T15:52:22-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"9aa157c5-9543-6604-811e-498a90347c92","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/a0830037-86de-ea7f-4766-45bf8e8a106a"},"context":{"reference":"Encounter/cb763b3a-ff37-2755-bfc9-13fcab452d49"},"effectiveDateTime":"2022-04-14T23:31:02-07:00"}
{"resourceType":"MedicationAdministration","id":"84f38fb8-7b69-c936-7b96-6c3c936393f0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f69f5df5-b744-c8af-9f4c-d6a05329f2a7"},"context":{"reference":"Encounter/0febad5e-f041-e571-acf1-024f57f02fdb"},"effectiveDateTime":"2017-03-10T14:23:30-08:00","reasonReference":[{"reference":"Condition/b6dd2882-1ea0-f255-af6d-61a22b50eda4","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"419eb1bb-5f58-f0b3-dfca-ba5a07634916","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/7165b37e-020c-69b0-c853-f4d9f54e335c"},"context":{"reference":"Encounter/87c80434-48f5-ec9c-a7f0-340b612f5f0d"},"effectiveDateTime":"2017-12-19T19:11:54-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"dbed9051-66b2-db3a-f83d-a99b04e3c309","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/a0830037-86de-ea7f-4766-45bf8e8a106a"},"context":{"reference":"Encounter/b8d8b4d7-fece-4c94-7bb1-8bac09bbcf6e"},"effectiveDateTime":"2023-03-10T22:49:19-08:00"}
{"resourceType":"MedicationAdministration","id":"e6d32c1c-13b8-2d6d-725c-0b5a31931548","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/f69f5df5-b744-c8af-9f4c-d6a05329f2a7"},"context":{"reference":"Encounter/e41d0360-928d-fe0d-8355-e210b788895e"},"effectiveDateTime":"2018-09-28T12:56:25-07:00"}
{"resourceType":"MedicationAdministration","id":"db4ecbd3-b373-0d99-5550-9fb1921b17f2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/7165b37e-020c-69b0-c853-f4d9f54e335c"},"context":{"reference":"Encounter/888632eb-ad4b-2cf8-52ad-8add0e428c0b"},"effectiveDateTime":"2021-01-05T18:38:58-08:00","reasonReference":[{"reference":"Condition/747ff643-6653-1760-b6e8-3daefbfca6e9","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dea83bf0-76d3-5fb0-f017-fa6959577bbe","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/a0830037-86de-ea7f-4766-45bf8e8a106a"},"context":{"reference":"Encounter/ab9d0375-79a6-6910-c028-099c407693a0"},"effectiveDateTime":"2024-02-03T23:06:25-08:00"}
{"resourceType":"MedicationAdministration","id":"3584f17d-30bd-18d6-df87-879d8ed5139f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/7165b37e-020c-69b0-c853-f4d9f54e335c"},"context":{"reference":"Encounter/8c1f3305-301c-c9c7-774d-94f4496bea3c"},"effectiveDateTime":"2022-01-11T18:26:39-08:00","reasonReference":[{"reference":"Condition/747ff643-6653-1760-b6e8-3daefbfca6e9","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a68e406f-fb70-cd9b-e363-9d6b4ce4a89c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f69f5df5-b744-c8af-9f4c-d6a05329f2a7"},"context":{"reference":"Encounter/44872e3a-36bb-9b3b-93e9-96258e9501ee"},"effectiveDateTime":"2020-03-27T15:39:54-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"971f1789-60e6-1b14-213e-03c3588514f8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/a0830037-86de-ea7f-4766-45bf8e8a106a"},"context":{"reference":"Encounter/56baeee4-7dec-4a13-ae37-19821edca11b"},"effectiveDateTime":"2025-01-28T23:23:19-08:00"}
{"resourceType":"MedicationAdministration","id":"ebd47c9b-6905-8164-0085-641ab7c4ae25","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/5661999a-31f7-872f-da5e-c8559438ddb6"},"effectiveDateTime":"2016-09-02T23:55:57-07:00","reasonReference":[{"reference":"Condition/ae975a71-1e4f-e15b-67e3-c4e24ca53705","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6f3f0f27-f7d0-4f40-755d-66bffcfc8921","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/350fc34b-dfc5-4c9b-630a-4ece7c30ed4a"},"context":{"reference":"Encounter/624b0c6d-660a-3946-6fb0-8eb4ad3cc2e4"},"effectiveDateTime":"2016-12-30T23:05:03-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"cf77f7b1-99a8-5b76-848f-533c3ea6ed46","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f69f5df5-b744-c8af-9f4c-d6a05329f2a7"},"context":{"reference":"Encounter/4d60ad3b-f169-9b81-b163-23ce7ef1bc27"},"effectiveDateTime":"2021-04-02T15:54:04-07:00","reasonReference":[{"reference":"Condition/b6dd2882-1ea0-f255-af6d-61a22b50eda4","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d3a922fb-1c7d-4799-7591-25425b51a57f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f69f5df5-b744-c8af-9f4c-d6a05329f2a7"},"context":{"reference":"Encounter/6bfcc34c-2d08-d778-f2ef-4727bae48399"},"effectiveDateTime":"2022-04-08T19:56:28-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"0a552bc1-6bb5-8d4c-d53d-064d3754ef39","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f69f5df5-b744-c8af-9f4c-d6a05329f2a7"},"context":{"reference":"Encounter/be66ae0b-c736-3c4e-d533-e71c0fdd410e"},"effectiveDateTime":"2023-04-14T15:11:32-07:00","reasonReference":[{"reference":"Condition/b6dd2882-1ea0-f255-af6d-61a22b50eda4","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"213cf37d-a9a0-0f08-dff6-ea209df2bf52","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/f69f5df5-b744-c8af-9f4c-d6a05329f2a7"},"context":{"reference":"Encounter/29f87a3d-9ca6-0b50-6bf1-cd3ae49ec933"},"effectiveDateTime":"2023-09-02T13:08:03-07:00"}
{"resourceType":"MedicationAdministration","id":"0bbd0dba-8197-41b8-3af3-22a7de929335","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f69f5df5-b744-c8af-9f4c-d6a05329f2a7"},"context":{"reference":"Encounter/a88f5dc3-4f91-42cd-1f61-35887b0afb67"},"effectiveDateTime":"2025-04-25T15:03:34-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"155d72f9-a4fa-b784-6d30-4bf0913796a2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/5889da23-d981-9a34-e609-4d2760572891"},"context":{"reference":"Encounter/f65f1d7d-9ad1-5b0b-253c-10a4821ec8f6"},"effectiveDateTime":"2015-10-03T17:14:29-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"466e3733-ffbf-73ee-3a2b-96b43b59ea98","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/813fecb0-3490-ba58-3ea5-97d0f748d94b"},"effectiveDateTime":"2016-11-23T00:05:59-08:00","reasonReference":[{"reference":"Condition/8e936fd6-ab24-7607-3369-8398003a4569","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"442a4a56-d26b-d32c-8451-0f6ff3946ae4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0db2696e-a741-4939-a0c0-af0da55c7c52"},"context":{"reference":"Encounter/4baf1faf-2720-6d69-6e7d-022cbb7acde6"},"effectiveDateTime":"2019-05-20T11:50:20-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"ba4526c0-be7a-baba-dcf1-11dfba555c4c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8532ea13-c0d5-2278-8efe-9368ca551d37"},"context":{"reference":"Encounter/62160274-ebdb-55e3-8176-ab54955ac9f2"},"effectiveDateTime":"2023-12-11T15:22:08-08:00","reasonReference":[{"reference":"Condition/e81f9d10-c559-7c91-2b0b-3736ca5a665d","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d9b071b0-3268-1c23-e330-e480b06644ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0db2696e-a741-4939-a0c0-af0da55c7c52"},"context":{"reference":"Encounter/1103faeb-3831-5616-ff49-1a27e9c9357d"},"effectiveDateTime":"2020-05-25T12:01:47-07:00","reasonReference":[{"reference":"Condition/c80377e6-4743-b7f0-4c31-177023216de3","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1a7e11f1-30a5-b303-d7e3-6a519e505cf6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/b3104e13-7faf-8a3b-9fd2-5757588bf382"},"effectiveDateTime":"2020-01-29T02:14:33-08:00","reasonReference":[{"reference":"Condition/8e936fd6-ab24-7607-3369-8398003a4569","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e4cf8ad8-73df-a5b9-033f-1a30949d8967","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/5889da23-d981-9a34-e609-4d2760572891"},"context":{"reference":"Encounter/47dbc1ea-88ba-d04d-d77e-aec7f9eed12d"},"effectiveDateTime":"2021-10-09T17:05:12-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"2b93e2c6-b972-7702-7b1b-7eaa91fe3705","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/5889da23-d981-9a34-e609-4d2760572891"},"context":{"reference":"Encounter/46d1c759-691f-1677-3866-8439295dd2f9"},"effectiveDateTime":"2023-02-21T13:00:02-08:00"}
{"resourceType":"MedicationAdministration","id":"9b750985-8ed3-8c71-c3d9-9231033fcce3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8532ea13-c0d5-2278-8efe-9368ca551d37"},"context":{"reference":"Encounter/6b7ddb98-6180-4804-5c31-d399ef9d7c45"},"effectiveDateTime":"2024-12-23T13:41:55-08:00","reasonReference":[{"reference":"Condition/e81f9d10-c559-7c91-2b0b-3736ca5a665d","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"375d8a4e-9a21-fa6a-050e-7dcb1593de7f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/5889da23-d981-9a34-e609-4d2760572891"},"context":{"reference":"Encounter/71300ab2-4505-3fd2-d277-7067936be535"},"effectiveDateTime":"2024-10-12T17:31:09-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"29430eaa-7db1-b2ea-3132-8bd51ced8944","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/25ea54d3-cc65-d26b-0b8c-b1caca771265"},"effectiveDateTime":"2020-03-25T03:38:37-07:00","reasonReference":[{"reference":"Condition/8e936fd6-ab24-7607-3369-8398003a4569","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cae31d5d-4465-5c7c-4668-751f30964ff9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/5889da23-d981-9a34-e609-4d2760572891"},"context":{"reference":"Encounter/d9dba887-2cea-6bba-6cef-684cf09d34dc"},"effectiveDateTime":"2025-02-10T13:23:27-08:00"}
{"resourceType":"MedicationAdministration","id":"b6ec0ecf-5ef5-b236-7452-0045e5aa5c2a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/f4cd4293-8de6-0451-ff87-d0032c51f092"},"effectiveDateTime":"2020-05-27T00:58:42-07:00","reasonReference":[{"reference":"Condition/8e936fd6-ab24-7607-3369-8398003a4569","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0d3f0d9c-9224-95e9-9dde-9d7a9ab87875","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0db2696e-a741-4939-a0c0-af0da55c7c52"},"context":{"reference":"Encounter/17db158c-c505-6301-e275-819c158303f2"},"effectiveDateTime":"2022-06-13T12:44:12-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"c1d1a6a4-a994-83ee-b58f-0d535d730898","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/5bf34a84-7cbc-8af6-7201-3e7c6300535a"},"effectiveDateTime":"2020-10-21T00:39:38-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"9f9468fa-82db-2278-ca4b-d2a10d6cc2b3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"312617","display":"predniSONE 5 MG Oral Tablet"}],"text":"predniSONE 5 MG Oral Tablet"},"subject":{"reference":"Patient/577efb54-1d3c-bbcf-ed49-ba393adcec94"},"context":{"reference":"Encounter/a74fa2a9-dea2-d7a4-6018-c245d9f4f410"},"effectiveDateTime":"2017-09-28T08:34:05-07:00"}
{"resourceType":"MedicationAdministration","id":"2b36e63f-5a26-91a4-ff1e-610d11a96869","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/0f2ca29c-dafc-3cd9-a260-441b5efac972"},"effectiveDateTime":"2020-11-24T23:30:29-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"9935ab27-6236-0252-694b-2c6a069e1153","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/577efb54-1d3c-bbcf-ed49-ba393adcec94"},"context":{"reference":"Encounter/5b63ecb4-b895-0554-9f80-1b2149497898"},"effectiveDateTime":"2025-02-09T07:36:17-08:00","reasonReference":[{"reference":"Condition/7b61c75d-a6fb-34d3-a5fc-c771621e060a","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"043dd0d5-4660-f192-f4e2-f5780049d124","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/99d93c1e-26c4-7b12-ace0-0144195d4862"},"context":{"reference":"Encounter/72367862-0b9f-180f-7466-aa40aa87d2d4"},"effectiveDateTime":"2025-05-02T19:46:30-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"ac744df5-7f7e-bde8-15c2-5a4c54e31f6e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/28b00c96-e47b-b9b0-fccb-35ef4c508dcd"},"context":{"reference":"Encounter/ba488c40-839c-9f4c-70a2-1e1688f2c3cb"},"effectiveDateTime":"2017-07-17T17:12:48-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"b200f1fe-481d-8c50-7b29-6f37f0742131","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/28b00c96-e47b-b9b0-fccb-35ef4c508dcd"},"context":{"reference":"Encounter/d46dfb0c-6985-47b6-56e0-ca0d6ec5ef3d"},"effectiveDateTime":"2018-07-23T15:52:36-07:00","reasonReference":[{"reference":"Condition/cd6acba1-c0c0-8b8b-c82f-f981b5d7fabe","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"680bf1e7-7f70-448e-98e9-7b62520c5e31","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/28b00c96-e47b-b9b0-fccb-35ef4c508dcd"},"context":{"reference":"Encounter/ace51406-21a6-8681-ad8f-93a7ae870ba9"},"effectiveDateTime":"2019-08-19T12:47:29-07:00"}
{"resourceType":"MedicationAdministration","id":"f271b57c-c6a7-9ab5-721e-df3e6818ab09","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/28b00c96-e47b-b9b0-fccb-35ef4c508dcd"},"context":{"reference":"Encounter/c8977530-9fda-7bab-759b-0de94f04aedf"},"effectiveDateTime":"2020-08-13T13:06:10-07:00"}
{"resourceType":"MedicationAdministration","id":"8d6be4c4-796a-1220-d481-1eabce6485c9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2e129197-9473-3950-f956-23cded2f29b3"},"context":{"reference":"Encounter/6fa642e8-a5b6-361d-be6f-8b1a140a9d09"},"effectiveDateTime":"2018-12-27T02:37:07-08:00","reasonReference":[{"reference":"Condition/d8bfe874-a4f7-e2eb-dfa7-2f5501fb60a9","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d89fcb49-aa5d-13de-74f6-602a7eb77224","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/28b00c96-e47b-b9b0-fccb-35ef4c508dcd"},"context":{"reference":"Encounter/e65ec006-147a-81de-4908-42cbae0d8913"},"effectiveDateTime":"2021-08-09T15:48:21-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"152be3b7-27d6-b4d3-66dc-218097310856","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/28b00c96-e47b-b9b0-fccb-35ef4c508dcd"},"context":{"reference":"Encounter/2f363f61-95d3-1827-6036-0c9ae5686609"},"effectiveDateTime":"2021-08-16T12:42:29-07:00"}
{"resourceType":"MedicationAdministration","id":"4e8e4b94-291f-2bc5-9d54-70cdfd06a696","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/4ce3aa35-0087-bc11-0ca5-0112881345dc"},"effectiveDateTime":"2021-11-16T23:39:34-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"3c4c8233-b0e7-bd7e-5744-3c569362901a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/28b00c96-e47b-b9b0-fccb-35ef4c508dcd"},"context":{"reference":"Encounter/8a9f138f-3c54-7ec5-1816-56682aec0aff"},"effectiveDateTime":"2022-07-12T13:00:43-07:00"}
{"resourceType":"MedicationAdministration","id":"497207dc-426d-8de4-73ee-f73679cb541f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/174f4bd8-c191-06ab-b9d0-a048fa8a261c"},"effectiveDateTime":"2021-12-28T23:45:02-08:00","reasonReference":[{"reference":"Condition/8e936fd6-ab24-7607-3369-8398003a4569","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e70b512f-98b0-e074-1f42-151438fdf61a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/28b00c96-e47b-b9b0-fccb-35ef4c508dcd"},"context":{"reference":"Encounter/0fa56f3c-e241-c64e-bede-e54ab785c9e5"},"effectiveDateTime":"2023-06-07T13:18:27-07:00"}
{"resourceType":"MedicationAdministration","id":"0621f870-b3b5-c1ff-f16a-050b00ab119c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/133b9cdf-3251-e471-cd6e-d5d0ba7b92ae"},"effectiveDateTime":"2022-01-26T00:53:31-08:00","reasonReference":[{"reference":"Condition/8e936fd6-ab24-7607-3369-8398003a4569","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9e8652fe-f7cc-82d1-9517-f841f3acb4fb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/9e0ca355-acd7-1a42-0827-2136f7f1672e"},"context":{"reference":"Encounter/c43f32db-45b6-7eed-5eb5-ee0b2eb9bee0"},"effectiveDateTime":"2020-04-03T00:58:48-07:00","reasonReference":[{"reference":"Condition/1b2020a6-a6da-42f5-2be9-95dc6739c5bd","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d3a10dc0-8ecb-0aab-67ad-6ef2f96a4682","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/91d07348-8dcf-74c3-2486-0d695381dccf"},"effectiveDateTime":"2022-03-16T03:59:43-07:00","reasonReference":[{"reference":"Condition/8e936fd6-ab24-7607-3369-8398003a4569","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"34861eb7-324e-7f5e-1fd0-8f26899830cc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/28b00c96-e47b-b9b0-fccb-35ef4c508dcd"},"context":{"reference":"Encounter/c2defdea-ad3f-c8c9-342c-2d15411d4c47"},"effectiveDateTime":"2024-06-01T13:36:21-07:00"}
{"resourceType":"MedicationAdministration","id":"758ad1f6-a967-bbf7-9590-1d4f6ed10a05","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/28b00c96-e47b-b9b0-fccb-35ef4c508dcd"},"context":{"reference":"Encounter/d0c3c0f1-5c44-a16a-248f-5775b6cd151b"},"effectiveDateTime":"2025-04-27T13:53:53-07:00"}
{"resourceType":"MedicationAdministration","id":"8e1b7b18-17c3-0a6c-6a07-2114d2344788","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8b874ddf-c1e0-3fc4-a9c9-ce4677ed0636"},"context":{"reference":"Encounter/cc1c5dfd-8b38-e852-372c-83ad0bf20480"},"effectiveDateTime":"2015-12-28T21:51:36-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"7a92716e-0618-02a3-8e1b-f415d50da97a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/6169958f-4339-d169-f120-329fc8804bf8"},"effectiveDateTime":"2022-06-15T00:56:48-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f4daa613-819f-23a1-ad7b-3d69d9d5bc55","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/90948807-e59c-cb14-1e40-e20d400849fe"},"context":{"reference":"Encounter/5cb03a9a-3555-bd27-7f47-fd81abf348ec"},"effectiveDateTime":"2024-10-21T02:06:42-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"0b4a7e16-9846-3459-7e34-432c313aef01","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8b874ddf-c1e0-3fc4-a9c9-ce4677ed0636"},"context":{"reference":"Encounter/69f2e964-fe99-6a0b-35da-40bc950b248f"},"effectiveDateTime":"2025-01-06T21:55:08-08:00","reasonReference":[{"reference":"Condition/9f9aef82-c0a8-46a6-e0de-e81db7f3fef7","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"40f3cb9b-bff5-0eea-b1a9-1b39ab4787d9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/0fe6b63f-1fbd-dc1b-ef94-e09b4a6bb292"},"effectiveDateTime":"2022-10-12T03:33:27-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"b5546307-3b03-03ae-a911-cdc25ea6b658","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/b14e152b-f413-4d93-36f2-acf6d923d3d2"},"effectiveDateTime":"2023-01-04T00:14:21-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"041096cf-cef9-232a-0eaa-f7de374cc943","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/9721d726-b239-5e5b-4bdc-b1cda0bf42eb"},"effectiveDateTime":"2016-02-06T01:31:14-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"58ed7c2e-311e-dde5-b894-83c8de2820bd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c4e82903-7f77-8f9e-1d58-5d7569948ce6"},"context":{"reference":"Encounter/8f4fb9a4-6943-895b-b9fa-036a4f4012a6"},"effectiveDateTime":"2022-04-28T22:35:21-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"fd6932b6-674c-a4c8-a7ff-7e3a4c25212d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1665060","display":"cefazolin 2000 MG Injection"}],"text":"cefazolin 2000 MG Injection"},"subject":{"reference":"Patient/c7e09f54-7b6e-4be9-4df3-76389dbc6d84"},"context":{"reference":"Encounter/58384f71-0e7f-dfe5-7ddb-acf0b00c2dbb"},"effectiveDateTime":"2017-09-06T20:52:31-07:00"}
{"resourceType":"MedicationAdministration","id":"9d625cfa-86d1-e9e4-c807-efdb800708fd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1659263","display":"1 ML heparin sodium, porcine 5000 UNT/ML Injection"}],"text":"1 ML heparin sodium, porcine 5000 UNT/ML Injection"},"subject":{"reference":"Patient/c7e09f54-7b6e-4be9-4df3-76389dbc6d84"},"context":{"reference":"Encounter/58384f71-0e7f-dfe5-7ddb-acf0b00c2dbb"},"effectiveDateTime":"2017-09-06T20:52:31-07:00"}
{"resourceType":"MedicationAdministration","id":"e1f86a92-f346-49c3-5e93-7a1f88991334","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1796676","display":"25 ML protamine sulfate (USP) 10 MG/ML Injection"}],"text":"25 ML protamine sulfate (USP) 10 MG/ML Injection"},"subject":{"reference":"Patient/c7e09f54-7b6e-4be9-4df3-76389dbc6d84"},"context":{"reference":"Encounter/58384f71-0e7f-dfe5-7ddb-acf0b00c2dbb"},"effectiveDateTime":"2017-09-06T20:52:31-07:00"}
{"resourceType":"MedicationAdministration","id":"6f2c4f7c-ed38-e14b-01d6-a8b15704c33d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1740467","display":"2 ML Ondansetron 2 MG/ML Injection"}],"text":"2 ML Ondansetron 2 MG/ML Injection"},"subject":{"reference":"Patient/c7e09f54-7b6e-4be9-4df3-76389dbc6d84"},"context":{"reference":"Encounter/58384f71-0e7f-dfe5-7ddb-acf0b00c2dbb"},"effectiveDateTime":"2017-09-06T22:43:32-07:00"}
{"resourceType":"MedicationAdministration","id":"01386b21-c590-56e2-4f97-7aae5ae32085","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"311700","display":"Midazolam 1 MG/ML Injectable Solution"}],"text":"Midazolam 1 MG/ML Injectable Solution"},"subject":{"reference":"Patient/c7e09f54-7b6e-4be9-4df3-76389dbc6d84"},"context":{"reference":"Encounter/58384f71-0e7f-dfe5-7ddb-acf0b00c2dbb"},"effectiveDateTime":"2017-09-06T22:43:32-07:00"}
{"resourceType":"MedicationAdministration","id":"4e13e2d0-12c4-4b3b-7d9b-a91abc291ce2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1808217","display":"100 ML Propofol 10 MG/ML Injection"}],"text":"100 ML Propofol 10 MG/ML Injection"},"subject":{"reference":"Patient/c7e09f54-7b6e-4be9-4df3-76389dbc6d84"},"context":{"reference":"Encounter/58384f71-0e7f-dfe5-7ddb-acf0b00c2dbb"},"effectiveDateTime":"2017-09-06T22:43:32-07:00"}
{"resourceType":"MedicationAdministration","id":"6f6355eb-4021-61c0-7eef-eb3e09c4b01f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1234995","display":"Rocuronium bromide 10 MG/ML Injectable Solution"}],"text":"Rocuronium bromide 10 MG/ML Injectable Solution"},"subject":{"reference":"Patient/c7e09f54-7b6e-4be9-4df3-76389dbc6d84"},"context":{"reference":"Encounter/58384f71-0e7f-dfe5-7ddb-acf0b00c2dbb"},"effectiveDateTime":"2017-09-06T22:43:32-07:00"}
{"resourceType":"MedicationAdministration","id":"67e965bc-9a04-b419-9ccf-56b56359e0b3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"200243","display":"sevoflurane 1000 MG/ML Inhalation Solution"}],"text":"sevoflurane 1000 MG/ML Inhalation Solution"},"subject":{"reference":"Patient/c7e09f54-7b6e-4be9-4df3-76389dbc6d84"},"context":{"reference":"Encounter/58384f71-0e7f-dfe5-7ddb-acf0b00c2dbb"},"effectiveDateTime":"2017-09-06T22:43:32-07:00"}
{"resourceType":"MedicationAdministration","id":"4a7ae68b-d343-9b1d-fce3-ba239726c071","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1729584","display":"remifentanil 2 MG Injection"}],"text":"remifentanil 2 MG Injection"},"subject":{"reference":"Patient/c7e09f54-7b6e-4be9-4df3-76389dbc6d84"},"context":{"reference":"Encounter/58384f71-0e7f-dfe5-7ddb-acf0b00c2dbb"},"effectiveDateTime":"2017-09-06T22:43:32-07:00"}
{"resourceType":"MedicationAdministration","id":"37dc807b-9c25-a15c-5ce7-f0e7955eac10","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c4e82903-7f77-8f9e-1d58-5d7569948ce6"},"context":{"reference":"Encounter/cd584423-ecbb-7507-4e02-fd18399bcba7"},"effectiveDateTime":"2024-05-09T23:26:05-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"7097b21b-63aa-c624-8edd-1a657a9a8b43","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c4e82903-7f77-8f9e-1d58-5d7569948ce6"},"context":{"reference":"Encounter/15770eed-1b6a-a2d8-219a-f4a7dc24b70e"},"effectiveDateTime":"2025-05-15T23:25:00-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"83f3ca18-d8a0-7aa1-20f9-19b6c3fb655e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/c69125cd-69d4-d3f2-8e9f-79925bc2b172"},"effectiveDateTime":"2023-05-10T00:55:12-07:00","reasonReference":[{"reference":"Condition/8e936fd6-ab24-7607-3369-8398003a4569","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4d1897a3-0e6f-cb0a-be39-06b35c3b3f83","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/ca60c32f-16fd-463a-1ef9-60b0c83fcb89"},"context":{"reference":"Encounter/a075e797-64c2-08b3-1c8b-ab97abe02fba"},"effectiveDateTime":"2019-03-12T00:37:42-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"597f6e78-0f52-58ac-03fc-5dd333417740","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/2db0bf68-a517-f85a-ed14-6274ac20eac5"},"effectiveDateTime":"2024-01-02T23:31:15-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"75823daa-9894-d88a-f2f6-7face5c43798","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/59b304c2-4862-2d8d-c969-16854f805941"},"context":{"reference":"Encounter/e3f014f2-59c2-9f67-a7c4-40ff5d853772"},"effectiveDateTime":"2015-10-16T03:02:06-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f7109d89-e9db-bd0e-3877-22c450c5ffdd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/2a3390cf-a615-b74e-92a1-596e124b6de5"},"effectiveDateTime":"2017-07-22T00:06:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8e7086e6-36a5-9212-ff75-63a8b06cdba1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/ca60c32f-16fd-463a-1ef9-60b0c83fcb89"},"context":{"reference":"Encounter/ec12e217-1793-2a38-a5d2-22813659c614"},"effectiveDateTime":"2022-03-29T03:26:24-07:00","reasonReference":[{"reference":"Condition/641480d3-932a-776e-956e-10c0b1af004a","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"423543b5-6266-3412-670b-bed193d17832","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/59b304c2-4862-2d8d-c969-16854f805941"},"context":{"reference":"Encounter/b3c5a3fc-044c-d0dd-af40-890b7f100683"},"effectiveDateTime":"2016-09-30T02:32:23-07:00","reasonReference":[{"reference":"Condition/20158727-30e9-52a8-5b57-45fdd9761a6a","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"37116454-1e1b-57ff-53e2-0ba0fc639597","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/bfa3ea3f-6707-1d76-bbff-197832b2e385"},"effectiveDateTime":"2017-07-25T02:38:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"31d9ebe4-4f4e-0c57-ffce-7d8b311b16cb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/dc70cf26-c2e9-3d15-15b1-3ff1a06a4855"},"effectiveDateTime":"2017-07-28T05:27:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4557fd2c-904f-99c4-d9e6-658036c19d26","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8806295e-f379-b3e7-1262-dd86028711c8"},"effectiveDateTime":"2017-08-11T22:57:28-07:00","reasonReference":[{"reference":"Condition/4fa0c31d-5a89-b9d3-e8be-e162891202c4","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cd19d0a4-b9fe-15e1-0143-a3de4c9389e9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/0fdbb238-844c-4af2-6ab3-3cc2f435d434"},"effectiveDateTime":"2017-08-18T23:46:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"35b4b79c-aed3-4776-13d5-5335ecd946f8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/ca60c32f-16fd-463a-1ef9-60b0c83fcb89"},"context":{"reference":"Encounter/0a565961-ff9e-0e28-f799-fac57e32d9ac"},"effectiveDateTime":"2024-04-09T01:44:32-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"9cbf2622-dbdb-5535-ec73-29423d300e62","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/caa87fd8-9f6b-1aac-b8d0-75a329eb27ec"},"context":{"reference":"Encounter/d2a3850b-19b1-dc86-8fd6-e6b1300e9c3d"},"effectiveDateTime":"2019-04-10T16:14:12-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"66dab1b7-15b3-e83b-5577-1edbd10fcbf1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/eaaac768-c854-6d56-1f79-6cf67eaed7b6"},"context":{"reference":"Encounter/3fee5353-1b73-a06f-c8f0-1a594c334c5f"},"effectiveDateTime":"2016-10-18T11:32:29-07:00","reasonReference":[{"reference":"Condition/25911759-f3e1-422e-f861-d9098604689f","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2e4948d7-6c8f-bf25-70e6-7c7493a17f98","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/70261804-a29d-7359-1581-bfc400522dd7"},"effectiveDateTime":"2017-08-22T02:10:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bc508620-3bde-f825-4003-0d5465b23238","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/33f9b5b8-da51-8bbf-cec1-500a15654984"},"effectiveDateTime":"2017-08-25T04:49:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ce96806c-8ca7-a3d1-6c81-eb1e1aad3921","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/b2bd692d-2033-33b5-c890-421cc13ccf3a"},"effectiveDateTime":"2024-06-05T04:02:53-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"d172a3b1-72c1-2173-fb34-ccf50cd60b10","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c2bec559-df8e-c9a5-beb9-e01e5e062c81"},"effectiveDateTime":"2017-08-28T08:33:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ff4c7dcc-f406-3528-242a-745d12a17949","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"807283","display":"Mirena 52 MG Intrauterine System"}],"text":"Mirena 52 MG Intrauterine System"},"subject":{"reference":"Patient/59b304c2-4862-2d8d-c969-16854f805941"},"context":{"reference":"Encounter/fcf10981-2bc5-5d7c-9d87-0d4509d7f9c9"},"effectiveDateTime":"2018-10-13T23:51:15-07:00"}
{"resourceType":"MedicationAdministration","id":"e3126780-d60f-79da-ccaf-b1155c1313ef","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/16706e52-1514-cb39-3e5c-3c46dada7c9c"},"effectiveDateTime":"2017-08-31T10:42:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6e68e25f-e190-b3b5-3f10-2f4b3271fbd2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/bd44e700-5c97-50cc-c860-d69f7a7b7283"},"effectiveDateTime":"2017-09-03T14:30:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4b281e49-62dc-ec8f-fb9b-60e6968e417d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/092ed170-df15-322a-9a07-d66473467a43"},"effectiveDateTime":"2017-09-06T18:20:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"62f0d418-d464-848b-a33a-972acb0cf213","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/59b304c2-4862-2d8d-c969-16854f805941"},"context":{"reference":"Encounter/7c8b3424-8be1-8509-ef02-e2b1d47075ea"},"effectiveDateTime":"2019-10-04T02:51:18-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"6c2b0428-772e-7a4d-df6d-a15c2c9497f5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5acd0e73-256f-f3cb-268b-4013bfc0e8e1"},"effectiveDateTime":"2017-09-09T22:09:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"618188f9-4c9c-03b5-3228-d5e7a91e41d2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/a5ca55ab-2cc8-2705-cc08-52e2bce0088a"},"effectiveDateTime":"2017-09-13T01:35:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4f3a8ae1-1b8f-7a7b-38d8-768ed2d31490","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8af7fa57-190e-b91a-e6c0-90f85726de02"},"effectiveDateTime":"2017-09-16T04:25:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fbcb3060-0f4c-1d75-cad0-fa7c311927ea","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/716811d3-f13b-3d22-d5ac-0c14fd426b7a"},"effectiveDateTime":"2017-09-19T06:45:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a5b31574-6d4d-e285-8de4-7bf9a7b56d77","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ee7efddf-deed-0a1d-3703-7b48ff33d311"},"effectiveDateTime":"2017-09-22T09:47:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e9d4b2e5-6abf-fa75-b34c-fba5de0297a9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ea78efdd-4cf4-2061-6b79-36bbd4778a90"},"effectiveDateTime":"2017-09-25T12:18:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"21cf540f-6857-e421-c849-02d723664c74","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/21ff9137-fb87-8dbb-1162-8bedacc96fe3"},"effectiveDateTime":"2017-09-28T14:43:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"028cb442-774e-4e9a-37d8-471a3f09ffad","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/caa87fd8-9f6b-1aac-b8d0-75a329eb27ec"},"context":{"reference":"Encounter/5fea246e-89be-7deb-4e9a-406b85452a20"},"effectiveDateTime":"2022-04-27T16:38:13-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"a7b56363-4636-be3e-e4cc-56014d6ae811","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/9d7fa382-a883-5fd2-923b-0443175cf6d2"},"effectiveDateTime":"2017-10-01T16:46:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d391a0c1-79a6-d32c-2909-c8d198c3115f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c7e09f54-7b6e-4be9-4df3-76389dbc6d84"},"context":{"reference":"Encounter/5e62bfbb-9e25-4bf3-3dad-bd5f1cfff5c1"},"effectiveDateTime":"2020-09-29T13:47:34-07:00","reasonReference":[{"reference":"Condition/311c7246-b2f2-6b73-0c78-c0f197dd64f6","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e369d5e3-4935-c7dd-ceda-705e1d7b177b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/7b74a345-809e-b39d-6b81-c4a77aec5606"},"effectiveDateTime":"2024-10-30T01:25:08-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"4a039e47-071a-5358-07a7-4014118f22ae","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4130cda1-f413-c70d-ab92-9a46bc8b9a9f"},"effectiveDateTime":"2017-10-04T19:21:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bfe776c7-ec91-7ca8-a986-4236861516bd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5ea0516d-a286-52fe-697c-fb5eb931fd13"},"effectiveDateTime":"2017-10-07T21:48:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0397504b-15cc-faef-be7c-274c7c523556","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7cc43c44-f300-de68-f29f-14d8dc0591c8"},"effectiveDateTime":"2017-10-11T00:42:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5100cc93-099d-3ba5-21a8-198b67ff51c2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8732bb95-1041-97f1-6269-0dfe07f16fc1"},"effectiveDateTime":"2017-10-14T03:47:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4fb19661-dd35-5e35-a838-6c69115f3173","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/a78ec52f-f411-2073-8d47-b06b5c3969f1"},"effectiveDateTime":"2017-10-17T07:26:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9bbcd71b-868e-699a-038f-f54597f4eed5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3e64dc11-1eae-ca75-b573-083e10ddf6f0"},"effectiveDateTime":"2017-10-20T10:29:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"af1be723-4331-695f-4c4f-d4b04d51dca2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/04688c9f-97fd-da28-be51-f7ff47ef62a9"},"effectiveDateTime":"2017-10-23T12:54:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"445a0d02-34e4-cefc-a597-1d82c8a52e71","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1605257","display":"Liletta 52 MG Intrauterine System"}],"text":"Liletta 52 MG Intrauterine System"},"subject":{"reference":"Patient/59b304c2-4862-2d8d-c969-16854f805941"},"context":{"reference":"Encounter/b04fc526-c4c2-1c0e-3958-a88f1fbed379"},"effectiveDateTime":"2023-09-20T11:55:16-07:00"}
{"resourceType":"MedicationAdministration","id":"24fb9616-384e-5299-eb38-f8180558c768","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e4681465-a363-369e-518e-c6156814b2ca"},"effectiveDateTime":"2017-10-26T15:38:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"72679ab1-7500-cb67-1f3c-3af50f15b507","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ed062a2f-dd85-caa2-103c-63770f99ad8a"},"effectiveDateTime":"2017-10-29T19:01:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7bf82b0b-e4c3-d4ee-c6a9-0db7326b5cb4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c7e09f54-7b6e-4be9-4df3-76389dbc6d84"},"context":{"reference":"Encounter/4d953046-c115-7ed7-43b7-b6cbcc152448"},"effectiveDateTime":"2021-10-05T14:02:40-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"6b67d226-8fe8-9251-dbdb-14c3c3e22e0e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/48d652f2-6a0f-a821-596e-580cf318f365"},"effectiveDateTime":"2017-11-01T21:40:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"69d9e753-cd87-3b40-dea9-ddf70469084a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/dbc34191-f9ea-43e3-8d2d-9a03936f7a99"},"effectiveDateTime":"2017-11-05T01:11:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"275f1af3-b60f-79e0-10ff-28caee9313f5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/1dd5291e-c873-cf80-d2a3-b5f1164c12ab"},"effectiveDateTime":"2017-11-08T04:04:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"77c756ef-868e-5e1a-dfd2-d997c7f4e354","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/39f4859f-ccbd-e822-5ac1-7d8d8c75dd29"},"effectiveDateTime":"2017-11-11T07:06:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"72e86090-5d45-9e8b-f822-c8a402c0fff1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f4658a02-dca7-9b65-b7d8-4c2bb85871d4"},"effectiveDateTime":"2017-11-14T10:56:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2d6929d4-6fe4-d559-ab29-9d170d18e339","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/54bed0d2-75e0-a08b-9c95-1abaf3224a0d"},"effectiveDateTime":"2017-11-17T14:30:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f0f59591-bcd5-2117-8971-fa3ce8d9f8f8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/c7e09f54-7b6e-4be9-4df3-76389dbc6d84"},"context":{"reference":"Encounter/6932d9d5-6190-839e-76fd-bad6214be08a"},"effectiveDateTime":"2022-10-11T13:46:45-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"04998fe9-c68d-8837-6cbd-4d44a7f40d71","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/401add1e-539c-d81c-0d63-727ef15cf849"},"effectiveDateTime":"2017-11-20T16:56:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d38d5aeb-16a8-e6eb-ff69-6a3c7d2e2153","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/740f1d95-9edf-7110-afda-ac86acf89b39"},"effectiveDateTime":"2017-11-23T20:37:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1c7a774e-a936-5ec7-1904-a56a985cf84d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/487f85f2-5517-1426-ca01-10e9c27b17b0"},"context":{"reference":"Encounter/3cf219da-5a58-6285-58ec-d45a9b3ecde0"},"effectiveDateTime":"2025-03-09T14:21:32-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"c23ebcef-cd6e-3862-c972-e6c30f0e2479","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/02f207d9-a343-bcd4-2de5-32dbdf46a414"},"effectiveDateTime":"2017-11-27T00:24:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"18705fa5-e8f2-a99b-7ef5-9a0e24f0aa8c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/cf9e1732-ecd7-0354-5b1c-551ee85766b5"},"effectiveDateTime":"2017-11-30T02:59:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b3b978b2-8f4b-e193-8441-a6367118ec08","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5cabc759-2f87-dc79-92b6-16375d64dbf1"},"effectiveDateTime":"2017-12-03T06:27:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"34ae269e-8e4b-778b-3b5e-436f35988112","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7cb6919f-13bb-f6d8-c0cb-7545e5ccb41e"},"effectiveDateTime":"2017-12-06T10:14:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a685822a-685d-9dff-9c16-895e9230e0a2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c7e5f2cc-afdd-f0e9-4219-afbddd2bb7b6"},"effectiveDateTime":"2017-12-09T14:12:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ebf90b57-a19a-0488-8d6a-b988a5341972","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d36994e0-1af8-3644-c2e6-dffc05f03be8"},"effectiveDateTime":"2017-12-12T17:14:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"edada9f4-02b8-7ca9-3c47-c30e901cb64b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6b997dea-55a3-8494-83d0-68d20e913c0d"},"effectiveDateTime":"2017-12-15T19:45:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"887eac54-c928-c3b5-9ee6-fffb4ff1684e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7f8c06b8-11c8-d378-665f-bfbd9e30d7ad"},"effectiveDateTime":"2017-12-18T23:29:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"84ea76d3-5f5d-ff89-99d4-18a5ab720323","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/0b665452-3610-f4f0-008c-055606071604"},"effectiveDateTime":"2017-12-22T02:22:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e41c41e-314d-49df-3820-7b746e57b334","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/0c414a1d-4ec0-12a1-8974-021822f13a0a"},"effectiveDateTime":"2025-02-25T23:39:25-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f47ec195-7226-53db-931c-052f870ff5ce","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/896428c6-2078-eb48-d32e-b3bf996c6992"},"effectiveDateTime":"2017-12-25T05:41:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4023075f-5151-4bd1-01f6-eeda2f4c7fc5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/851cad12-f0f6-4d69-519d-52139fb26dc4"},"effectiveDateTime":"2025-04-30T00:55:44-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"811a9dc0-0ec0-1021-d4c1-260a9fbc2689","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/51f6f53d-e37e-e430-eec9-d84b3ed152da"},"effectiveDateTime":"2017-12-28T08:18:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dccc1511-94c9-9751-011e-0a02c3331f95","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2fce4c06-154c-c490-3f64-117578f90849"},"context":{"reference":"Encounter/736dc875-a4e7-a7b3-0535-18a0b1bc0b14"},"effectiveDateTime":"2015-08-25T04:30:03-07:00","reasonReference":[{"reference":"Condition/f71a97ba-1b5b-221b-4e4c-c78ea52727c5","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5fa1ca44-c240-84e6-e33b-df2e6473309b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/951f9165-bdc0-cc64-3d21-ad47a09b10b9"},"effectiveDateTime":"2017-12-31T10:56:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6c6f9b6e-f247-e3bd-dfb2-38a33c9c747d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/bc17641d-2484-87dc-94f2-eb48fda08d9e"},"effectiveDateTime":"2018-01-03T13:26:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"26948222-2871-c472-fb10-895652450957","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f7f0651b-ffde-d82d-3008-66a2b4e165a1"},"effectiveDateTime":"2018-01-06T16:38:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9b623685-218c-9f0c-2854-5355c8d9b3a2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4ffbc60e-0a6f-36e5-3c3a-23a6aa31936d"},"effectiveDateTime":"2018-01-09T18:41:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"77db9e46-fc87-ff8b-c87f-201406fcd0e4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c081b35a-a110-5d7e-bd09-2414f9460f8f"},"effectiveDateTime":"2018-01-12T21:06:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2b25b915-cac2-91a7-658e-6dd2bed3f82c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/495b8f58-f293-e342-5b36-6cc4601de84b"},"effectiveDateTime":"2018-01-16T00:25:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6aba165a-7dbc-3522-99e6-9676b75d83bc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/65259e85-6b1e-519f-d98c-af186f0cf03d"},"effectiveDateTime":"2018-01-19T02:35:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"341d336b-6ffe-5ff6-0127-a83cf94d63f8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d1a56298-b589-d072-623c-8cb5253fad01"},"effectiveDateTime":"2018-01-22T04:46:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"10549cfa-b2aa-f4f5-fc1c-d69c01452823","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/a103e201-734e-e797-aaa9-88a3fc0ead8e"},"effectiveDateTime":"2018-01-25T08:04:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ae4f9880-6120-67c0-f01c-a2f532ca17f3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/0e560ce6-50fc-d643-4eec-f0fe00f7f788"},"effectiveDateTime":"2018-01-28T11:40:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"775f0848-1fba-ea3f-bf48-1eb07361780d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e3e248ba-e5a4-1268-09d2-2c12e870d950"},"effectiveDateTime":"2018-01-31T14:41:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"97a969ef-49f9-ebdc-c2f9-dd31e72e5e47","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3d7f6245-fcaa-7fd6-125c-d17512adddd5"},"effectiveDateTime":"2018-02-03T16:44:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"edadf05b-4237-3d4f-3514-9107c96b6723","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/740ecdcf-9284-260d-59f9-47aeb5abab88"},"effectiveDateTime":"2018-02-06T19:13:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cbe47d17-a629-2637-1ed4-b6b8f4c36373","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/40681076-ac84-f209-91c0-ed56133621cc"},"effectiveDateTime":"2018-02-09T22:42:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9423c139-0462-92d3-ce8c-be256ea3f958","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/fcc16815-4880-d9ad-9a62-26f27a753297"},"effectiveDateTime":"2018-02-13T01:14:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5e73ea60-d71e-0828-b21a-7aaea54a1e90","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/0cac3358-1862-39ca-ee0c-f3c0a1ab8396"},"effectiveDateTime":"2018-02-16T03:14:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"144c7caa-bd76-102e-67f3-0d7ae4c62696","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d10d1412-07ec-4328-a309-ddd7d298c7bd"},"effectiveDateTime":"2018-02-19T07:10:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b8ec94f8-366c-0213-e2bf-dda079f68947","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7b05e4a1-83df-d6ed-224d-25a5d6ccf812"},"effectiveDateTime":"2018-02-22T09:57:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"03adbb1a-5e21-ecb8-d6f6-a3064ba920e1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/b355bd8e-730a-d8a9-2c50-e04c1ef149b2"},"effectiveDateTime":"2018-02-25T12:07:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9c457d6f-e0e1-68c1-397a-0fe6dbf9dc04","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ffc914ce-3370-e2d2-c62d-36b3c82bea23"},"effectiveDateTime":"2018-02-28T14:07:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"258f5f4a-be3d-e7af-0d74-6117c8b2ba09","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/25c4b49f-0d60-31a1-5b0b-b197ec91d9d8"},"effectiveDateTime":"2018-03-03T16:54:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"abdf5918-1cd7-cc63-7fc6-d3f70252f289","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1c99c119-e910-3edd-8328-9cd2487e72be"},"context":{"reference":"Encounter/d13224e2-49da-bfe7-eeb4-ad837c514d33"},"effectiveDateTime":"2025-07-30T00:33:33-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"7fc47d06-ea56-a71f-4bb0-b6a838f0f45d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ba38b058-3ae7-116f-0a60-9780771da76e"},"effectiveDateTime":"2018-03-06T19:35:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"db86bb68-f822-7e43-e5fb-8de3095de010","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/daf82406-607a-85e6-bd8f-e202e275f803"},"effectiveDateTime":"2018-03-09T22:47:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cbf25668-7c8f-7c72-b597-6a7174531687","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7acb74a8-f78c-4209-12dc-9cf0fd664e01"},"effectiveDateTime":"2018-03-13T02:07:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c23f3673-4d5a-825a-4973-604697c32e60","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8c8c2b0b-9f7f-b5b1-e217-a7126a816ac7"},"effectiveDateTime":"2018-03-16T05:23:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d133bbf0-e414-a77a-7282-564629b1a3b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/614a4ab9-2c98-a663-a625-fbcd4c2e8003"},"effectiveDateTime":"2018-03-19T07:59:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9915eb7c-dd29-7bd7-0169-9212ae40b7e6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c8bccb9e-51d0-9542-87b3-ff85fe551de4"},"effectiveDateTime":"2018-03-22T10:22:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"37251f7a-1dd6-eb67-53f5-c6c74a7c060d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ef2519f3-099d-3aed-41ff-6c0225eb403a"},"effectiveDateTime":"2018-03-25T13:47:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"26911042-fdfc-fceb-f70f-26ab51a393bf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f2f6e525-2f90-34cd-4bec-335d3e8caeb0"},"effectiveDateTime":"2018-03-28T17:40:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"78dc3a12-9d74-03db-d632-5aaed7155275","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/02e3a4d8-738b-bfda-7a85-e9700ec1ee21"},"effectiveDateTime":"2018-03-31T20:39:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fbf3ee8b-599b-be2c-9653-44ae2dd55f7b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6c7b3ff2-18ad-11e5-e430-2e2d59cab470"},"effectiveDateTime":"2018-04-03T23:13:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"66a4a833-ccf7-6af1-00b9-91d9e2a124f5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/04bced04-383b-2c8e-6848-46aaa11eb89f"},"effectiveDateTime":"2018-04-07T02:26:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"10bbb212-f64f-ede9-b754-883de95e563c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ad96c5f9-722f-4488-5df4-10ce4b829d33"},"effectiveDateTime":"2018-04-10T04:43:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"13db6233-604f-e02a-ba74-b7d3b85e487d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/59e0b409-7b5c-e5e7-e58a-ab411d04e8de"},"effectiveDateTime":"2018-04-13T06:58:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"71664b53-7221-af25-b403-802231785f98","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3adea1db-383a-7d01-7863-c3623c2f73dc"},"effectiveDateTime":"2018-04-16T10:52:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ad20e181-01fe-4f65-efbe-1653d20ec7d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c089f410-6cb6-3257-9bda-27cdf1ced85b"},"effectiveDateTime":"2018-04-19T14:39:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6c439dd1-ec7b-e4fd-df86-3b06c3451c15","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d6e42ab1-1e42-8f2e-ebce-65add751fd18"},"effectiveDateTime":"2018-04-22T16:43:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4da60b7a-ce97-f5f4-09ad-3fa4a1e5a27d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/9ea5396b-ee3f-50f2-cea8-d4d46dcabd41"},"effectiveDateTime":"2018-04-25T19:14:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d23bda31-c4b5-dfad-1f73-8ae79ad2b055","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/a80404ca-d726-7141-d069-aedb70e4e9df"},"effectiveDateTime":"2018-04-28T21:23:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c646d62a-1811-61e3-4d7a-fffd663dca38","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4f0d1f38-4380-5e15-9cc6-751a0a96c718"},"effectiveDateTime":"2018-05-02T00:13:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9f3a9b57-3aed-d1df-3a7f-c9d907f846b3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/76efca88-23f9-fff8-c48c-347037b1ceb1"},"effectiveDateTime":"2018-05-05T03:34:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c17683ca-9dc7-6caf-36e7-6932d768bb4a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/87896219-dd2f-59b2-519b-b5f895fd211d"},"effectiveDateTime":"2018-05-08T07:20:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3ccd99e0-54b6-67b5-0d74-e71c106d2dd2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/320e50d2-13e4-0546-512f-a5fe45ec75e3"},"effectiveDateTime":"2018-05-11T10:51:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3609b0e7-602e-472c-77e0-651005eb57ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/b574e64f-3c3b-3026-ccff-4ae98f074223"},"context":{"reference":"Encounter/67635972-8739-a414-40bb-3031878d9fef"},"effectiveDateTime":"2023-12-18T07:05:05-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"9e4f8471-36cc-9869-db0d-94e9539d3fb6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/78b5eb56-8d97-e22a-bd18-9daafe0c4676"},"effectiveDateTime":"2018-05-14T14:06:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"29c9dabd-d203-1205-6433-c8ade974788a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/34ff3ded-d676-f885-d239-f202691d400b"},"effectiveDateTime":"2018-05-17T16:39:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f6fa5b4b-15e8-e394-ecf1-596c7c6e1dfe","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d834388e-ddb3-4534-a6a1-9a6d444bacfc"},"effectiveDateTime":"2018-05-20T19:28:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6ac10841-85cb-29fe-490e-1ea9d971c9de","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e4e01b2b-c545-787f-b3af-09c2343351a7"},"effectiveDateTime":"2018-05-23T22:17:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c28472fe-8b21-f769-95d4-a30048292b93","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/b6216b8a-45d4-a54d-8324-717312b654e5"},"effectiveDateTime":"2018-05-27T00:56:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7a6b8227-b7b7-a4bc-9a14-895be18af52d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e617d425-f344-4614-61c3-c3841ecaea5e"},"effectiveDateTime":"2018-05-30T04:48:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"67a22687-5450-d52b-c3ce-4357fb9e17f2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8a241d28-d6c1-e655-b7b3-52dd29b9c232"},"effectiveDateTime":"2018-06-02T08:12:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2f508caf-0e12-dd65-b11d-9723e24f7085","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/0dcb7e58-f4e6-dfdd-8339-0afef363dd25"},"effectiveDateTime":"2018-06-05T11:18:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e45529ed-abf2-ff44-eec9-fe3a32540111","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/2ca01ac2-ff9f-4c0a-218e-091324973016"},"effectiveDateTime":"2018-06-08T13:38:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ea9b47f5-6b46-ae0d-01be-7ecdde894b43","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3302adb3-7f63-43a2-0f83-0ce03d1e9585"},"effectiveDateTime":"2018-06-11T16:19:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"03c2b0b0-4f4e-21a5-d82f-405c911b2c19","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6b30dd54-b1fb-56e5-a6eb-01ff4407db12"},"effectiveDateTime":"2018-06-14T18:56:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e5de77a-462e-f04f-904f-e0ddcd631a22","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3853af84-f167-4f72-3ee9-211e9989eb13"},"effectiveDateTime":"2018-06-17T21:11:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c23c0afc-d4e7-94ae-4970-34d02719c8f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/2bcbbcf1-f355-8a81-ed49-c287d6e9f10e"},"effectiveDateTime":"2018-06-21T00:01:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"de2f9a23-0a47-3e66-5304-36ab98c90b71","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c685f3de-b5ce-049c-634c-5c43c8cdd248"},"effectiveDateTime":"2018-06-24T02:30:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"559bfca9-2276-bace-2dd5-9df7bd0c52c0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d4865ff9-23e7-82b9-f80a-d1a076321fb8"},"effectiveDateTime":"2018-06-27T06:04:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cc456a97-f431-4de5-006f-3deae7790ded","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/fb4a43a0-669e-f0db-05fc-deeb96d0bd73"},"effectiveDateTime":"2018-06-30T08:58:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8f93a264-4e4e-0d1d-6460-830c101b1792","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/90f80ef4-d895-e291-5a46-6f8b6cc6ba66"},"effectiveDateTime":"2018-07-03T11:48:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"888af5ac-bba9-688f-9ef3-495362923475","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e2dc937a-c767-42e7-38d5-48890f70ea32"},"effectiveDateTime":"2018-07-06T15:24:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"39480648-c89a-ae52-cf5e-6e9c6f4217bf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d06ab3c2-26da-34b9-78a2-5ed5021258ce"},"effectiveDateTime":"2018-07-09T18:20:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a6f9056a-28a5-bda0-f448-dc392ec28e47","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d9b91b24-73ec-70ad-419d-0539aa12653f"},"effectiveDateTime":"2018-07-12T22:03:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8d0bc0fc-7016-24db-a7f3-815cb3e301b6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1cd303e1-b284-5fe6-2e6d-d2a2a2e36e97"},"context":{"reference":"Encounter/232c0075-f126-b270-731a-26a7b45cf84b"},"effectiveDateTime":"2018-03-04T12:36:22-08:00","reasonReference":[{"reference":"Condition/8388a8d9-8538-47de-87a8-8603c997a8f1","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bc43da38-0a03-1207-f6ae-7fc8cc34788c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f45cc6b5-76e3-a643-05a4-172d746cbe28"},"effectiveDateTime":"2018-07-28T00:11:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"23c818ed-2c63-1f0b-a902-839ab0d22071","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/bfedc1a8-5623-8a80-ead9-6354ba1e24c3"},"effectiveDateTime":"2018-07-31T02:18:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"451ba76e-3260-818c-5a05-524416794526","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/15cab63b-6817-f037-dca4-98e178cf2d71"},"effectiveDateTime":"2018-08-03T04:27:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"59108561-ea6d-884d-c553-81691e975ba4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7926b6c2-1910-87d4-e050-a00722aa49cc"},"effectiveDateTime":"2018-08-24T22:58:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9a70a765-f606-0d7e-6757-67d938a342f9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c0569a41-c683-2964-a923-febee690f37d"},"effectiveDateTime":"2018-08-28T02:10:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f418a622-9d94-5817-b37b-54eed735a6b2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ed1fb3f9-0570-b00b-00ce-e978fd33bb74"},"effectiveDateTime":"2018-08-31T04:11:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4b1b649b-d4d9-0219-74ee-bcc83d49094d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c3b3b401-dc4d-3874-aa0c-e14782c1adbb"},"effectiveDateTime":"2018-09-03T06:50:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0b2b11d1-448d-6915-8dea-935253c2b5a3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1cd303e1-b284-5fe6-2e6d-d2a2a2e36e97"},"context":{"reference":"Encounter/c134cfdb-05ee-63e0-20c2-333f85536073"},"effectiveDateTime":"2022-03-13T12:58:19-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"ce9a6797-fd24-21e5-02c4-3af06a59eced","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7293cde1-f1cf-e953-385c-e8263806683d"},"effectiveDateTime":"2018-09-06T10:20:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9ce79d8a-9679-7c9a-b2b1-2a0bfcfeb705","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f320a576-ce6f-0ace-d050-fb27f4b6a3de"},"effectiveDateTime":"2018-09-09T14:10:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6bf8b766-771d-5078-5d1f-77d9b9ba8607","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/597d57f4-b636-6e94-c798-06226b957584"},"effectiveDateTime":"2018-09-12T17:38:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fd648f52-8e1e-ff24-4001-c4e591d44798","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8e66e234-9668-c5a8-b3a4-38420f9118d8"},"effectiveDateTime":"2018-09-15T21:33:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9f280099-36b6-7744-04e8-79d753871e92","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/51d19c75-eb6e-e31d-c831-6fcc2ebef024"},"effectiveDateTime":"2018-09-18T23:59:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"848038c9-4239-8ced-de31-0e7ac96db6c0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/609ef764-62e8-30ee-4ed0-776681e156eb"},"effectiveDateTime":"2018-09-22T03:23:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ba7fa13e-54de-d79a-5bce-3c0de3397fd4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7765627c-d179-063d-8d2f-311d4355f835"},"effectiveDateTime":"2018-09-25T07:04:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bbc5a8ae-886a-7625-702a-22f39ed2c9cc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8cea90f9-8fe7-645e-02d0-15dfdee137e1"},"effectiveDateTime":"2018-09-28T10:09:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6c47444d-7e6e-97fd-df89-e183259024a5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/0825075a-414b-b6c6-8421-c305588f9309"},"effectiveDateTime":"2018-10-01T12:33:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"17d181fe-2d83-c1d4-1455-1c1317311b07","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6a5e68c5-ec08-400c-8e2c-d7f042042790"},"effectiveDateTime":"2018-10-04T15:28:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6d49ee8c-86e7-63c0-cc61-6ff30c21cf1e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/077c1589-040e-f71f-5c40-cbe294c7032e"},"effectiveDateTime":"2018-10-07T18:42:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"66b624c1-9b9e-949e-4ad2-f568e90b5ee8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/102af086-f433-4239-ba01-322ea85f2d8a"},"effectiveDateTime":"2018-10-10T20:48:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ab796a50-8260-78f5-1211-dd931f96301f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/52f3d5dc-18e2-df8b-a510-e01a966834ec"},"effectiveDateTime":"2018-10-13T23:23:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3fa1dbbe-cf4d-b84f-168e-ad5cf11ac2c4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/0d057b3f-06f5-8eac-fe38-f43bcc73468b"},"effectiveDateTime":"2018-10-17T02:45:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9334bfc5-26df-75a0-0304-c5d543b01cee","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ac8569b5-2cf3-df8f-221e-6b46dee799a6"},"effectiveDateTime":"2018-10-20T06:10:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"33cd1e48-8065-a11d-3096-60158ada782a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/0193a8e6-3532-c12d-847d-68fab4832949"},"effectiveDateTime":"2018-10-23T08:40:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ef518e22-71dc-4194-711e-989748f98b57","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/bb7c615f-189f-f38b-4465-02145075c166"},"effectiveDateTime":"2018-10-26T12:38:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"da8ff3d6-ecd3-818a-ef79-a23196750524","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/362ac360-6f16-67cb-ed45-f9d7340bccae"},"effectiveDateTime":"2018-10-29T15:24:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"61a155b5-d3de-1652-253b-6a9f82588ea7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/147943fd-35b9-c075-bf11-7419663fce91"},"effectiveDateTime":"2018-11-01T17:31:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f6518228-38ce-6d95-4679-095c62a1cacb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d85c7476-85b9-b61e-92fb-d9f911f09977"},"effectiveDateTime":"2018-11-04T19:31:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d06bc815-0cfc-7fe1-0495-9b72831a0269","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/9e1a1775-95d9-dd65-7ef1-698ac8d4bfad"},"effectiveDateTime":"2018-11-07T23:01:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1962e4a3-2e1c-0213-4336-425a36458947","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8078bd6e-dae3-0e29-eec9-a7b5d3dc9632"},"effectiveDateTime":"2018-11-11T02:39:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7ffe8d89-9e25-ecb4-535c-8557cfad20de","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/fdca9906-c683-1861-5542-a5ad62077403"},"effectiveDateTime":"2018-11-14T06:07:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2d9c549f-4779-49ee-f1d5-f5ede26b0861","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ebf78302-fd34-5a08-6939-821b9363e5d2"},"effectiveDateTime":"2018-11-17T08:41:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8db49ce8-abf8-f62c-6608-d689fa93e9f4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5aa17083-c8cc-e69a-4c19-36b64066293b"},"effectiveDateTime":"2018-11-20T12:37:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8b99537a-fcf6-106c-5440-f3b49e44ab62","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/55087495-32a0-58b5-40b5-1352930c30e8"},"effectiveDateTime":"2018-11-23T15:18:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dc410ed7-cadc-1f9d-d038-f1e6332fc65b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/1de415a4-9dde-8bd9-09e1-db38e91b4420"},"effectiveDateTime":"2018-11-26T18:55:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9f2d9cca-a19d-1a71-4eca-729e65372f5b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/a5f72f48-8e9a-7453-3cef-1c503c2603df"},"effectiveDateTime":"2018-11-29T21:07:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"907f790b-de5e-10d5-a6e7-ccb29d538e03","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/314b8b6d-c1c3-80cc-7775-c3baf3428913"},"effectiveDateTime":"2018-12-03T00:56:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d9f9d255-d4b5-e7cb-2778-c059aad2b873","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c491532e-6f3c-e3d7-987d-dcfd4f4167b5"},"effectiveDateTime":"2018-12-06T04:23:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4bfa3681-2197-319b-fbf8-582b25314684","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/28d4f26b-c039-6bfc-575a-3ca6a4a8fb3e"},"effectiveDateTime":"2018-12-09T07:50:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e5a32ea5-6afc-6f03-e973-c465de3f0c39","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/daed1577-4152-e684-0adc-8ac6277eabb0"},"effectiveDateTime":"2018-12-12T11:18:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6c11563b-83b3-1b8d-df53-f3718b7e377d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6f0336ec-8771-6098-2da4-c0d5ce3a55e2"},"effectiveDateTime":"2018-12-15T13:28:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e975ddcc-3ea1-28fc-86ab-e9a1abb99c3f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/a0501a30-288f-d697-c8e0-7008a78dd786"},"effectiveDateTime":"2018-12-18T16:47:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fd7e4997-3769-33a5-3d05-7ff90473a87e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f07fc53d-b1a7-ec3c-93d2-b7b56958eca4"},"effectiveDateTime":"2018-12-21T20:15:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"164636a0-ca7a-3bd7-7476-537171c7c0ce","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4facbebf-402c-6ad8-a3f9-14d0f3bd78b4"},"effectiveDateTime":"2018-12-24T22:30:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a218df49-af1d-41e1-31b0-2116b9921a41","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ea8ba963-35fc-99eb-50cf-2c50198380cc"},"effectiveDateTime":"2018-12-28T01:32:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"aa50b358-bba8-fe44-b4c5-8bc89664c011","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e2d2f1c0-0d58-63af-2c73-83660a0bcac1"},"effectiveDateTime":"2018-12-31T05:28:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"abad700c-9128-c05d-ebf7-cf1f54a79bdb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/099e8a45-0bee-ee04-c71c-9d3957a4aa65"},"context":{"reference":"Encounter/58adebcc-9f50-b50e-07aa-e1892f35290c"},"effectiveDateTime":"2019-06-25T23:31:18-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"8be38882-b327-79c7-c203-826a639abc64","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/73722386-2d38-e0ef-9f7a-f8e37e647cd8"},"effectiveDateTime":"2019-01-03T08:16:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"56caf150-ec35-21dd-4e22-cdbb41d54933","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/25da61f8-f4f0-8c39-1019-8ed65c89bbe7"},"context":{"reference":"Encounter/6f399712-252e-d7ee-4b2c-9b6846d81ea7"},"effectiveDateTime":"2018-04-08T08:16:15-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"28cfa106-dc57-55a7-3dde-e70a243d99f0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/513245f1-2f38-f3e5-6195-c8a0c04e2ee7"},"context":{"reference":"Encounter/aebc5afe-da01-2a5e-c6e4-cf4856eafa53"},"effectiveDateTime":"2023-09-01T11:39:01-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"d10626a1-ebbc-9318-c1f0-4372930a1c19","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3a7cd553-0594-4281-6278-ab5a6cfc49a7"},"effectiveDateTime":"2019-01-06T11:33:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d847fa37-1327-7ee5-0e70-0f644b9ac183","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5eb96c58-3048-eda0-5c12-b49f261a1e62"},"effectiveDateTime":"2019-01-09T15:23:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"66ed344e-fc91-f8ef-0102-1e005d39b173","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/9f0af13c-72b7-5e7b-0406-a20887031deb"},"effectiveDateTime":"2019-01-12T17:56:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"64af6765-cdfa-e877-7e3e-c7d910981ea7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/62738712-055d-c088-6b68-d2ac9dbbd9f4"},"effectiveDateTime":"2019-01-15T20:50:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6cead60a-7dc4-413b-86fe-0892b7658fd6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/76e81093-3ee5-5acf-6a13-5eff5f6b2512"},"effectiveDateTime":"2019-01-19T00:20:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dc7294d9-3b90-8ef7-79b3-fb5e75fcff67","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e83426a6-d9c5-c60c-5732-e4b0e15e762e"},"effectiveDateTime":"2019-01-22T04:10:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1a55b656-f4c2-91b6-54c2-2ee79063f83b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e6ad1d74-4fe8-f25b-084a-2c5f84f50c6f"},"effectiveDateTime":"2019-01-25T07:56:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9149e456-3a0c-19cf-928d-f79807168ea8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4f470d45-6219-6d29-b3a6-3aa0be4f41d0"},"effectiveDateTime":"2019-01-28T11:08:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d4221b9b-33d3-9af4-027c-dfd4d5223617","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/07a11bd6-8e00-1f57-dc23-ed607c19e7d8"},"effectiveDateTime":"2019-01-31T14:33:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d93b49d3-e94a-0605-6f9b-c80e13cf4ecb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/8bf515e5-4028-66bb-168b-452784047e70"},"context":{"reference":"Encounter/130be622-6420-a910-1b19-6adbd90e30f1"},"effectiveDateTime":"2015-04-27T12:16:28-07:00"}
{"resourceType":"MedicationAdministration","id":"36d60b1b-c616-8337-03e0-7ff4e77546d9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/bc4c47e9-6690-1cd5-73d7-2b62272a6644"},"effectiveDateTime":"2019-02-03T16:45:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3fa969ed-a7c2-7cb8-d599-dd3044f8c91e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/96ce8d1d-5111-f080-06a7-f7de1e343a0e"},"effectiveDateTime":"2019-02-06T20:24:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ecf5aa9c-0951-5e8a-7230-173cdc798ff1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/758bbde7-f3f1-7ebf-1914-7867c049eba9"},"effectiveDateTime":"2019-02-09T23:11:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"79bd0839-97b1-db51-6442-1ea1eb58a5e0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6b558d97-41bf-07f4-e85a-b75698f872dc"},"effectiveDateTime":"2019-02-13T02:45:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bd27658d-aad6-5c4c-6921-231c06579c9b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/25da61f8-f4f0-8c39-1019-8ed65c89bbe7"},"context":{"reference":"Encounter/920e8f9c-3217-d550-f229-df14be93582e"},"effectiveDateTime":"2024-04-14T08:12:06-07:00","reasonReference":[{"reference":"Condition/9d8963cf-ba97-a50f-49c1-5b1a8e82452e","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5434c766-69d3-0616-7e08-2ceec9bc8d4a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8bd856e1-35ae-1a3a-d9cb-e5d6d4a8b4fd"},"effectiveDateTime":"2019-02-16T06:23:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0ecd822b-8989-adc1-1020-095fb35d138a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8f486d5e-d931-668b-ce54-79e3330d95b5"},"effectiveDateTime":"2019-02-19T09:41:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bd57f98a-5dfd-0cb2-2c66-61de04c9211d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/69a80672-7bca-c466-9c05-e5fb0bc21939"},"effectiveDateTime":"2019-02-22T13:39:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"745908d6-39a6-908b-072e-bc1806b10565","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8e0a09c3-de89-e3ae-0575-a2e50cc21642"},"effectiveDateTime":"2019-02-25T17:32:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e2741f61-e49a-b2dd-6e5d-af6918c48644","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/24ea71d9-6674-7cac-0adf-ecc58fccbbbd"},"effectiveDateTime":"2019-02-28T20:46:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9de06177-3d32-e576-d781-b0127395109a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/177e4386-8f6e-58cf-0ea0-de0d418ef25b"},"effectiveDateTime":"2019-03-03T23:45:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b2918270-92ed-b1d7-1ae5-293eacc29fe6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3de9797a-7dcf-3e4c-7f7b-453ecce07d20"},"effectiveDateTime":"2019-03-07T03:04:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5b28a4a9-1fe3-204d-bb9b-e74656580148","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/75c78d8a-9c48-6246-4b0f-9255da6bec22"},"effectiveDateTime":"2019-03-10T07:58:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f3a97f36-bb61-68d0-90df-f82a7fe1dc13","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ccde6a25-f238-1c9a-41a1-df2e9a65d979"},"effectiveDateTime":"2019-03-13T11:54:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"55d7d3d6-3910-8913-49eb-a1b8061afded","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6e11ac61-db34-aa17-9bca-e2f850e51ebd"},"effectiveDateTime":"2019-03-16T15:43:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"77809315-26ea-29b5-17c1-ee5b43bad103","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/443f654e-3a36-3146-17e3-761af1d9ef2f"},"effectiveDateTime":"2019-03-19T18:19:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f5c3105c-fdb1-757e-1b76-d4ea1b690a3d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/099e8a45-0bee-ee04-c71c-9d3957a4aa65"},"context":{"reference":"Encounter/9afd3815-aec2-3fae-d8d6-96a383509c5e"},"effectiveDateTime":"2025-07-29T20:12:41-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"4bd77795-e646-3e4c-c0b1-8ba9d7a80b56","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ade1f626-4480-b6f2-adbc-c71eaf0a656f"},"effectiveDateTime":"2019-03-22T20:51:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"931c8ef1-26cc-3994-355e-52f9439ce0e2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7344a098-e0ad-216a-1adc-f474df8c966c"},"effectiveDateTime":"2019-03-25T23:34:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f68cf00f-9a78-7ca1-4528-36998d60b643","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/0c39c66f-3f54-e9ae-153b-b687f2446375"},"effectiveDateTime":"2019-03-29T03:04:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7dfce1b4-a7a3-4156-b79e-304ff032976a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/919e59dc-7aee-b4f0-a380-60c72f594a71"},"effectiveDateTime":"2019-04-01T06:25:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b4ec0aa7-0c81-177a-563a-a5f1998f73b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3e477222-da1d-104f-2e97-5938e4d51a97"},"effectiveDateTime":"2019-04-04T08:39:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4a170784-ded3-0616-73ea-71166e960d4a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/b4627c93-a55c-e92e-f521-5d3a76650f10"},"effectiveDateTime":"2019-04-07T11:08:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ba576773-24c3-0186-cf41-1c5c4dd3c520","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/36268ea3-9a5a-12df-3bf1-dc4d9c08c6f4"},"effectiveDateTime":"2019-04-10T14:35:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"27166d9b-d494-b09f-43e7-14e97ce2d75f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7d09ee92-9de8-f7cb-e55d-c53d0062e7c6"},"effectiveDateTime":"2019-04-13T18:34:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ae15fe30-0b29-75d7-1669-a504b29547e6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3a3b8f38-dd35-f76b-a50d-f74626e5dbe7"},"effectiveDateTime":"2019-04-16T21:20:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c64b1cef-9ebe-381d-cd7f-46c309530bf2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/854d64ac-2763-fbb4-f22e-a83841635d22"},"effectiveDateTime":"2019-04-20T01:12:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0c6c14cf-beb1-de2a-b581-d0de270584ff","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/2ce83f90-f867-1f4e-a040-1dc3a825ad2c"},"effectiveDateTime":"2019-04-23T03:26:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"23517ebc-941f-2cab-2d15-18d17dd4b70c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d27295fa-2563-f9be-a16b-bf17012a5630"},"effectiveDateTime":"2019-04-26T06:15:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ea719f47-6516-f5fa-4aa3-c1146f8bd0d0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d139fddf-85e2-f89f-a798-fae1dfadfaf7"},"effectiveDateTime":"2019-04-29T09:41:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"06b62238-62bc-e383-9cd2-f2dfb06b3b96","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/26fe1853-e0ab-1835-74b4-2317ecd45962"},"effectiveDateTime":"2019-05-02T12:51:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c57c09db-aeef-7462-f1b5-ab2a4a4e2c8e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c6bc09dd-a0e1-a399-84f5-fea976c6c33a"},"effectiveDateTime":"2019-05-05T16:35:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"79b5f950-0687-3bc7-ee90-ff1c762908d1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/33060977-e9c6-a0c3-219d-b4ff47e92801"},"effectiveDateTime":"2019-05-08T19:21:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b712ff10-3743-11e2-f180-8a1c76847867","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4c026c79-1787-642c-14c5-98a087aa9fa7"},"effectiveDateTime":"2019-05-11T23:18:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f0264024-64c3-60b3-a4a8-0d2ed99e86e0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/2f9f3c7f-74b7-6b15-1a4a-2570aa966b2a"},"effectiveDateTime":"2019-05-15T02:14:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5a1e5d48-21a2-3e46-6493-387e34c60013","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/de3cc41b-726c-ef97-b9e7-cb3f250430ca"},"effectiveDateTime":"2019-05-18T04:20:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2e508069-2f8d-d3cd-101d-8ade0ad4312b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ba6733a5-4aa3-131e-f405-32534e662171"},"effectiveDateTime":"2019-05-21T08:15:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"212e861c-0608-1ecd-4daf-0d502fdb8c26","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3213b717-2468-49da-95f8-e1f8b73ba9eb"},"effectiveDateTime":"2019-05-24T10:29:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"38eadb60-de41-292d-d621-b4f7c9699c6f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/befa6d94-6532-cf53-4b74-673bad0a1d38"},"effectiveDateTime":"2019-05-27T13:21:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"07cfe497-378c-795e-7e61-a7190496ee39","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f05af4d8-bcdc-aa0e-ecc2-744ed34b9995"},"effectiveDateTime":"2019-05-30T16:54:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8bd18290-53f7-96a3-be55-1ca53daea42d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e46e2d3c-8dce-edda-1f55-ecc94914e2e1"},"effectiveDateTime":"2019-06-02T20:24:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6cc57877-ca8e-2f65-af62-af5d8450e7d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e6e0f58d-fb79-1e0d-1dce-fec20b235c80"},"effectiveDateTime":"2019-06-05T23:35:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"87e47d4c-82c4-7e43-9259-58f35d0fe010","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5f0cc480-7e90-d8a1-bf52-272abd5c165e"},"effectiveDateTime":"2019-06-09T01:55:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c3bca953-1cb5-d62c-1178-170794d2a6d4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/66d52ebd-c71a-27b8-0dc2-da4ba32d3f17"},"effectiveDateTime":"2019-06-12T04:30:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"966d44bf-ca87-1f9a-37bb-e038a97e7bd4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/50132ad5-4b3f-bfa0-9c7d-fb1eecd499e3"},"effectiveDateTime":"2019-06-15T07:35:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"80742261-de9a-b984-dc27-62e912c48cf3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f53d2309-4b32-e4d2-da8a-d0de6ee6f695"},"effectiveDateTime":"2019-06-18T09:57:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7d0a55fd-b4ca-b729-2a9e-65c4fbb2e064","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8bf515e5-4028-66bb-168b-452784047e70"},"context":{"reference":"Encounter/4c9cc8db-5b9d-644d-011f-155ce85345f4"},"effectiveDateTime":"2022-04-02T15:09:23-07:00","reasonReference":[{"reference":"Condition/97547796-d1c3-5795-b2f8-253e8e182faa","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0783d461-4638-bb1b-7720-1e0e4d6ce4ee","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/95e89215-33a5-2b14-9ff4-92b2a73ff3d3"},"effectiveDateTime":"2019-06-21T13:12:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2958efec-5271-695a-c68f-edb2c671dc9c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/1d52ee17-8b63-1289-3d0e-1f07565cd597"},"effectiveDateTime":"2019-06-24T15:54:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8ab5fad8-1ef9-b486-c2d2-cb7f6cba25cc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/599f8833-31cd-251d-686a-3f31f97cd78f"},"effectiveDateTime":"2019-06-27T18:22:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"99acd7db-5843-ebcf-0200-7ebc11f694de","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c25fb4d4-e5b6-7d28-12eb-e6ef9fcf8a3d"},"effectiveDateTime":"2019-06-30T21:33:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"caf37701-d367-b1d3-01fd-4007abdaf471","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f1f25c55-a1d0-f828-c1b7-9cbddd0eef7f"},"effectiveDateTime":"2019-07-03T23:47:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e2e88c85-2b18-c75f-f0ac-8dbd9e5b6496","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/0e68a132-c98f-57a0-d81d-499cffa483b6"},"effectiveDateTime":"2019-07-07T01:59:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"93012cd7-ba5b-8270-ccc4-25e622af2952","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3a2bda32-a630-65c1-9669-81eca4761577"},"effectiveDateTime":"2019-07-10T05:17:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e84cae0c-9bca-bf45-f2c1-8a640ed3a112","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5bc812a1-b41d-e3ef-75da-4564bad6ac2c"},"effectiveDateTime":"2019-07-13T08:55:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2eebe887-1f96-12ce-e7bb-64e1e33027b7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/aa0bd9da-756e-73c7-b394-8a19bb537303"},"effectiveDateTime":"2019-07-16T12:51:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"359beb86-ed3d-fdbc-a5d5-8cd588ccfb1f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/80477e1a-b021-dcf6-53f8-f6edb59ffe30"},"effectiveDateTime":"2019-07-19T16:14:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fad313aa-1135-e820-93b4-7a2f4ba448d5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/1d2c16bb-479b-6852-1569-290099ec33a7"},"effectiveDateTime":"2019-08-02T22:44:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"61a136f9-b3cd-5042-a53b-4be36d708ed1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c5947a8a-314e-209a-6a18-6ddafc5639b2"},"effectiveDateTime":"2019-08-06T02:17:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"72a60c94-8553-8764-f8c2-dd3bd321a3a3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/86b0eb31-7165-a5a7-01c2-3afed4f05a89"},"effectiveDateTime":"2019-08-09T05:31:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a83c6002-7d82-dbe8-4679-cd0ab7242a84","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/9129e221-f895-d79e-fceb-d92629c962e6"},"effectiveDateTime":"2019-08-12T08:48:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0a8582d1-1f97-5942-c489-e897a3316e2b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/78cb082f-5332-738a-7c6c-52d86ca470b9"},"effectiveDateTime":"2019-08-15T12:40:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2110ec76-617b-3f65-63ae-23baf550e7d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5f67d856-b845-c372-3862-d5a7d82a0a0b"},"effectiveDateTime":"2019-08-18T15:45:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0c4a2678-7a0c-d50c-b3fc-4349215aa735","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3aabb618-748d-92df-2c36-6310168caa5a"},"effectiveDateTime":"2019-08-21T19:41:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9e1aa719-c219-cee6-d7bb-f5b56869ec32","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/b3b89f96-5dae-31c5-f412-0a44ab02d6fa"},"effectiveDateTime":"2019-08-24T21:47:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0f6a4191-2505-276a-98e2-052b39eee1ef","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4f415aba-44c7-d931-71c8-d1d4a05d977b"},"effectiveDateTime":"2019-08-28T01:35:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"994f2278-8d5a-c8ba-ffd4-5ce736c82c0b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/28a63e50-fd47-1740-83fe-48b092fc268a"},"effectiveDateTime":"2019-08-31T04:33:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d9e00292-5327-aa46-1138-c7793b9aece4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f029c0bc-bff4-dea2-acc3-5cc07b2b16b5"},"effectiveDateTime":"2019-09-03T08:09:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d3d4ef9c-1f80-7c7e-2270-9dfe02b0b620","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4326c5fc-1a73-dbfc-8a6d-85e45c101726"},"effectiveDateTime":"2019-09-06T10:38:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c6407bda-f823-bc40-cd74-a5ae6e2fb702","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/733dbadd-6784-ca4f-24fd-64df7722f728"},"effectiveDateTime":"2019-09-09T12:54:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c4b22f97-51db-00ad-2420-37c866f65a7c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1665060","display":"cefazolin 2000 MG Injection"}],"text":"cefazolin 2000 MG Injection"},"subject":{"reference":"Patient/f2c7d78d-1879-3a35-d39b-c0bb79975f3b"},"context":{"reference":"Encounter/44c28983-2476-bcc5-3716-9f9f79cac9de"},"effectiveDateTime":"2023-05-16T20:18:11-07:00"}
{"resourceType":"MedicationAdministration","id":"8db2ec35-068e-36c4-fc7c-6c8087f4bbfe","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6768d097-7fb6-915a-af8b-a909b7c9ac24"},"effectiveDateTime":"2019-09-12T15:30:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"71242144-46cc-8fbc-51a7-3295fc6975b3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1659263","display":"1 ML heparin sodium, porcine 5000 UNT/ML Injection"}],"text":"1 ML heparin sodium, porcine 5000 UNT/ML Injection"},"subject":{"reference":"Patient/f2c7d78d-1879-3a35-d39b-c0bb79975f3b"},"context":{"reference":"Encounter/44c28983-2476-bcc5-3716-9f9f79cac9de"},"effectiveDateTime":"2023-05-16T20:18:11-07:00"}
{"resourceType":"MedicationAdministration","id":"1b68823e-b97f-c3d1-03db-c4dbf0e88e48","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/34ac1559-5491-318f-bc90-d4e0c35ce1eb"},"effectiveDateTime":"2019-09-15T18:49:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c64608a4-e7a7-46b3-4d7a-32785e74eec2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/0e86b1cc-5bf8-5e09-29d3-b1bcb8fb7e03"},"effectiveDateTime":"2019-09-18T22:33:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d23f5591-250e-2bbd-a0b2-51016696d458","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1796676","display":"25 ML protamine sulfate (USP) 10 MG/ML Injection"}],"text":"25 ML protamine sulfate (USP) 10 MG/ML Injection"},"subject":{"reference":"Patient/f2c7d78d-1879-3a35-d39b-c0bb79975f3b"},"context":{"reference":"Encounter/44c28983-2476-bcc5-3716-9f9f79cac9de"},"effectiveDateTime":"2023-05-16T20:18:11-07:00"}
{"resourceType":"MedicationAdministration","id":"4780958c-f404-cc3a-fe5b-63ffef751f2a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1740467","display":"2 ML Ondansetron 2 MG/ML Injection"}],"text":"2 ML Ondansetron 2 MG/ML Injection"},"subject":{"reference":"Patient/f2c7d78d-1879-3a35-d39b-c0bb79975f3b"},"context":{"reference":"Encounter/44c28983-2476-bcc5-3716-9f9f79cac9de"},"effectiveDateTime":"2023-05-16T21:34:14-07:00"}
{"resourceType":"MedicationAdministration","id":"8f9c22eb-0891-7c0c-7957-aa25bd551621","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/fb028014-4876-d39c-834a-3f1a48e24925"},"effectiveDateTime":"2019-09-22T02:03:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"63a38c74-4d0b-a176-3fb8-48a1f3bf3e35","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"311700","display":"Midazolam 1 MG/ML Injectable Solution"}],"text":"Midazolam 1 MG/ML Injectable Solution"},"subject":{"reference":"Patient/f2c7d78d-1879-3a35-d39b-c0bb79975f3b"},"context":{"reference":"Encounter/44c28983-2476-bcc5-3716-9f9f79cac9de"},"effectiveDateTime":"2023-05-16T21:34:14-07:00"}
{"resourceType":"MedicationAdministration","id":"48d18416-48ff-4904-2f15-1e2b32baf013","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/90ee6582-d9dc-fe79-5468-164e5cc3f562"},"effectiveDateTime":"2019-09-25T04:13:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a060a34f-77bd-5377-fe77-7ea9461cc181","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1808217","display":"100 ML Propofol 10 MG/ML Injection"}],"text":"100 ML Propofol 10 MG/ML Injection"},"subject":{"reference":"Patient/f2c7d78d-1879-3a35-d39b-c0bb79975f3b"},"context":{"reference":"Encounter/44c28983-2476-bcc5-3716-9f9f79cac9de"},"effectiveDateTime":"2023-05-16T21:34:14-07:00"}
{"resourceType":"MedicationAdministration","id":"97b29561-61d7-c6c2-7343-fbe69c46b87a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/262a8e3c-dea2-5013-8a5c-ea366d41c014"},"effectiveDateTime":"2019-09-28T06:21:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"956447d1-f3cc-0aa6-5440-5c8e2172be43","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1234995","display":"Rocuronium bromide 10 MG/ML Injectable Solution"}],"text":"Rocuronium bromide 10 MG/ML Injectable Solution"},"subject":{"reference":"Patient/f2c7d78d-1879-3a35-d39b-c0bb79975f3b"},"context":{"reference":"Encounter/44c28983-2476-bcc5-3716-9f9f79cac9de"},"effectiveDateTime":"2023-05-16T21:34:14-07:00"}
{"resourceType":"MedicationAdministration","id":"1db89621-e803-268b-e382-6e577f25a328","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/49e34738-cbca-9166-c7bf-512676ed8857"},"context":{"reference":"Encounter/7bf67e74-b7c5-8d96-c239-7ddce1b37f38"},"effectiveDateTime":"2021-03-26T12:38:25-07:00","reasonReference":[{"reference":"Condition/9be597d0-c8b0-fd47-efb1-0e406ea022e5","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"887ce7d5-ea48-7b05-9ee5-3b7cd9e350d7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/9b4fbf24-7f10-631a-081f-c3c924d9335e"},"effectiveDateTime":"2019-10-01T08:32:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"49bd804e-53c2-1274-ff5a-66453467f3e1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"542347","display":"isoflurane 99.9 % Inhalation Solution"}],"text":"isoflurane 99.9 % Inhalation Solution"},"subject":{"reference":"Patient/f2c7d78d-1879-3a35-d39b-c0bb79975f3b"},"context":{"reference":"Encounter/44c28983-2476-bcc5-3716-9f9f79cac9de"},"effectiveDateTime":"2023-05-16T21:34:14-07:00"}
{"resourceType":"MedicationAdministration","id":"f124fe6a-7ddc-8fb7-b194-016ab77dde53","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c6b08234-9924-9768-b195-9ea82f19d0f4"},"effectiveDateTime":"2019-10-04T11:38:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a84c44b0-491b-4ff5-89b9-fa4d2f12309b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1729584","display":"remifentanil 2 MG Injection"}],"text":"remifentanil 2 MG Injection"},"subject":{"reference":"Patient/f2c7d78d-1879-3a35-d39b-c0bb79975f3b"},"context":{"reference":"Encounter/44c28983-2476-bcc5-3716-9f9f79cac9de"},"effectiveDateTime":"2023-05-16T21:34:14-07:00"}
{"resourceType":"MedicationAdministration","id":"98b8a771-17ce-0189-ada2-639808218523","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6f7bdbae-1a05-e584-a729-8d8aee52bbd6"},"effectiveDateTime":"2019-10-07T14:12:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c6a8adb5-9e5d-879e-fdd4-81d26f04d580","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5056739c-722f-bf4b-d3e8-8f8c6b8635e0"},"effectiveDateTime":"2019-10-10T16:40:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8b280d9e-96da-13df-939b-503bce66f4ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/0ce63712-091f-da6f-6694-8558514f01b0"},"effectiveDateTime":"2019-10-13T19:33:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9dbfacb4-905e-723a-8fdc-615fa6c6c5e1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/b231897c-b0c7-0d1d-045d-3855baa7aeab"},"effectiveDateTime":"2019-10-16T22:27:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9932ff03-90a6-2892-fe21-2d560d632692","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/49e34738-cbca-9166-c7bf-512676ed8857"},"context":{"reference":"Encounter/945821d5-d174-0263-d199-9d30f9f09e09"},"effectiveDateTime":"2022-04-01T10:28:40-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"5a35d36a-4ca5-d8a0-a81b-0f2d54c2a947","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/2627bff7-6062-d2c1-ed63-ee8f9d0084b2"},"effectiveDateTime":"2019-10-20T01:42:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b49806e0-868e-4c1d-23c9-f925e7f4d158","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ef381a35-5318-0c2b-5061-49635bd6246c"},"effectiveDateTime":"2019-10-23T05:00:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f6c9e3c0-bc4d-3e89-7c04-52faa5e8eff0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/1ecc5e1f-3f5c-7207-37ca-2c4fac77e6a2"},"effectiveDateTime":"2019-10-26T07:15:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a7090184-c70d-b371-164b-0875587438ac","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/b0fb4ea3-c986-33db-4bf0-fdaf9da74e4d"},"effectiveDateTime":"2019-10-29T10:53:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d0d5ed45-3c9f-6902-40e6-2fbd067bc5af","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/49e34738-cbca-9166-c7bf-512676ed8857"},"context":{"reference":"Encounter/a98b9813-fa40-73c9-a767-406bc33e875b"},"effectiveDateTime":"2023-04-07T10:27:31-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"0ad8e883-bb43-b430-013f-7c24c3317479","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e9de0c19-1bd5-96cc-6a5b-2ce29787b44c"},"context":{"reference":"Encounter/338214a9-c435-af40-247e-ffa0533ee8da"},"effectiveDateTime":"2016-08-31T17:05:19-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"0d7c461a-d66b-1d6b-65b5-e769723d9c12","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3fce7a54-fd49-0969-2f5f-84ae685c5193"},"effectiveDateTime":"2019-11-01T13:00:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c63d6483-475b-0906-4d71-8e56c1eb6d0b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/288d3924-24d8-211f-a7cd-1060070498cb"},"effectiveDateTime":"2019-11-04T15:13:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f4830850-ef70-7c98-9128-1eb943177239","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/858366db-d3bd-f5d8-6179-f671eb1036b7"},"effectiveDateTime":"2019-11-07T17:41:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d6f396f2-06b8-5f64-1990-cea30a07cfd8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/2d555810-8ef1-84cf-8d8a-3dd9e978996b"},"effectiveDateTime":"2019-11-10T20:08:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1f4dbb7b-28a2-576d-a047-e3b4c9f0f347","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/2aa93ef4-38d7-f907-3e89-d8f04d4c2928"},"effectiveDateTime":"2019-11-13T22:36:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f16f78f0-26e2-5472-2fda-a2db23801a3e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/49e34738-cbca-9166-c7bf-512676ed8857"},"context":{"reference":"Encounter/25bdc0e1-4f85-fc75-5a2d-22cda293b9ec"},"effectiveDateTime":"2024-04-12T10:39:34-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"0b680a0c-21ed-1772-13db-4ca959a61dc4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/81e439ec-e950-846a-0549-383b1d4a2063"},"effectiveDateTime":"2019-11-17T01:29:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0d9c44df-253d-b9e1-e9d5-e62dc11c4374","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7a4d9feb-2494-b091-d39d-5f1c31322b4a"},"effectiveDateTime":"2019-11-20T04:59:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"42736e8c-e5e2-13bf-71f3-7ff36b1c8341","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d6ef642d-aab2-60d8-f9b0-50e98f7aa6e7"},"effectiveDateTime":"2019-11-23T07:53:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"598318cf-c6eb-afdb-fc8a-4dde2f3f56d3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/857e5470-13da-dff1-6752-4c48609c93b6"},"effectiveDateTime":"2019-11-26T10:29:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"237e3693-31da-7ad2-0ebe-5363d9286d19","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5ed64895-080c-f0d4-dadd-ef8c422e6e94"},"effectiveDateTime":"2019-11-29T13:18:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d31c8924-270e-50d7-88f1-a493a3ac16a3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/49e34738-cbca-9166-c7bf-512676ed8857"},"context":{"reference":"Encounter/b6c82b92-ca19-318e-fd5e-5448c2adeea4"},"effectiveDateTime":"2025-04-18T10:48:03-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f49f8a82-b737-7f89-0989-48eb92ee4324","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/41a028b6-3e06-90e7-0e47-aee9c9be2bde"},"effectiveDateTime":"2019-12-02T15:51:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d4a13f8f-422f-a22e-a1d5-8329571960b7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/86d93e9c-761d-2ae7-6db7-165e1cd5b11a"},"effectiveDateTime":"2019-12-05T18:17:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b50eef23-6f11-d4a9-36de-36d6a3b38709","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e9de0c19-1bd5-96cc-6a5b-2ce29787b44c"},"context":{"reference":"Encounter/2ced3666-87c0-0437-3666-cf134b68b7ea"},"effectiveDateTime":"2021-09-29T17:18:24-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"97480f15-0a9a-be09-fd5e-7768b1956128","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c85865ad-2e43-cfb9-2eef-0760d6601567"},"effectiveDateTime":"2019-12-08T20:48:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cfa53d6d-9f71-29e1-03cf-10eb309346e9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3e90a90b-01a2-f19f-db4f-05f2aba18d63"},"effectiveDateTime":"2019-12-11T22:52:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ff6642b6-b951-17cc-86e8-0fc12e308c4c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c2b0e20f-7d5b-2837-2fcc-3c8ce5cba87e"},"effectiveDateTime":"2019-12-15T02:26:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c763e5aa-462f-b24a-4576-c71c4d63dc1e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5b082010-c582-d994-0528-b377cf326661"},"effectiveDateTime":"2019-12-18T06:02:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"af9002ec-c67c-b57f-1065-7c74a9c620fe","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/cfca9896-3237-ec05-8ec1-d32d7f2c5662"},"context":{"reference":"Encounter/af91f50f-0f0e-be73-5d5c-5ee60ce22024"},"effectiveDateTime":"2018-09-05T09:26:44-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"6fe6eff7-2c1d-a0b4-83c0-8a48dfe2bf4d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/e9de0c19-1bd5-96cc-6a5b-2ce29787b44c"},"context":{"reference":"Encounter/884087fa-33e9-7d0a-d0cd-9432d93caa0b"},"effectiveDateTime":"2023-08-09T20:04:15-07:00","reasonReference":[{"reference":"Condition/9e1d37e0-716f-7101-6d8f-6d7d6c3fea64","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"43029d4f-15b8-ef25-859f-d5344ab24f98","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/22a7e39e-a81e-528a-bae1-fe3cebf3b920"},"effectiveDateTime":"2019-12-21T09:06:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6b11d39a-f7b1-fff4-06d2-ffd499009be9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/70a9ef3c-66b2-9cdc-94c6-f5a76a033965"},"effectiveDateTime":"2019-12-24T11:51:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4db6cde4-f50f-77ea-3776-376de65311ff","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d6b9060b-5ede-3863-f098-0c339c597931"},"effectiveDateTime":"2019-12-27T13:57:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0b0f676f-5b91-7a85-f4ce-f0db24551499","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/12d639f5-3393-46b4-7483-3e1fc7c8dc82"},"effectiveDateTime":"2019-12-30T16:15:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"77d96aaf-08c1-ecc0-9ee1-ddf1a5f9e1f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/10351558-3773-29c7-7e77-404b97252a3c"},"effectiveDateTime":"2020-01-02T19:05:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2c05cf28-d729-800d-9f48-6c60d05f04cd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/a41b1595-3b5c-f30b-c1f7-09bcc7f24688"},"effectiveDateTime":"2020-01-05T21:58:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2eb61db3-5a5f-d2e2-40d2-ee5aa85f2312","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/088419a0-f32b-64af-964f-e1159589df64"},"effectiveDateTime":"2020-01-09T01:21:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5f740e25-36e5-ba1d-5fc7-cb8753b6616b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/68211098-7187-619c-1704-b7e8acc1b145"},"effectiveDateTime":"2020-01-12T04:57:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2700bfc4-d528-ee43-43d1-6712d67e6435","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/50458082-2bcd-255f-c905-bfc96ee1356c"},"effectiveDateTime":"2020-01-15T08:01:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0bb1bc46-bd45-ff25-4e4e-f4500cb99798","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/07efb5d0-a799-3c75-6c69-09de2455ab81"},"effectiveDateTime":"2020-01-18T10:07:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2c7b2f43-8899-0619-564e-b0188b160d4d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/59bb0be8-3d87-a28a-680d-52e98bd1a81b"},"effectiveDateTime":"2020-01-21T12:44:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"907ec0a4-3da3-ce15-a6e7-144b3fce06e2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/934dfeb4-da98-917c-6374-000167d0e9f6"},"effectiveDateTime":"2020-01-24T15:25:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e524bc10-7273-818a-fa0e-7cbb3065c524","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/77cb549e-33a2-f91a-443f-747c026db2d4"},"effectiveDateTime":"2020-01-27T18:25:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"371045f6-9efe-3ebf-53e0-ed44a5550b27","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/016774ea-1146-ec27-a6e4-66daf31e1bf6"},"effectiveDateTime":"2020-01-30T21:14:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8890f8f1-5b71-1083-9ef9-4c985f1decce","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6239af3f-e63f-4358-3c3d-66b17d8e36fd"},"effectiveDateTime":"2020-02-03T00:39:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e790fcf1-fafc-1018-3b38-011ddecf2681","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/12d77878-c5f1-94b3-40a9-39fad7cddb23"},"effectiveDateTime":"2020-02-06T02:39:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"29f54ddc-5031-2966-c72d-734cd8599ca8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3371cc09-6716-8dfc-ef56-82f946e6eeb6"},"effectiveDateTime":"2020-02-09T06:29:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c16e88d7-c501-b2af-f0d8-58e62d5559b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/381bbbd8-aef6-a29d-b6e9-47a80d1ca243"},"effectiveDateTime":"2020-02-12T09:50:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f577e0ba-9da8-de2e-0c39-c62ed74a2ccb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8e4dfa9d-c0a8-3d4d-0bc4-1d97c0d1a4c1"},"effectiveDateTime":"2020-02-15T13:01:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5d3bf726-48f1-efe2-e38f-d7998b8f2813","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/dc8d8192-4362-011b-05c8-c239b7a13ecd"},"effectiveDateTime":"2020-02-18T15:46:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"67faf726-411b-5048-f0d7-cf9983b8887d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f8296f89-7ffe-4241-a227-2d288a67393c"},"effectiveDateTime":"2020-02-21T18:31:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b96f6e8c-ddf3-f88d-c9d2-6ff3632e6900","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ca2307a0-75dd-9030-0de8-d373fbf90c20"},"effectiveDateTime":"2020-02-24T21:02:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08697c95-7daa-1e8b-8da3-ed107e859ff1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/40332d0a-a555-b168-3f26-7b6ad83d5d87"},"effectiveDateTime":"2020-02-27T23:02:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a7052e31-719b-c817-b32f-33750bb0b1d9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/bd7a05f0-4327-8a67-4319-ea2c45dee729"},"effectiveDateTime":"2020-03-02T01:57:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"61a12f7d-b3cd-c982-a53b-446775fa568b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/de1503f1-723c-c392-7d48-ac04f252855d"},"effectiveDateTime":"2020-03-05T05:25:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"51c2885a-c99b-c9fc-ede7-544499d56b4a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/29e03951-8429-de66-4c2a-be0e3361e542"},"effectiveDateTime":"2020-03-08T09:26:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5b78e262-a19b-91dd-f79f-acb481d5332b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/fac4a49f-f72c-1c9f-9ece-6716bd5036bc"},"effectiveDateTime":"2020-03-11T11:46:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7ea61301-0093-359d-04c2-e3a84ea79d78","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/25cbe10a-dd3b-7a03-e9f6-2ff2055c8795"},"effectiveDateTime":"2020-03-14T15:07:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"84903ac2-f0d7-afa3-2601-372c1efa9988","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/cfca9896-3237-ec05-8ec1-d32d7f2c5662"},"context":{"reference":"Encounter/71dc1d44-b6f9-143b-ffc7-0d1d0835da20"},"effectiveDateTime":"2024-10-09T08:58:54-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"a67e2692-d12a-92cf-2a3c-43637878a837","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d6a69665-4554-e45f-ad2d-4601fbae3ab6"},"effectiveDateTime":"2020-03-17T17:35:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d92640b0-0f21-1dd9-0328-0dba8402847f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/362d493f-be46-8476-3135-3ea8725c99ac"},"effectiveDateTime":"2020-03-20T20:58:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4564f922-bf5c-2655-ecb3-108fd2384325","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c7191d58-0582-090a-13a0-8fc89dee4637"},"effectiveDateTime":"2020-03-24T00:20:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c641ba5b-be6b-a468-4d75-e42f44868dd9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/18a46405-c59a-6afd-2656-f9bd8879e6c4"},"effectiveDateTime":"2020-03-27T02:29:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2bce18a9-df40-ef6d-9f10-b5e244ea0ca5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c1d940ed-f6b1-e12d-b95c-abbf00f88f27"},"effectiveDateTime":"2020-03-30T04:39:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3cefeaf6-c97b-ca51-d924-bc18b5b56b9f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f0ff746b-657c-bfbb-d4e7-74a03b20ad9c"},"effectiveDateTime":"2020-04-02T06:43:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a70fceca-7dca-a68a-dddf-58c6b76bf526","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/26a74a41-4b69-bf34-922a-d51a2ff273bf"},"effectiveDateTime":"2020-04-05T09:03:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"05824e8b-c36d-a6a9-54a3-0ff248a8178c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/10f7d81d-c1b5-1a16-849d-4a516e61d24f"},"effectiveDateTime":"2020-04-08T12:14:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c93c70a8-8054-c77a-6a8b-0ce35770cbb4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/998ac529-77ea-c438-2c4c-37d9b1a3d9c1"},"effectiveDateTime":"2020-04-11T15:17:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"27042e66-7803-32e3-43d4-d5b4966dd7a1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5d8df7c9-23d9-5b2a-ff2f-2d47da99bb20"},"effectiveDateTime":"2020-04-14T17:35:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c43f7766-4daa-c0f0-8210-bfd99047f96e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e85dad01-f540-5b13-e788-0937735d9645"},"effectiveDateTime":"2020-04-17T21:33:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7e2e8e01-aa6b-ff3e-b7cf-dc9deb47b5ca","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5d55e1d2-214b-f5f2-234c-b9ad2ac405fa"},"effectiveDateTime":"2020-04-20T23:39:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b6916873-ddb4-b9ab-f7f7-edae4ec0464f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/bf956034-c062-9f56-d7c6-dd43465362a4"},"effectiveDateTime":"2020-04-24T03:18:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f3423aa0-eb0f-76aa-dd06-890c62d310bf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/559e7d90-04c8-7d59-615c-81a485cec149"},"effectiveDateTime":"2020-04-27T06:23:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e13e09c3-5307-3ce0-5620-4124284909eb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/618a54cb-15ef-9976-32da-f69fa0f3d52e"},"effectiveDateTime":"2020-04-30T09:44:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"35cd74f1-dab0-66b7-02d7-e9d4220e8e99","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/2b810fa4-a772-3321-6a4f-1f7620402e58"},"effectiveDateTime":"2020-05-03T12:15:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dee975d5-2bb4-0f5d-74c9-7c359ef6ac96","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d43895c6-383f-e668-6314-0ddef2471418"},"effectiveDateTime":"2020-05-06T15:26:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"908c9d40-b7db-3cdc-cf28-d6e2067789c8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/49dd6fc0-a54d-191f-322d-a5da4d3cc18a"},"effectiveDateTime":"2020-05-09T17:27:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d2bc9b9b-3189-843b-c5db-3fd4d2d8208a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/00b60f14-df6a-7d76-f1e1-9f1ce03c3480"},"effectiveDateTime":"2020-05-12T21:01:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8ea1fc2d-9a54-d3d0-b129-30576ddef21e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/0f59e1c8-c969-371f-4685-e96ac1e422a9"},"effectiveDateTime":"2020-05-15T23:29:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5b689dbf-5c76-e9bf-e3db-e05c951cd842","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/b1c894f0-cf35-4235-695e-75853643eecb"},"effectiveDateTime":"2020-05-19T02:45:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2b27e956-5eda-f31c-f39b-2bf39784efd4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4e6f882a-8b1d-5159-8fbd-7188fbcd94c1"},"effectiveDateTime":"2020-05-22T06:21:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c1e0bef4-2326-e814-fa8e-c2c9c39a2ab1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/1fe204b5-169e-28e3-08a8-46a06e353e35"},"effectiveDateTime":"2020-05-25T09:26:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ccb72725-def9-7445-db53-1f992196acf7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/662ca8aa-bf32-564d-9a5f-07418f9b3d0a"},"effectiveDateTime":"2020-05-28T12:47:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0b37f1b5-8b66-4c1e-8f72-87d25c0d9a4b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/12ce2e87-9319-2db2-f55f-913b4d18125f"},"effectiveDateTime":"2020-05-31T15:31:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6c22d5aa-6e28-a86f-0637-bf703f09d773","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/88eedc75-8d82-dc9b-6a3e-fb1001308e6c"},"effectiveDateTime":"2020-06-03T18:54:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c6878405-ad11-779f-b04d-74e6ff9511b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/470fce6d-d3e0-cd82-17a4-75afb60aff98"},"effectiveDateTime":"2020-06-06T21:28:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"129262a0-5937-fe8a-97cc-d424a4cf5ff0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f9681ddf-9450-6567-5f6e-d7f6e2962164"},"effectiveDateTime":"2020-06-10T00:44:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7e35d905-6b03-422d-4467-ca9dde45df66","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/fb7b15a2-f1b1-aca8-8ec5-2e07e7f2a9d8"},"effectiveDateTime":"2020-06-13T04:11:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"346cda81-e44b-69f7-0177-4f650cf42159","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/917205c2-118e-b9e7-dd17-5ab8117c9582"},"effectiveDateTime":"2020-06-16T06:11:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6dde3693-bfd8-f952-b132-536467272cdc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f8c491d1-858d-b437-13b7-d94b088a6afa"},"effectiveDateTime":"2020-06-19T08:40:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2e505749-735b-d602-101d-61be56a4aacf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/505964c5-1a58-0a63-174a-1656982597d8"},"effectiveDateTime":"2020-06-22T12:07:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"eeedc3bd-dff7-8189-03d7-8a6ff9668524","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6810b38a-a690-7a9c-9ae0-c7ad8cf2c077"},"effectiveDateTime":"2020-06-25T15:42:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cbcf8298-bf16-e7c7-5893-1cada8ddba79","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e8f1d444-3583-809d-de7d-8841a539ca30"},"effectiveDateTime":"2020-06-28T19:39:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c2418d23-a4bb-58c8-c975-b6f732a10910","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8041a6ae-48bb-8037-f628-a877f2c63aa0"},"effectiveDateTime":"2020-07-01T22:34:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c8c0fc33-520a-0834-1c68-1880215e1e9d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/70f76a8e-16b1-c16a-2b74-f5d88b9c4654"},"effectiveDateTime":"2020-07-05T01:58:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dfc0df49-986f-7fa3-5f30-4116a2e4633d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/1dbd075e-5abc-4266-726f-142294d8c24e"},"effectiveDateTime":"2020-07-08T04:03:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e237705c-9f9c-870a-a98a-df10a3369bf4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c0124939-63d8-2da1-5b81-9c9c8014384e"},"effectiveDateTime":"2020-07-11T07:38:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"23d182be-cc9f-3068-43d5-1cd3b666a3ff","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/0006a1db-2e71-f6a6-2eb9-16082d58f212"},"effectiveDateTime":"2020-07-14T10:34:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3d35b726-73f1-b24c-b8d0-b799b68eeb3e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/9c16b82f-08cf-ac8a-d360-7ed0480fc9d8"},"effectiveDateTime":"2020-07-17T13:46:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b20974c4-fe61-d9c7-9e17-19a4ffb193dd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/3b7d07db-86ce-742e-3d5b-c5a6485ca6a7"},"context":{"reference":"Encounter/1cb64edb-65b8-7529-29ab-2e9d961ed126"},"effectiveDateTime":"2018-01-09T07:01:12-08:00","reasonReference":[{"reference":"Condition/614f9e9b-4d39-b7c0-337d-ef72da944776","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cf011881-1f97-32b8-96b5-75a9233147a2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f7bc04a1-884d-6ae7-c4f6-809b361c7324"},"effectiveDateTime":"2020-07-20T17:30:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e8f4cb70-af4a-fe44-f369-af5ae802e011","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/61805568-ab3f-aaaf-db5a-5106fd974b26"},"effectiveDateTime":"2020-07-23T20:15:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a72c9d56-565d-3ddf-7220-d6f7a4f9c4e9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/b10f00da-bc90-5b0f-8584-237278ddf3b1"},"effectiveDateTime":"2020-08-08T00:09:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dab5f35f-fd5f-7667-46d2-c4074ba3fbd2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e675a769-9414-7aad-fbe7-2d87667d7119"},"effectiveDateTime":"2020-08-11T02:52:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"272fd726-adeb-2cd6-3884-af99f08865ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3aaf7849-65ad-0eab-dc97-e5cbc929311a"},"effectiveDateTime":"2020-08-14T05:07:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"375c9da5-9684-8012-ba0a-21c2672bce58","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/b435c8c1-dfe1-7875-055d-73010127fb69"},"effectiveDateTime":"2020-08-17T07:12:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7ae86969-36bc-e042-c26d-18bb538d8790","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d85946c5-43ca-aba2-d6a7-c952d8611ae2"},"effectiveDateTime":"2020-08-20T10:21:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6d94cf1a-7db6-a795-fe9d-d812b757f631","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6004c13f-8d26-8979-2ffd-5fdef6b83afb"},"effectiveDateTime":"2020-08-23T12:52:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1621de29-f107-3ca4-8b06-767e316909ae","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/facf7f9d-cbd6-224c-cbcb-032191f68df1"},"effectiveDateTime":"2020-08-26T15:39:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f588a5b5-a658-fe9e-79e3-67d277004ce9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/14d1befd-adee-0e8d-6ba1-33577877264a"},"effectiveDateTime":"2020-08-29T17:57:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7a6e6e8c-bde3-87c9-a081-aff3431dfa25","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/df7cdac3-6484-ed41-c6be-637212ce018f"},"effectiveDateTime":"2020-09-01T20:38:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"58af28ec-122c-7f0a-dde9-9b502a17d070","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8dc1f4ef-879c-ec22-614d-58c284d73219"},"effectiveDateTime":"2020-09-04T22:41:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cc92af2e-268e-fe97-3efe-bbb0a7f583d2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/a22bd8a6-c6aa-abe3-413e-ad5216b365c9"},"effectiveDateTime":"2020-09-08T00:50:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"88a60167-46af-34ea-f8ad-35911a42d50c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/06cd8b83-af2b-b791-2cd6-ea1280fc7e21"},"effectiveDateTime":"2020-09-11T03:06:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"887a3842-88c3-b82d-9ee2-8be9b0862a3f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4be519e8-aa49-3af0-1e4d-8249d18a2874"},"effectiveDateTime":"2020-09-14T06:56:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2fde4932-22d8-3e46-3a53-2e3a73eb6013","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ccbd5593-99f9-4fe0-28ea-f1fff01ddd9c"},"effectiveDateTime":"2020-09-17T09:33:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7e5b4d9a-a697-a406-f53b-6bec01472260","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/0e6281bc-63e8-dbcd-80af-93a443546694"},"effectiveDateTime":"2004-08-15T07:37:19-07:00","reasonReference":[{"reference":"Condition/fef46ab6-d569-f44f-15e8-1b83d49bb4ec","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"84764347-4235-7eae-18d7-b3ccc969a882","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/278045b1-c142-b43b-0d5e-c84c065128cd"},"effectiveDateTime":"2020-09-20T12:19:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c63c5dd3-1802-bffe-4d70-87a6aca3d8e7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/a8946025-286e-58bb-c494-ea06998ff013"},"effectiveDateTime":"2020-09-23T14:29:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"32b60e4c-5ce1-1357-bcd2-def3ab349b82","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7bf2341d-ff79-8a61-3f12-c16b29b47741"},"effectiveDateTime":"2020-09-26T18:09:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b1364b29-fea8-41cf-1989-f254424964de","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c7fd101f-62a6-3ca3-1671-0feaabfa7394"},"effectiveDateTime":"2020-09-29T20:27:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"02dade49-efe3-292e-bbbb-2016fa580e86","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/08363a4e-df29-5ba5-7d59-b66caff4fdb8"},"effectiveDateTime":"2020-10-03T00:16:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e137f2d2-ce44-ed84-0837-ffa5ae6908f2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/3b7d07db-86ce-742e-3d5b-c5a6485ca6a7"},"context":{"reference":"Encounter/0e7b659e-8c77-bafd-3632-68a092c3fc7d"},"effectiveDateTime":"2023-02-07T07:04:06-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"6ceb3c0a-5efc-818c-81d5-06dc3ce8c526","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6db2d5fe-8df6-002a-77f1-9d37738a7265"},"effectiveDateTime":"2020-10-06T03:49:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bc592aa8-f625-dd32-4a01-9deb935f3b6b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/b6dd48e6-22a9-fe4a-6637-5b2a1c4507b5"},"effectiveDateTime":"2020-10-09T06:09:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f95005eb-53af-e2a2-7966-6e3efadc2b0d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/20500e55-3073-986d-6297-c265132974a0"},"effectiveDateTime":"2020-10-12T09:30:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fc2648b8-5130-d6f5-6f00-b6ba36469cf9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/cdea5481-9cf6-3353-729d-22bc2b4a657f"},"effectiveDateTime":"2004-09-26T07:56:14-07:00","reasonReference":[{"reference":"Condition/fef46ab6-d569-f44f-15e8-1b83d49bb4ec","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cdf90845-c078-1b16-4fb2-1eae141f47e1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7c3efa2b-dd9a-4a26-c6c4-be46a646e9b5"},"effectiveDateTime":"2020-10-15T13:17:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"484e1f25-2add-6470-b2a8-5f659e2001a9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4bad27fb-d72c-882e-6d7f-563a7f164d93"},"effectiveDateTime":"2020-10-18T16:18:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a10e0f49-7a25-7fcf-0961-b67746b7acde","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/a52716cf-d8a4-27cc-28e3-075c79bb6a8f"},"effectiveDateTime":"2020-10-21T19:37:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f4f56c2f-70a3-a86e-8851-09730ab8923a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/b9e7caa5-087d-6981-4f0f-20970e3e34f6"},"effectiveDateTime":"2020-10-24T22:41:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6bc101a1-519b-7cd7-087c-3f7d71d51e26","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/47e901b6-4d84-7d21-2a5c-f58e8f4b84de"},"effectiveDateTime":"2020-10-28T02:26:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"341f4b6d-5016-0ff6-0129-c0533a1ea538","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e3fe9f7f-aa04-1d00-169f-ec83c8c0fab9"},"effectiveDateTime":"2020-10-31T05:28:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a2ef19c9-5014-8fcf-0b42-c0f9221fe1de","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5307a631-23cc-e125-9049-68ba526f28a0"},"effectiveDateTime":"2020-11-03T08:04:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9dca6f17-38c5-191f-a81f-24f905cf8e05","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c7c53914-07ff-9dd6-3d11-413f9987537c"},"effectiveDateTime":"2020-11-06T10:59:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3fbcb86b-d8b5-b380-8e1e-623d8cd28427","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/bfa07d54-866c-ad1f-8aaf-3d364f5c01e0"},"effectiveDateTime":"2020-11-09T14:52:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"284f801c-3ae6-b743-d1d3-1a3124b30c8f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4d9d36af-29ba-7b7d-13d0-c563e8e46ca8"},"effectiveDateTime":"2020-11-12T17:36:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6def03c5-8283-1243-a862-211f939478c8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/41ecea1d-cd2d-b6c3-8ae2-869840472bb7"},"effectiveDateTime":"2020-11-15T20:25:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"31557b19-219a-48b9-1385-86cf564fd55e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1605257","display":"Liletta 52 MG Intrauterine System"}],"text":"Liletta 52 MG Intrauterine System"},"subject":{"reference":"Patient/12ac41a4-5504-d20d-a0b2-2e16d9043942"},"context":{"reference":"Encounter/64aab278-efcb-4354-d5f0-5cc2068b4b7c"},"effectiveDateTime":"2015-12-25T03:10:11-08:00"}
{"resourceType":"MedicationAdministration","id":"56bdde49-3809-d777-ecbb-6016427ebdc1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5ad2c797-b86d-2cf7-daed-90ae0e2b9b90"},"effectiveDateTime":"2020-11-18T22:26:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7e3f4b04-fb58-577d-67f7-52995da28c64","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/8deac592-d4bb-d5d2-816d-c672778ea5d4"},"effectiveDateTime":"2007-10-14T10:25:02-07:00","reasonReference":[{"reference":"Condition/fef46ab6-d569-f44f-15e8-1b83d49bb4ec","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"642471fd-88b9-2a3e-f2a4-0fd64b19113a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/552e6700-18ca-0d9f-00fb-6008112fbdfb"},"context":{"reference":"Encounter/a185e6d5-f822-49e0-cd03-5c0e1206f467"},"effectiveDateTime":"2017-06-22T23:34:16-07:00","reasonReference":[{"reference":"Condition/b789f5de-e096-9340-a185-fc186a24c30c","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3bec5072-8871-f8dd-6ec0-eaf39eda4c84","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ba12a660-7e02-dc95-231b-d00a77a85502"},"effectiveDateTime":"2020-11-22T00:57:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e975eb75-6b50-a245-8412-fbbdde933f7f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/370445a5-eff1-2537-0cee-7c7e46e17497"},"effectiveDateTime":"2020-11-25T02:57:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b5592aa3-fced-4e5f-1fd9-9de69a26ed0c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4b78a37f-e4f3-2973-3921-4e32b1d132b7"},"effectiveDateTime":"2020-11-28T06:38:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"da77d24c-e8a5-bbfb-28e0-82371cc28ca3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/68a08ac6-9fa9-91e9-8cd0-ceef558dee5a"},"effectiveDateTime":"2020-12-01T10:36:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"19ad2f26-c68d-a098-8cfa-ac3757f425d2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7426750a-2253-7169-3d67-19f1cbd6addc"},"effectiveDateTime":"2020-12-04T13:05:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ff9c0f0c-1979-afcf-8e1a-a0729eb42325","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8f795cb4-47de-c1b7-a1e1-40d197469bfd"},"effectiveDateTime":"2020-12-07T16:17:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"978f17d5-b6ae-c7da-fe14-524914442d1b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f8410239-dcd9-9774-358c-4254f0cdd416"},"effectiveDateTime":"2020-12-10T19:06:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7b685366-3c76-b225-b3db-960376297e76","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/b2fdb61b-4a58-36c5-1e20-41916f2411f1"},"effectiveDateTime":"2020-12-13T21:47:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"92526f3d-09c0-69d1-081d-bc4d839df5f8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/552e6700-18ca-0d9f-00fb-6008112fbdfb"},"context":{"reference":"Encounter/388b5a1d-6fdd-a75d-9dda-a794971778ce"},"effectiveDateTime":"2018-06-28T19:30:37-07:00","reasonReference":[{"reference":"Condition/b789f5de-e096-9340-a185-fc186a24c30c","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"02c8adb8-f531-0218-2c9c-4925f17a094c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/fbb0f98e-2d65-768a-6e90-609452020c57"},"effectiveDateTime":"2020-12-17T00:36:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f2382427-17b0-7c66-40d5-01979174b608","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/a431860e-2118-3537-f90d-927dd4da0c1b"},"effectiveDateTime":"2020-12-20T04:25:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5184cd7e-99f6-1539-2f2b-9331a931c6be","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/552e6700-18ca-0d9f-00fb-6008112fbdfb"},"context":{"reference":"Encounter/61723777-ab3d-75bb-c3b0-c7c8564153d1"},"effectiveDateTime":"2019-07-04T19:55:25-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"31c951b7-f84f-e5b8-d901-2e95655e4e0b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6223e941-30ae-97fa-c47b-d86d67225927"},"effectiveDateTime":"2020-12-23T07:25:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2651c2c2-b793-150e-a451-50d9218b3d40","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/35a558e4-f09f-3a9c-d43c-108f9dbbae05"},"context":{"reference":"Encounter/291dcbbe-c649-fe82-9ed1-9a74df9698b8"},"effectiveDateTime":"2024-06-13T12:07:52-07:00","reasonReference":[{"reference":"Condition/daf3cbfc-aa3e-6a63-9b30-8b4e90f4a3bd","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"888bb454-db28-bbe7-9ef4-07fc138700c5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/b6940c08-c265-5655-7181-f3c1d7a54c2c"},"effectiveDateTime":"2020-12-26T10:48:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ff44c194-b4e6-fc17-5b86-052ec9d0ca4f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/a791c77c-755c-8a02-7e7a-82d5df7045a5"},"effectiveDateTime":"2020-12-29T12:53:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a7ad6cc2-0f4c-57b7-8ed9-04111119622c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e56402df-827f-3e7c-3f1a-9f1a418c2149"},"effectiveDateTime":"2021-01-01T15:02:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d80bc192-8ead-a3ad-0e20-452ca3977225","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7dd5240d-48fd-e0cb-b508-b1e0e2473b0f"},"effectiveDateTime":"2021-01-04T17:40:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"80547cfa-ed74-efb2-eb80-b69c3c11d926","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/b641df25-9b4d-5171-ab07-0481ca74fe4f"},"effectiveDateTime":"2021-01-07T20:23:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"007a4766-2b08-dc77-e780-4fd96da6164d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/df9e329a-8b86-3705-0e5d-a50a0f7646de"},"effectiveDateTime":"2021-01-10T22:49:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6b77694e-f959-bd6f-058c-531dd0ad8873","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f0f01e61-901c-a206-87b5-1cfca127c389"},"effectiveDateTime":"2021-01-14T01:38:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"66dce39b-1980-bfc1-de83-07d4bacf5cb0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/319fc2b2-0576-eb7c-867b-15038e67d558"},"effectiveDateTime":"2021-01-17T04:33:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4b2a821f-9fa3-f52b-6184-8953c977935b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e0c03b78-a2ce-2118-789b-71f91a069d46"},"effectiveDateTime":"2021-01-20T08:26:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"906ee633-1e2e-331b-e231-dec5ecc51339","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/347eb3cf-1d32-6c22-aeef-0c719d4da91a"},"effectiveDateTime":"2011-09-20T08:19:37-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"88c88867-41f3-5042-0941-cf73243e8a9e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/347eb3cf-1d32-6c22-aeef-0c719d4da91a"},"effectiveDateTime":"2011-09-20T08:19:37-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ef9be8a2-4d10-954e-c842-e994db28b5ca","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/347eb3cf-1d32-6c22-aeef-0c719d4da91a"},"effectiveDateTime":"2011-09-21T11:05:37-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"308554de-ebf2-4808-15a1-851fe3a3b60a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/347eb3cf-1d32-6c22-aeef-0c719d4da91a"},"effectiveDateTime":"2011-09-21T11:05:37-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"498a8927-6f70-4ea3-58b3-6aaf6d5cf913","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/347eb3cf-1d32-6c22-aeef-0c719d4da91a"},"effectiveDateTime":"2011-09-22T14:52:37-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"020c1f67-ea0a-486a-e728-5067a79fb66b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/347eb3cf-1d32-6c22-aeef-0c719d4da91a"},"effectiveDateTime":"2011-09-22T14:52:37-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"63e47d17-5ca5-a9b6-a684-b6b8ab429d3e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/bb94c497-dc33-eb25-426c-1252b5d466fe"},"effectiveDateTime":"2021-01-23T12:06:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6d4d0ed7-1a8b-8bfb-dd2d-4beffe18596d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2c3fc8fe-92d1-ae93-4fe3-fac4469aac99"},"context":{"reference":"Encounter/d0d85ac7-b24d-9d42-eed3-d4945cc28574"},"effectiveDateTime":"2019-09-10T23:49:14-07:00","reasonReference":[{"reference":"Condition/723532f9-6912-fe22-a71b-d949e9ac7d7f","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"26392a6b-6f9b-e409-c209-9dae0cd5cf23","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/69bf1a88-b81e-6af4-2a30-118b4282344b"},"effectiveDateTime":"2021-01-26T15:24:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"58d6c766-3c37-e679-74d6-97d97ed52068","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8876583e-1dea-2222-4b17-1faba5971d0f"},"effectiveDateTime":"2021-01-29T18:04:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"37480e61-9da9-cbef-1f5e-76b544e8305a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/769e40fc-3adc-f04b-f483-619f013efc2b"},"effectiveDateTime":"2021-02-01T21:10:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f5ef5e48-6be6-7a84-0815-55288a383f18","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f00fba1a-152b-a6f8-bdd3-bb329529615e"},"effectiveDateTime":"2011-10-30T04:51:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e7ad1592-462e-3307-871f-2e014d625cdb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/9e395b36-e067-1d12-1edc-0e99adc9983b"},"effectiveDateTime":"2021-02-04T23:36:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"431d8f69-80ac-368e-94e2-227ba6a316ac","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f00fba1a-152b-a6f8-bdd3-bb329529615e"},"effectiveDateTime":"2011-10-30T04:51:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e926b213-c0c2-c9a6-3039-27d8769e4a20","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f00fba1a-152b-a6f8-bdd3-bb329529615e"},"effectiveDateTime":"2011-10-31T05:01:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"23abd2ae-f277-68ab-8f52-d3a1809c5434","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f00fba1a-152b-a6f8-bdd3-bb329529615e"},"effectiveDateTime":"2011-10-31T05:01:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"901674cc-e95b-f985-0025-9daf3d700600","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f00fba1a-152b-a6f8-bdd3-bb329529615e"},"effectiveDateTime":"2011-11-01T05:59:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5fcaf2ef-775b-2458-c3a6-7368be6dc4f8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f00fba1a-152b-a6f8-bdd3-bb329529615e"},"effectiveDateTime":"2011-11-01T05:59:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"de7c3a9b-e148-e8d1-1fdb-1dcf3de6b585","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2c3fc8fe-92d1-ae93-4fe3-fac4469aac99"},"context":{"reference":"Encounter/a622d190-267a-3ba4-aba3-03ecde99ec4b"},"effectiveDateTime":"2020-09-08T23:54:49-07:00","reasonReference":[{"reference":"Condition/723532f9-6912-fe22-a71b-d949e9ac7d7f","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9d6a6bec-0c4f-dab1-44a9-d1b7a05e4305","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/55a3a377-dadd-9b4a-e5af-c7db5c009492"},"effectiveDateTime":"2021-02-08T03:06:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f9d52ca6-af96-984a-22b8-115aa911085a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/913c1cbe-9840-db3a-1d90-0d21f71bec44"},"effectiveDateTime":"2011-11-29T06:59:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ccd5a66f-1551-dde5-00ff-7a0f0960906d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5e2845e5-5ca3-b4b2-73a8-a48b54e74429"},"effectiveDateTime":"2021-02-11T07:01:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"700121f1-e337-b196-3925-abe1aeeeef24","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/3cbb996c-2f08-b776-6efb-647cb40c792a"},"context":{"reference":"Encounter/b7138285-d27d-c6c8-49fb-adb2ad64cd16"},"effectiveDateTime":"2021-06-16T12:31:04-07:00"}
{"resourceType":"MedicationAdministration","id":"24d6c7bf-1b47-56d6-4133-5e3e4ab558bb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/913c1cbe-9840-db3a-1d90-0d21f71bec44"},"effectiveDateTime":"2011-11-29T06:59:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"456a7202-928f-7d51-2f3a-8c8692531766","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f0b89b43-478a-93e0-3248-13149b16ae45"},"effectiveDateTime":"2021-02-14T10:43:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ed671c6f-2165-4cb9-c7c0-c37013f37b5c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/913c1cbe-9840-db3a-1d90-0d21f71bec44"},"effectiveDateTime":"2011-11-30T08:30:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2eff344f-8442-3217-959b-3819bcfcbd80","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/913c1cbe-9840-db3a-1d90-0d21f71bec44"},"effectiveDateTime":"2011-11-30T08:30:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"64a25334-b1a8-3f84-a145-def35d952944","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/913c1cbe-9840-db3a-1d90-0d21f71bec44"},"effectiveDateTime":"2011-12-01T10:05:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fc2cd926-9ddc-3e45-06a1-c143d4070013","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4666b9a6-604f-bf49-1d9d-21e06e6e5df6"},"effectiveDateTime":"2021-02-17T13:04:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"03d4b2e1-ddfc-7721-dfd8-7d1a99e735ef","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/913c1cbe-9840-db3a-1d90-0d21f71bec44"},"effectiveDateTime":"2011-12-01T10:05:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"910d8c55-dea9-f12e-7402-d01df91a0057","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/913c1cbe-9840-db3a-1d90-0d21f71bec44"},"effectiveDateTime":"2011-12-02T12:10:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ffe37922-9ddd-c058-204d-395f41699568","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/913c1cbe-9840-db3a-1d90-0d21f71bec44"},"effectiveDateTime":"2011-12-02T12:10:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a862b6ea-7dda-4960-ae08-1eeab77b97fd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/92a644e8-bb3f-ad6f-c68f-d35171249577"},"effectiveDateTime":"2021-02-20T15:26:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fed134a3-1629-62fb-029b-6d61be337198","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/913c1cbe-9840-db3a-1d90-0d21f71bec44"},"effectiveDateTime":"2011-12-03T13:09:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6bd41999-f5ab-b83c-fa03-c39c7952b92e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/913c1cbe-9840-db3a-1d90-0d21f71bec44"},"effectiveDateTime":"2011-12-03T13:09:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"72bb7aab-4376-8892-da59-2452446916ca","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/223c4659-5430-fa86-9f9b-2d1b89c0cbd4"},"effectiveDateTime":"2011-12-30T16:54:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2c36b726-7be9-26d9-7277-4799be8660e8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8337cdd0-c7f1-27bf-75d6-db750b020d14"},"effectiveDateTime":"2021-02-23T17:40:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0b85c39f-0772-4d35-f2f0-2d5f4415db4e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/223c4659-5430-fa86-9f9b-2d1b89c0cbd4"},"effectiveDateTime":"2011-12-30T16:54:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ad258b27-1d38-08c4-5055-66a7967f2523","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/223c4659-5430-fa86-9f9b-2d1b89c0cbd4"},"effectiveDateTime":"2011-12-31T17:51:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f3f75b5c-1b15-cea1-0320-3ee7ef7bc912","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/223c4659-5430-fa86-9f9b-2d1b89c0cbd4"},"effectiveDateTime":"2011-12-31T17:51:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"635d9c9f-14a7-e3b5-3404-eb23e5efe5d2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/711d36b0-83d5-246a-eec1-c01ee9264751"},"effectiveDateTime":"2021-02-26T20:09:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0bc5754c-292d-b762-2f40-fd03094c0929","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/223c4659-5430-fa86-9f9b-2d1b89c0cbd4"},"effectiveDateTime":"2012-01-01T21:24:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"49ef45cb-5371-9cf0-b7f1-2ae7c5a9556b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/223c4659-5430-fa86-9f9b-2d1b89c0cbd4"},"effectiveDateTime":"2012-01-01T21:24:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4433197f-83a9-03f7-d292-153d6d69409a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/223c4659-5430-fa86-9f9b-2d1b89c0cbd4"},"effectiveDateTime":"2012-01-03T01:23:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5b689d6d-39eb-ab1f-63db-e00a7402f1a3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/779225d6-f3ad-b582-e328-e8bb4fe3ef19"},"effectiveDateTime":"2021-03-01T22:49:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7ab9c39c-2c5f-4d34-7677-ad5c6902db93","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/223c4659-5430-fa86-9f9b-2d1b89c0cbd4"},"effectiveDateTime":"2012-01-03T01:23:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2bbf452e-7a52-d739-ddfe-0c130c9c99f6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/3cbb996c-2f08-b776-6efb-647cb40c792a"},"context":{"reference":"Encounter/ca871402-9577-508a-4742-c9546200bedb"},"effectiveDateTime":"2022-02-09T17:01:16-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"74f97f81-70b5-ccf8-c380-52db02d29d9f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/020078da-c80d-d503-1c69-1e22d282a312"},"effectiveDateTime":"2021-03-05T01:53:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"916defa6-864c-8e42-11e7-36c729e78c1e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d83cd6da-57e3-1e20-6ad4-40d87fa8bf00"},"effectiveDateTime":"2012-01-27T06:33:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"39ee48f1-f8b1-d8fb-a5e5-b6f3ddce5b89","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d83cd6da-57e3-1e20-6ad4-40d87fa8bf00"},"effectiveDateTime":"2012-01-27T06:33:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a000bfc9-5b4e-5fcf-0854-670d441ffcde","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/13986fa1-7c10-99d3-59de-3eda91a5f730"},"effectiveDateTime":"2021-03-08T03:57:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f7478671-9c52-89f2-72b5-8856b8d5c794","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d83cd6da-57e3-1e20-6ad4-40d87fa8bf00"},"effectiveDateTime":"2012-01-28T08:04:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2d6a3c8f-b0f5-c6b8-34fe-ae9ca77bb470","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d83cd6da-57e3-1e20-6ad4-40d87fa8bf00"},"effectiveDateTime":"2012-01-28T08:04:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"172dde4c-e6df-e6a2-b386-952d0531aee1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d83cd6da-57e3-1e20-6ad4-40d87fa8bf00"},"effectiveDateTime":"2012-01-29T11:28:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d5fdaadd-e450-32e1-0a27-7e8019ece669","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/aaa30932-23d2-7aaa-1e23-89daf8370143"},"effectiveDateTime":"2021-03-11T07:55:06-08:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"34c1de4d-81f0-6a66-d11a-952da04232a5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d83cd6da-57e3-1e20-6ad4-40d87fa8bf00"},"effectiveDateTime":"2012-01-29T11:28:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"908340b9-1def-4e51-a6eb-946062d99693","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/40ed047a-9952-e5e0-4b69-dbf3f4e543d2"},"effectiveDateTime":"2021-03-14T10:56:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6bf4a288-a19c-1154-3d4f-34bca536263e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/3ce020bf-c9a5-1523-af51-d5ef987f57e1"},"effectiveDateTime":"2021-03-17T13:30:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c46bed1b-4237-234b-6761-53b5496b4d1f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/cc147f51-35ec-d18e-023a-97166a2c4ab0"},"effectiveDateTime":"2021-03-20T16:22:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"28695cc3-5c6c-aaa5-526c-1c54f61afa7a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2c3fc8fe-92d1-ae93-4fe3-fac4469aac99"},"context":{"reference":"Encounter/fed1f464-91e9-c71b-9755-078df045cf1f"},"effectiveDateTime":"2021-09-14T23:32:41-07:00","reasonReference":[{"reference":"Condition/723532f9-6912-fe22-a71b-d949e9ac7d7f","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3691001d-1fc5-26e6-77f7-8557942be527","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/a51d7bb5-3aa9-a001-734f-28c080acf1c2"},"effectiveDateTime":"2021-03-23T19:34:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"036e77b0-7646-d68a-deee-f0f7977315ff","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d83cd6da-57e3-1e20-6ad4-40d87fa8bf00"},"effectiveDateTime":"2012-01-30T14:09:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"43d7fe20-a141-3946-45bd-1aa5523f10b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d83cd6da-57e3-1e20-6ad4-40d87fa8bf00"},"effectiveDateTime":"2012-01-30T14:09:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f76c527d-394a-4863-dc88-d7da9039b665","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d83cd6da-57e3-1e20-6ad4-40d87fa8bf00"},"effectiveDateTime":"2012-01-31T15:15:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"35a6c095-0345-742f-56fe-1650dec5ed76","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d83cd6da-57e3-1e20-6ad4-40d87fa8bf00"},"effectiveDateTime":"2012-01-31T15:15:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6f3caa4b-3fd7-af25-b1d9-e48298941f98","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/09457517-fc8c-cc59-dcc6-b61435fc4e55"},"effectiveDateTime":"2021-03-26T21:40:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cd940201-6407-1c40-ebe5-ca6323ff9320","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d83cd6da-57e3-1e20-6ad4-40d87fa8bf00"},"effectiveDateTime":"2012-02-01T19:01:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c70693b2-9a0a-4702-7f0e-2824b27a4520","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d83cd6da-57e3-1e20-6ad4-40d87fa8bf00"},"effectiveDateTime":"2012-02-01T19:01:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bab5f009-f75f-be14-54d2-c0b145ee9311","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6590115b-5232-38f5-86c8-d502a122b0be"},"effectiveDateTime":"2021-03-29T23:53:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0fdcc1e2-1b6f-b073-192b-9de5e5a8df98","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/9518f7d7-ec36-efba-3a5f-f006aedd1584"},"effectiveDateTime":"2012-02-28T22:05:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"69d5bb59-6d2c-6260-d7d7-a07604bee707","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/9518f7d7-ec36-efba-3a5f-f006aedd1584"},"effectiveDateTime":"2012-02-28T22:05:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9603c1c9-0262-92c3-d078-409519e3f948","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6b05619e-9c20-d4c1-6204-ff804b70005f"},"effectiveDateTime":"2021-04-02T03:46:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b4f3229b-52c0-c56a-d712-7c4253b353b6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/9518f7d7-ec36-efba-3a5f-f006aedd1584"},"effectiveDateTime":"2012-02-29T23:58:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"019d76bb-4bef-b29a-1298-4473538424fb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/9518f7d7-ec36-efba-3a5f-f006aedd1584"},"effectiveDateTime":"2012-02-29T23:58:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ea7fe248-7fa4-b50d-7d9f-8f69e964f1b1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/9518f7d7-ec36-efba-3a5f-f006aedd1584"},"effectiveDateTime":"2012-03-02T02:56:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ca5e48d6-155f-540d-3369-b6d7fa7bed0b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/9518f7d7-ec36-efba-3a5f-f006aedd1584"},"effectiveDateTime":"2012-03-02T02:56:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7f3eec8e-6403-06b8-86d3-5ef5535f3470","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/9518f7d7-ec36-efba-3a5f-f006aedd1584"},"effectiveDateTime":"2012-03-03T06:40:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7eaf57cc-d34c-51bc-d91f-66f5b81a3074","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/9518f7d7-ec36-efba-3a5f-f006aedd1584"},"effectiveDateTime":"2012-03-03T06:40:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b4525c95-928f-7d4f-9e24-78513d131764","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/12356566-f968-fbf5-613e-bc786b0ca25d"},"effectiveDateTime":"2021-04-05T07:36:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9321bf3b-6289-6246-0330-e82036401361","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/9518f7d7-ec36-efba-3a5f-f006aedd1584"},"effectiveDateTime":"2012-03-04T09:54:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9dd70cda-ed95-4a4a-1e50-54018b4ad326","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/9518f7d7-ec36-efba-3a5f-f006aedd1584"},"effectiveDateTime":"2012-03-04T09:54:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e932368d-df4c-7b0a-ba60-535e869b0cec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/9415a30a-0491-5965-f15f-18a2c895a334"},"effectiveDateTime":"2021-04-08T11:19:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"68730851-f5c4-1b23-5892-1eba496b6493","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6d0ea818-99bc-5f99-eb08-0b9541754766"},"effectiveDateTime":"2021-04-11T13:19:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"43562bcd-41bd-f223-0392-cf629c76d20d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/8b9effca-ea06-45fa-cad2-dc9dac85b7b5"},"effectiveDateTime":"2012-03-29T21:15:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1af9faab-4438-9b92-85dd-7a52452b29e7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/8b9effca-ea06-45fa-cad2-dc9dac85b7b5"},"effectiveDateTime":"2012-03-29T21:15:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ed58af0d-50e7-c5e9-0f2d-c073d6223a89","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/2dac4f11-4494-e36b-85e3-9f051f44ebdd"},"effectiveDateTime":"2021-04-14T17:09:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8aef5308-e411-2c1c-7d7d-a8ce4d64d31d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/8b9effca-ea06-45fa-cad2-dc9dac85b7b5"},"effectiveDateTime":"2012-03-30T23:37:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2f3f324d-6845-771c-7ddb-3617a19c8cc1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/8b9effca-ea06-45fa-cad2-dc9dac85b7b5"},"effectiveDateTime":"2012-03-30T23:37:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"be13ebd7-3904-6b23-0c59-7c79060ee00d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/8094ce1c-8b30-ac6f-01f8-518531ef641a"},"effectiveDateTime":"2021-04-17T19:45:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cf3f644f-5352-9216-addb-68198cab1ea4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/8b9effca-ea06-45fa-cad2-dc9dac85b7b5"},"effectiveDateTime":"2012-04-01T02:55:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"397a5854-10b5-c98c-8810-413370d29a33","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/f886390b-9f07-16e4-50f9-0ab44e462cf4"},"effectiveDateTime":"2021-04-20T23:38:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2e6fc192-6616-a770-8342-852c7b007a4d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/c9ddb566-f365-db53-343f-f5f34febb5ff"},"effectiveDateTime":"2021-04-24T02:43:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7d0e68e7-4ba1-2508-c3fd-d6e930bdd14e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/8b9effca-ea06-45fa-cad2-dc9dac85b7b5"},"effectiveDateTime":"2012-04-01T02:55:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0378c8ac-26be-f354-def9-41f355749cc8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/bba2e2f9-00f6-667a-e2ed-5f1bc6cf2010"},"effectiveDateTime":"2012-04-23T17:54:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4d09665e-1c9f-906f-aa74-b947c3a082fd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/bba2e2f9-00f6-667a-e2ed-5f1bc6cf2010"},"effectiveDateTime":"2012-04-23T17:54:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cb24a5f5-1063-65a0-6ebc-1608064d25dd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/bba2e2f9-00f6-667a-e2ed-5f1bc6cf2010"},"effectiveDateTime":"2012-04-24T18:39:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7b9bc355-fb6b-2037-5342-c44889c8e083","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/bba2e2f9-00f6-667a-e2ed-5f1bc6cf2010"},"effectiveDateTime":"2012-04-24T18:39:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7e5a958b-2512-2eee-b7fb-e42854ea02da","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d9b34a28-613f-b9fd-2039-c01d8a52aaed"},"effectiveDateTime":"2021-04-27T05:39:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"59c2ecd0-14a6-6bb7-689e-6d495bd57761","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/bba2e2f9-00f6-667a-e2ed-5f1bc6cf2010"},"effectiveDateTime":"2012-04-25T20:00:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"499dfb59-552c-6a98-b79f-e076115b12d3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/bba2e2f9-00f6-667a-e2ed-5f1bc6cf2010"},"effectiveDateTime":"2012-04-25T20:00:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2c929458-b7b3-bff0-1373-faddf2288744","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/b9b4b569-dac2-0ef6-24ed-ca919f28bcdc"},"effectiveDateTime":"2021-04-30T07:48:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9fd507fa-62c2-db00-e708-30ed8e9e5b79","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-21T09:35:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"794dbf9e-c2d5-0a69-f2e3-a95eff78a3fd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-21T09:35:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1be379f5-8a7d-f5ce-1b4d-3a322e17a219","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-22T13:20:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c4d2dc4f-71b7-299b-ea52-932f9008f671","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-22T13:20:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"49010823-e2e5-1f1f-093d-abbda5ca4089","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-23T15:40:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"97d29e4a-95bc-5eb4-6727-033bfc419929","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/6642418c-f76c-10d4-e6ac-ec1314bc9691"},"effectiveDateTime":"2021-05-03T10:23:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"df831c53-6a9c-8f9a-7408-c3545d2af6a6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-23T15:40:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d84cc170-6543-3a17-edfb-9d742f7cd7bb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-24T18:53:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0cb59cdd-da74-cf63-6370-0ced035b45f3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-24T18:53:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"38b18327-9fc7-07e1-e8b1-5ea8190e3bc3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-25T21:47:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"847ac35f-0a36-a1af-8478-7b669ea9dfda","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-25T21:47:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"69da73ba-2198-b3a0-d7dc-58d6f1d47de3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-26T23:34:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9d7b3ca4-12bd-b2fc-a145-76448a523998","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-26T23:34:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b7df7832-293b-2ac0-17c9-386eccd548f5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-28T02:03:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"96d4d48e-3e53-0176-63e3-eebe35331fc8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-28T02:03:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d41a278e-2cab-4d9b-3cee-fbbdd3ac402a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-29T04:51:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4774cd25-5552-ba82-ff7c-61989bf95bff","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-29T04:51:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d0cb4fa4-bdec-dfe1-04f5-234b79bc9969","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/0fdc87df-a4b8-c69a-955a-51be2de087b1"},"effectiveDateTime":"2021-05-06T14:19:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a45ab272-c570-d106-edd7-cc807d786579","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-30T07:18:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"49dfd92b-5376-40d0-b7e1-be4825d58753","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-30T07:18:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cbcf8299-2e2a-6bd2-9d53-1cae17fde9c7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/bf2b0036-7d41-cc3c-a05b-a9d19e9fb920"},"effectiveDateTime":"2021-05-09T17:00:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"845b4f88-855d-744a-04d4-96bd4878a026","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-31T08:31:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f853120d-edab-e4d5-c0d5-a10961ca849b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/f0baa358-b708-febf-90ac-708a8947d324"},"effectiveDateTime":"2016-05-15T15:39:14-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"578ebb3d-a62d-24d3-7068-19d9a9f75e79","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-05-31T08:31:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"13e7de4c-d57f-c6aa-caba-952cf3d193e6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-06-01T12:20:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"db28ae6b-c847-7727-ab9b-f10902bb3d8e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/2e4f705d-3b64-2915-6585-c1f54e8a28c7"},"effectiveDateTime":"2021-05-12T20:08:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8e8eb9b8-3182-9c47-ace0-86f4e8555327","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-06-01T12:20:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"62e372c8-67f5-0293-d64d-33050b8f93a2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-06-02T15:52:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"69ba7846-2257-33a8-d7bc-5d62f6dfaf43","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-06-02T15:52:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"908bb112-8ec2-0be7-a6f4-04b9ddbbb509","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7728e476-fc10-5003-7c83-d1b72b454702"},"effectiveDateTime":"2021-05-15T23:12:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d37432d9-02e7-d364-7dec-823fdeeb9d9e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-06-03T18:02:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8819ba8f-0351-8003-bd68-c47bded1f94a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f724999a-6033-89cc-c9b1-58ea27c1fc61"},"effectiveDateTime":"2012-06-03T18:02:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"088145b6-f2df-ee53-f486-040cfd1bdc23","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/6d85ec2b-a1ec-1dfb-dc46-25e2db887885"},"effectiveDateTime":"2016-06-28T17:45:23-07:00"}
{"resourceType":"MedicationAdministration","id":"499b2bda-8877-a600-9916-d63c9edff9a7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/a3926680-1451-b13d-b1a4-6aa6c9a67334"},"effectiveDateTime":"2021-05-19T02:56:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d4a7dfa4-bdba-9ee1-08d1-b34cbbbfb269","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/5046335f-1537-583c-1187-c1c5bb325100"},"effectiveDateTime":"2021-05-22T05:43:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3e3c7d2c-83c5-a9c4-6bd8-b6cdd262ebbc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/d7493a0e-ff4e-53dd-972d-3938505d5e7a"},"effectiveDateTime":"2021-05-25T09:27:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"463e9960-cb3f-ab8a-66e2-583df12b93fd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/aa96a58f-efa7-ca25-be01-51f6cc63f80a"},"effectiveDateTime":"2016-11-19T16:10:14-08:00"}
{"resourceType":"MedicationAdministration","id":"2deb7c64-92e9-ee26-018e-c34bf0f42a14","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/ad496f68-108c-ad88-6815-28f8492a6c68"},"effectiveDateTime":"2017-03-25T18:02:05-07:00"}
{"resourceType":"MedicationAdministration","id":"6aa3d11b-5dab-944d-5223-2942581ba376","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/4cde071a-c312-64cb-b1ac-0e7e673a9d88"},"effectiveDateTime":"2012-07-15T04:51:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2f47f99f-c8d7-58d2-0eb5-fb84e5c743d7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/4cde071a-c312-64cb-b1ac-0e7e673a9d88"},"effectiveDateTime":"2012-07-15T04:51:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d46934d9-88c1-2c15-c6f7-ad243010d316","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/4cde071a-c312-64cb-b1ac-0e7e673a9d88"},"effectiveDateTime":"2012-07-16T05:39:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0b788de3-7c1a-4ad4-e6f9-072ab83f9e7b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/4cde071a-c312-64cb-b1ac-0e7e673a9d88"},"effectiveDateTime":"2012-07-16T05:39:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"28048d59-ac21-f3b5-fbad-0ceacfa927de","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/ce7a2e0c-3af1-9d32-480b-261e2aedafa2"},"effectiveDateTime":"2021-05-28T12:39:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0a6c5399-64b9-2c06-fcfa-cc42dc7ed306","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/4cde071a-c312-64cb-b1ac-0e7e673a9d88"},"effectiveDateTime":"2012-07-17T09:16:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c6c8b79b-b945-ada2-7ed0-4c0f7e916bd0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/4cde071a-c312-64cb-b1ac-0e7e673a9d88"},"effectiveDateTime":"2012-07-17T09:16:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bdacaf01-0ec8-36d2-781c-be29f6587218","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/4cde071a-c312-64cb-b1ac-0e7e673a9d88"},"effectiveDateTime":"2012-07-18T11:33:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a8d07e30-0acc-fdd7-1124-258189fe78e6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/58105e9f-901e-6e6c-0281-8036144de17d"},"effectiveDateTime":"2021-05-31T15:15:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cf67dfd5-a221-c9c0-86d5-e1babf13d129","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/4cde071a-c312-64cb-b1ac-0e7e673a9d88"},"effectiveDateTime":"2012-07-18T11:33:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"045180ac-e787-82ff-efd5-1ac1d15c0312","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4829ef0b-6d1f-9ae6-6a0e-ee6626b276c6"},"effectiveDateTime":"2021-06-03T18:28:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9903e99a-9242-524a-197d-30db45235326","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/e674fcc3-d853-efa8-d71f-b9f42a982345"},"effectiveDateTime":"2012-08-13T12:38:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fd1f1c62-f8ef-aa08-bf20-c363eb7e2b6e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/e674fcc3-d853-efa8-d71f-b9f42a982345"},"effectiveDateTime":"2012-08-13T12:38:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"75089b32-457c-27e6-82f1-ac8ffd83bc5a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/e674fcc3-d853-efa8-d71f-b9f42a982345"},"effectiveDateTime":"2012-08-14T14:05:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cf47e04b-49d9-547b-26b5-e23066dccec0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/e674fcc3-d853-efa8-d71f-b9f42a982345"},"effectiveDateTime":"2012-08-14T14:05:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5fa11628-eef8-f44a-a33b-2b12c39965bb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/9f5c0534-f092-9f69-aa18-1a0fc60bdba3"},"effectiveDateTime":"2021-06-06T21:53:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"97abfb73-3ab6-5fcb-5952-fc65c9386fd7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/e674fcc3-d853-efa8-d71f-b9f42a982345"},"effectiveDateTime":"2012-08-15T14:14:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0374a70d-552d-93d8-def5-2054963599b8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/e674fcc3-d853-efa8-d71f-b9f42a982345"},"effectiveDateTime":"2012-08-15T14:14:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9568dea7-fd5e-f2fc-9933-18d58e9fe998","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c9056766-4035-789b-5350-8377067cc69f"},"effectiveDateTime":"2012-09-13T13:52:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1dd3ac6b-9688-d09b-1ec6-3af6fad90e42","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c9056766-4035-789b-5350-8377067cc69f"},"effectiveDateTime":"2012-09-13T13:52:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"36433593-552e-2e36-034d-aa7db58c81f8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/e441527a-b6e0-01ca-1ca2-6064e1686a12"},"effectiveDateTime":"2021-06-10T01:08:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"47816841-4ba0-ef42-ff88-fcb5a9678f1f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c9056766-4035-789b-5350-8377067cc69f"},"effectiveDateTime":"2012-09-14T14:29:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b083fbb0-ef5f-6961-5426-e9e5ee49299e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c9056766-4035-789b-5350-8377067cc69f"},"effectiveDateTime":"2012-09-14T14:29:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4fcaf0da-9408-bc05-7fa6-7153db4ec2b8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c9056766-4035-789b-5350-8377067cc69f"},"effectiveDateTime":"2012-09-15T15:07:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"66d547f9-aa2c-33de-b8a6-c9a6762313fc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c9056766-4035-789b-5350-8377067cc69f"},"effectiveDateTime":"2012-09-15T15:07:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9e774a60-09ab-8c69-2d03-aea2bd528d5c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c9056766-4035-789b-5350-8377067cc69f"},"effectiveDateTime":"2012-09-16T16:25:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7e5a9a15-422a-dd20-f53a-b86713b76576","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c9056766-4035-789b-5350-8377067cc69f"},"effectiveDateTime":"2012-09-16T16:25:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e9684575-6755-00f4-b3a2-787e4513dcf8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c9056766-4035-789b-5350-8377067cc69f"},"effectiveDateTime":"2012-09-17T19:47:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a0066ea6-fe96-b351-c37d-69170dbf9c1d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c9056766-4035-789b-5350-8377067cc69f"},"effectiveDateTime":"2012-09-17T19:47:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f57a9bfb-19a4-f3f6-aedf-f5c41ec2eae1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/33848393-d871-f689-3770-f114772f545c"},"effectiveDateTime":"2017-09-21T18:18:22-07:00"}
{"resourceType":"MedicationAdministration","id":"347f3eda-a9ad-bf25-771c-79873da14798","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/9e19e150-3459-98d8-b4fb-df17f4df03c5"},"effectiveDateTime":"2021-06-25T23:01:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"43b89b99-02c2-3704-783e-5557dec6013e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c9056766-4035-789b-5350-8377067cc69f"},"effectiveDateTime":"2012-09-18T23:31:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9146c22c-e6ba-0005-0155-eb15b8d0e700","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c9056766-4035-789b-5350-8377067cc69f"},"effectiveDateTime":"2012-09-18T23:31:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"69f5ded1-a8f3-5a70-d7f7-c3eed2da9e43","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/b5be881f-477f-006c-6d6f-fa86b9713c1c"},"effectiveDateTime":"2012-10-13T06:42:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"852d013b-a9ec-4485-0cd3-dd3f74269854","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/b5be881f-477f-006c-6d6f-fa86b9713c1c"},"effectiveDateTime":"2012-10-13T06:42:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0ba1a76d-7508-0188-208b-7cf1d6864522","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/70e92a4b-bdb6-d750-0885-9d0c3289c279"},"effectiveDateTime":"2021-06-29T01:01:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"62f51061-e022-c2cd-ac81-be69144c9678","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/575dd2bd-9f04-b064-eded-2c9f7d5b0406"},"effectiveDateTime":"2021-07-02T04:30:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a34d76bb-497e-37c1-e146-64735112ac6b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/b5be881f-477f-006c-6d6f-fa86b9713c1c"},"effectiveDateTime":"2012-10-14T07:12:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9ecfc01a-c8d7-6a4a-1f49-07656cb6f926","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/b5be881f-477f-006c-6d6f-fa86b9713c1c"},"effectiveDateTime":"2012-10-14T07:12:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"52ec65bf-cd9b-ad67-e182-08220b42ae59","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/b5be881f-477f-006c-6d6f-fa86b9713c1c"},"effectiveDateTime":"2012-10-15T09:36:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2935b1c0-9caa-c1dc-bdaa-5ed3ae9879e3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/b5be881f-477f-006c-6d6f-fa86b9713c1c"},"effectiveDateTime":"2012-10-15T09:36:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b32f867d-cd56-9bdf-dc18-e5f380110bee","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/b5be881f-477f-006c-6d6f-fa86b9713c1c"},"effectiveDateTime":"2012-10-16T10:21:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"90abd051-0b41-b286-00ba-f93a6ab76541","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/b5be881f-477f-006c-6d6f-fa86b9713c1c"},"effectiveDateTime":"2012-10-16T10:21:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"af3476bb-5c8a-47c3-250f-2473641ebc76","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/b5be881f-477f-006c-6d6f-fa86b9713c1c"},"effectiveDateTime":"2012-10-17T11:48:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a4546a79-79c8-3f84-e0f8-100d289da944","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/b5be881f-477f-006c-6d6f-fa86b9713c1c"},"effectiveDateTime":"2012-10-17T11:48:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ca580e78-9dbe-4a71-5953-846fd136cef4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/d5286016-8b98-5d80-3964-bfe0aabd7e1e"},"effectiveDateTime":"2018-05-19T18:35:58-07:00"}
{"resourceType":"MedicationAdministration","id":"371f3c4b-5f8b-4faf-d3ef-e39a0ceb7d6b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/dcb97186-c133-da52-e98f-ab0a287bf30f"},"effectiveDateTime":"2021-07-02T21:23:23-07:00","reasonReference":[{"reference":"Condition/bdd36fb6-96bb-aba9-a2ef-e92538a0ca92","display":"Awaiting transplantation of kidney (situation)"}]}
{"resourceType":"MedicationAdministration","id":"43e64109-4cc3-609c-8488-0e13c1ae3c11","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/dcb97186-c133-da52-e98f-ab0a287bf30f"},"effectiveDateTime":"2021-07-03T22:46:26-07:00","reasonReference":[{"reference":"Condition/57a28cd3-6c28-970f-66bd-e7c4613a4692","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"34c2f3b3-597f-2ef6-01cd-689e3a40c258","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/dcb97186-c133-da52-e98f-ab0a287bf30f"},"effectiveDateTime":"2021-07-04T23:27:54-07:00","reasonReference":[{"reference":"Condition/57a28cd3-6c28-970f-66bd-e7c4613a4692","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"cd5f4a97-f3eb-05e5-0189-1e438c614d4d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/dcb97186-c133-da52-e98f-ab0a287bf30f"},"effectiveDateTime":"2021-07-06T00:26:29-07:00","reasonReference":[{"reference":"Condition/57a28cd3-6c28-970f-66bd-e7c4613a4692","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"f50e4ef2-737d-9f64-37ab-89ad4d692bd8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/dcb97186-c133-da52-e98f-ab0a287bf30f"},"effectiveDateTime":"2021-07-07T01:05:32-07:00","reasonReference":[{"reference":"Condition/57a28cd3-6c28-970f-66bd-e7c4613a4692","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"2053a725-f029-18d8-4be0-cb9932c65394","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/dcb97186-c133-da52-e98f-ab0a287bf30f"},"effectiveDateTime":"2021-07-08T01:40:40-07:00","reasonReference":[{"reference":"Condition/57a28cd3-6c28-970f-66bd-e7c4613a4692","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"31b8ef28-7f99-0619-5b8c-9b006a046d4d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/dcb97186-c133-da52-e98f-ab0a287bf30f"},"effectiveDateTime":"2021-07-09T02:22:13-07:00","reasonReference":[{"reference":"Condition/57a28cd3-6c28-970f-66bd-e7c4613a4692","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"bcaba792-c4c8-0263-b77e-4a007ccf96d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-14T13:16:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4b28230c-e94f-5f79-b39b-65aa240e34f2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/dcb97186-c133-da52-e98f-ab0a287bf30f"},"effectiveDateTime":"2021-07-10T03:20:02-07:00","reasonReference":[{"reference":"Condition/57a28cd3-6c28-970f-66bd-e7c4613a4692","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"feff9590-ffb0-3e3e-359b-995b3a2da790","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-14T13:16:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3264fefe-f8d5-1e41-50b6-d2f585735521","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-15T15:30:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"497a48fc-119b-7390-e6da-5f1472d514de","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/dcb97186-c133-da52-e98f-ab0a287bf30f"},"effectiveDateTime":"2021-07-11T04:17:23-07:00","reasonReference":[{"reference":"Condition/57a28cd3-6c28-970f-66bd-e7c4613a4692","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"fe5dba5d-269b-1919-353d-d8aefa91a5b8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-15T15:30:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"beac1a90-db5c-3fe9-391c-29b9c55d474e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-16T18:19:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1a273bed-331d-91ed-97e2-605f62b15334","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/7c061c9b-35bb-2baf-3cad-8db1e17c26d3"},"effectiveDateTime":"2018-09-23T16:15:41-07:00","reasonReference":[{"reference":"Condition/b454214f-1cb4-01e5-1b1f-1e6b89950b69","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"498b7f8e-886b-23be-a1bb-4b6dded37765","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/dcb97186-c133-da52-e98f-ab0a287bf30f"},"effectiveDateTime":"2021-07-12T04:54:55-07:00","reasonReference":[{"reference":"Condition/57a28cd3-6c28-970f-66bd-e7c4613a4692","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"24f8bfdf-0a08-4d8e-0517-11b30c171685","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-16T18:19:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f65181e7-8ddc-1de9-ff35-1bfc77b23474","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/dcb97186-c133-da52-e98f-ab0a287bf30f"},"effectiveDateTime":"2021-07-13T05:36:04-07:00","reasonReference":[{"reference":"Condition/57a28cd3-6c28-970f-66bd-e7c4613a4692","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"b8c6fa2a-0698-b26f-147d-c7cb476d38fe","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/5e8dd4a0-a9f9-acd4-5f0e-d1f317e2c6ca"},"context":{"reference":"Encounter/baa84cbc-e77c-c8ff-ba57-ef5fca672927"},"effectiveDateTime":"2016-10-20T09:49:51-07:00","reasonReference":[{"reference":"Condition/123ecce9-481a-2a35-0b80-11809904bfd3","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d7c17144-71bb-721e-00b1-28aec1fba657","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/8f509e71-72af-eab5-37a2-ee5687774a84"},"effectiveDateTime":"2019-02-13T17:52:41-08:00"}
{"resourceType":"MedicationAdministration","id":"194ef2cf-d1e0-b009-9de3-49de3a345761","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/dcb97186-c133-da52-e98f-ab0a287bf30f"},"effectiveDateTime":"2021-07-14T06:18:18-07:00","reasonReference":[{"reference":"Condition/57a28cd3-6c28-970f-66bd-e7c4613a4692","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"f28d0147-e146-4795-f51b-dd4bab80c94b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-17T21:25:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f5672c2e-56c2-d4fc-3cb7-62eea89e5576","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-17T21:25:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"10518328-f6a0-a678-37d3-5ea96fe7f6db","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-18T23:17:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0aec53ea-399b-8631-998d-1a393d428723","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-18T23:17:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08598a9b-4b39-efec-2bde-dc424c2c7e8d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-20T02:26:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3bbce1e9-21d5-9a24-64a6-f42176f00a33","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-20T02:26:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2d99d33f-80ac-368f-7f6e-02eaec6316ad","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-21T04:36:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5a429aa3-5615-98f1-832c-b2790bf00900","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-21T04:36:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b9caebb8-db5b-1f25-70a6-6c3222ac08a0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-22T05:32:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3dad0c73-80ff-fc2e-181d-1b9c6b1d2b85","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-22T05:32:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7c5ae350-8206-2aae-b33b-01a2564b38f4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-23T06:26:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c622104f-be9a-8fe2-7e29-a4c4cfde2170","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-23T06:26:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4826437d-f0fd-b723-0862-e726905fd20d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-24T07:13:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9a9d9d8a-1da9-1db6-84c5-7610d8192cdf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-24T07:13:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"038a9d61-4df6-fc81-df8e-679bd94979df","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-25T08:35:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"28f2162a-1c8a-1d81-cbc6-b581c38b100f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/deb6fc7c-906f-6ca1-afa0-84812d81a834"},"effectiveDateTime":"2012-11-25T08:35:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2cec4eb3-1126-a810-d3ed-4141bbe9849d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6ce5dc7c-8991-e3cc-e825-8e9ab5f907d1"},"effectiveDateTime":"2012-12-19T23:56:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"78a681b5-82d1-bde0-a0fe-fbd253790c94","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"205923","display":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"}],"text":"1 ML Epoetin Alfa 4000 UNT/ML Injection [Epogen]"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/7c15bf6e-c05f-d21f-504d-9e98815a220e"},"effectiveDateTime":"2021-07-23T23:05:06-07:00","reasonReference":[{"reference":"Condition/53550b6a-0a30-2af1-cf2c-7346710f7210","display":"Anemia (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b0d65635-7be7-686a-85db-742c6a1932f5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/e9b3267a-aa36-4929-aee5-903e49192865"},"effectiveDateTime":"2019-08-12T19:11:40-07:00"}
{"resourceType":"MedicationAdministration","id":"1bec1bca-b19b-99b3-aa96-dea73f429aa5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6ce5dc7c-8991-e3cc-e825-8e9ab5f907d1"},"effectiveDateTime":"2012-12-19T23:56:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2bfd86ce-3234-8c9b-2cf0-15794b030e42","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6ce5dc7c-8991-e3cc-e825-8e9ab5f907d1"},"effectiveDateTime":"2012-12-21T00:58:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"03b5520b-9c8a-40dc-982a-aad21097f8e3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6ce5dc7c-8991-e3cc-e825-8e9ab5f907d1"},"effectiveDateTime":"2012-12-21T00:58:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"08e64960-6f91-298e-a621-22eea1959cd0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/b2d3eb9e-4894-c23d-a815-bb651ab235ca"},"effectiveDateTime":"2021-07-30T21:27:36-07:00","reasonReference":[{"reference":"Condition/57a28cd3-6c28-970f-66bd-e7c4613a4692","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"8654ab3d-2c11-eddc-486e-e9d92fdc288a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6ce5dc7c-8991-e3cc-e825-8e9ab5f907d1"},"effectiveDateTime":"2012-12-22T02:31:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"69c2fb14-a6a4-6740-d7c4-e031fd85745f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6ce5dc7c-8991-e3cc-e825-8e9ab5f907d1"},"effectiveDateTime":"2012-12-22T02:31:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"085280a5-94c4-e511-c4e8-ba0004d40dfb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6ce5dc7c-8991-e3cc-e825-8e9ab5f907d1"},"effectiveDateTime":"2012-12-23T04:24:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"be0647c6-a9a5-001e-8840-f6ec37fbdc22","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6ce5dc7c-8991-e3cc-e825-8e9ab5f907d1"},"effectiveDateTime":"2012-12-23T04:24:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"88871d30-428d-79c3-4348-569f1dc6a720","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1605257","display":"Liletta 52 MG Intrauterine System"}],"text":"Liletta 52 MG Intrauterine System"},"subject":{"reference":"Patient/5e8dd4a0-a9f9-acd4-5f0e-d1f317e2c6ca"},"context":{"reference":"Encounter/1869ca11-ded2-d46b-0573-7cdb60cb33be"},"effectiveDateTime":"2019-09-12T07:05:22-07:00"}
{"resourceType":"MedicationAdministration","id":"ddcad612-83a3-9688-88d5-165a6d63d32c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6ce5dc7c-8991-e3cc-e825-8e9ab5f907d1"},"effectiveDateTime":"2012-12-24T08:15:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a4d5880e-1da9-0e7e-8f98-182018191da7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6ce5dc7c-8991-e3cc-e825-8e9ab5f907d1"},"effectiveDateTime":"2012-12-24T08:15:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c7b15c49-64b5-31da-b82d-132983070876","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-20T09:56:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7b574923-5e8a-8b1e-f49e-a3932079669e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-20T09:56:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"de70eda8-ae3d-e7fa-541a-e5545bf5ef8f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-21T13:44:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a7544b14-9347-1c68-c4be-c8ff7eb51e4d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-21T13:44:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5aa1eabf-108e-919b-3fc4-29074df44d08","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/5e8dd4a0-a9f9-acd4-5f0e-d1f317e2c6ca"},"context":{"reference":"Encounter/e52632e1-2042-6279-c7c8-a60a85813989"},"effectiveDateTime":"2019-10-24T13:07:36-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"02a9b7c2-003e-e6b9-0a3e-2d6ecc193471","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-22T16:06:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fc5e7e24-b536-fd90-333e-9c768bea2cfa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-22T16:06:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"aac18e4e-2afe-a946-6994-17c50b1cfb1d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-23T19:13:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b8d7c8f6-740d-60f6-9846-c6a1277f1148","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/5ddeffb0-8e0b-52ef-1331-9b9292587fa8"},"effectiveDateTime":"2020-07-07T19:29:15-07:00"}
{"resourceType":"MedicationAdministration","id":"f6909f69-59ac-7d86-6ff7-24a3cf95a20a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4c37d611-0b2a-1c76-9026-9c78f664fbdf"},"effectiveDateTime":"2021-08-20T21:04:20-07:00","reasonReference":[{"reference":"Condition/57a28cd3-6c28-970f-66bd-e7c4613a4692","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"43b59c68-6c14-ceec-8870-0c7795002e55","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-23T19:13:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a16c399d-fc51-ed8d-87e3-19bc4e28b7ca","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-24T21:49:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9911d2ce-2f74-7da6-634e-b9450f92cf7d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-24T21:49:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dda98f33-eaca-dea7-2504-e27809a65f21","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-25T22:28:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4976d992-44d5-d619-feab-1b7ffcdd6a8e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-25T22:28:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bbef98d7-8367-2adf-d95d-951d82d52cc4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-26T23:59:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"83471d27-14dc-77bc-9e29-5695f0168e3a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/5e8dd4a0-a9f9-acd4-5f0e-d1f317e2c6ca"},"context":{"reference":"Encounter/700e9f4d-4a9b-a22f-0f98-03f3bb9a79c5"},"effectiveDateTime":"2020-09-08T10:49:11-07:00"}
{"resourceType":"MedicationAdministration","id":"22fc413c-0684-c045-ed37-1d3492839c48","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-26T23:59:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"238bfbae-d98e-020e-03aa-4d85c5409505","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-28T03:47:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dc6b0494-711c-86b8-e3ff-7a4f5dc14470","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-28T03:47:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"046ef490-4e0f-7997-ee47-718ff7e313ab","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/bdaf4f79-8610-3c6a-12c2-971ec0fe054b"},"effectiveDateTime":"2021-09-10T21:23:11-07:00","reasonReference":[{"reference":"Condition/57a28cd3-6c28-970f-66bd-e7c4613a4692","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"d806bf90-9a85-0408-91ba-2950d728b1f6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-29T05:48:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6aed6eb2-7d6a-9afa-f749-eb14b70be997","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/fbe8abdd-6e8b-fd19-4e1a-1d8e529998c0"},"effectiveDateTime":"2021-09-17T22:58:48-07:00","reasonReference":[{"reference":"Condition/57a28cd3-6c28-970f-66bd-e7c4613a4692","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"15eab39b-bc1a-5146-17cf-d10b29e7ecb4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-29T05:48:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"008901ce-2d8a-39ff-0278-54850da88bd6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-30T07:36:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ffb34448-8a5a-f972-6973-80ec385ed818","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-30T07:36:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1e4d4c1b-b99b-857d-ad05-b69ff942866f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-31T10:07:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"94eeaad4-c367-1f60-b25f-7fdd42d52145","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-01-31T10:07:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2b7bd79c-6cba-483f-1099-49252151b641","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-02-01T12:17:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e02479c5-7ea7-1c40-fe76-50de09f09320","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/697c48e3-be4e-d0cf-254a-6c304068db55"},"effectiveDateTime":"2013-02-01T12:17:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c24bc4ff-54dd-996d-a97f-eed306fa9be6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/4f51113c-0736-dade-1644-360c075a97f8"},"effectiveDateTime":"2021-09-25T00:26:25-07:00","reasonReference":[{"reference":"Condition/57a28cd3-6c28-970f-66bd-e7c4613a4692","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"8ec76efe-9da8-860a-7ac8-9e2478189533","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/7ffd2496-d290-6c11-cc71-ef5f6ec67e3d"},"effectiveDateTime":"2013-02-24T05:08:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9b6e381d-fd22-1b0d-e725-183c4efa1d6b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/7ffd2496-d290-6c11-cc71-ef5f6ec67e3d"},"effectiveDateTime":"2013-02-24T05:08:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"51abe6a5-1051-66b9-5940-5ca89f526471","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/7ffd2496-d290-6c11-cc71-ef5f6ec67e3d"},"effectiveDateTime":"2013-02-25T08:47:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"588f8331-6f65-762a-489f-5eb1e8acd663","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/7ffd2496-d290-6c11-cc71-ef5f6ec67e3d"},"effectiveDateTime":"2013-02-25T08:47:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f11dada4-044b-e8f4-cd75-e8141374d501","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/7ffd2496-d290-6c11-cc71-ef5f6ec67e3d"},"effectiveDateTime":"2013-02-26T11:33:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a073b63b-bd28-4c76-0e9f-d3f3c4bcc27d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/7ffd2496-d290-6c11-cc71-ef5f6ec67e3d"},"effectiveDateTime":"2013-02-26T11:33:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1614de4e-3bdf-5a8c-24a5-152e5a3132b0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/7ffd2496-d290-6c11-cc71-ef5f6ec67e3d"},"effectiveDateTime":"2013-02-27T11:38:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7dfe9d46-dd51-6b1d-bee7-a0b4df36889f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/7ffd2496-d290-6c11-cc71-ef5f6ec67e3d"},"effectiveDateTime":"2013-02-27T11:38:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0c03774a-b44a-95fc-c7c9-2e2634c3dd5c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/7ffd2496-d290-6c11-cc71-ef5f6ec67e3d"},"effectiveDateTime":"2013-02-28T13:00:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"86504b3d-7211-e94d-647e-01d975dc2453","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/7ffd2496-d290-6c11-cc71-ef5f6ec67e3d"},"effectiveDateTime":"2013-02-28T13:00:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dc6c3a12-0d69-a32c-96a3-1a305f41dcb0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/7ffd2496-d290-6c11-cc71-ef5f6ec67e3d"},"effectiveDateTime":"2013-03-01T13:38:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5ed82a65-9ec4-6639-666c-a073ffb2f3f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/7ffd2496-d290-6c11-cc71-ef5f6ec67e3d"},"effectiveDateTime":"2013-03-01T13:38:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2cf12af5-52c0-dda8-d3f2-1d841bed508f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/5841cf38-a4be-2ce8-7ac0-97fd881715a1"},"effectiveDateTime":"2013-03-24T12:39:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9bbe3c22-f644-c06c-65f9-60d4c1e39c70","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/5841cf38-a4be-2ce8-7ac0-97fd881715a1"},"effectiveDateTime":"2013-03-24T12:39:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0e85378e-d216-992f-3771-cf8b0291093e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/5841cf38-a4be-2ce8-7ac0-97fd881715a1"},"effectiveDateTime":"2013-03-25T12:55:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b2fd3280-e472-73e4-2b2d-5a1cacf502e0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1665060","display":"cefazolin 2000 MG Injection"}],"text":"cefazolin 2000 MG Injection"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/c94a2f1b-380e-cf44-749e-a69105572b70"},"effectiveDateTime":"2020-10-19T14:43:46-07:00"}
{"resourceType":"MedicationAdministration","id":"69bc5e2c-6979-3b72-fcbb-e43bd77b208f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/5841cf38-a4be-2ce8-7ac0-97fd881715a1"},"effectiveDateTime":"2013-03-25T12:55:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"83abd407-58d4-7dc4-1152-d4f9e79e52bb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/5841cf38-a4be-2ce8-7ac0-97fd881715a1"},"effectiveDateTime":"2013-03-26T13:44:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d9ce7cf4-495b-331e-02be-34774bd4efa7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1659263","display":"1 ML heparin sodium, porcine 5000 UNT/ML Injection"}],"text":"1 ML heparin sodium, porcine 5000 UNT/ML Injection"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/c94a2f1b-380e-cf44-749e-a69105572b70"},"effectiveDateTime":"2020-10-19T14:43:46-07:00"}
{"resourceType":"MedicationAdministration","id":"a6e349e4-6932-1904-3a8d-36ffd733fe22","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/5841cf38-a4be-2ce8-7ac0-97fd881715a1"},"effectiveDateTime":"2013-03-26T13:44:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"10fbb672-0d70-e639-1890-2cc34ce733f1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/5841cf38-a4be-2ce8-7ac0-97fd881715a1"},"effectiveDateTime":"2013-03-27T13:54:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4ecf0829-9f80-da6f-bdd5-0d1d18912c4e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1796676","display":"25 ML protamine sulfate (USP) 10 MG/ML Injection"}],"text":"25 ML protamine sulfate (USP) 10 MG/ML Injection"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/c94a2f1b-380e-cf44-749e-a69105572b70"},"effectiveDateTime":"2020-10-19T14:43:46-07:00"}
{"resourceType":"MedicationAdministration","id":"5cfac30b-863c-8fa7-d348-7b131ab2e0e6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/5841cf38-a4be-2ce8-7ac0-97fd881715a1"},"effectiveDateTime":"2013-03-27T13:54:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4fb96e9a-a1c8-5cf1-2f28-749fa03ded43","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"311034","display":"insulin, regular, human 100 UNT/ML Injectable Solution"}],"text":"insulin, regular, human 100 UNT/ML Injectable Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/c94a2f1b-380e-cf44-749e-a69105572b70"},"effectiveDateTime":"2020-10-19T14:46:46-07:00"}
{"resourceType":"MedicationAdministration","id":"8d104d54-9ab5-6c30-2539-3d0c1db87a07","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1740467","display":"2 ML Ondansetron 2 MG/ML Injection"}],"text":"2 ML Ondansetron 2 MG/ML Injection"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/c94a2f1b-380e-cf44-749e-a69105572b70"},"effectiveDateTime":"2020-10-19T16:04:39-07:00"}
{"resourceType":"MedicationAdministration","id":"8bc436da-d26a-7860-6c84-fa507874b44e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"311700","display":"Midazolam 1 MG/ML Injectable Solution"}],"text":"Midazolam 1 MG/ML Injectable Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/c94a2f1b-380e-cf44-749e-a69105572b70"},"effectiveDateTime":"2020-10-19T16:04:39-07:00"}
{"resourceType":"MedicationAdministration","id":"99a91ea3-5102-ecad-5f97-460d113f9062","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c6728850-6f5f-4012-3fec-472a4bbb0bb4"},"effectiveDateTime":"2013-04-24T08:16:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ede3e27f-f4d2-794e-025b-be417659649a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1808217","display":"100 ML Propofol 10 MG/ML Injection"}],"text":"100 ML Propofol 10 MG/ML Injection"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/c94a2f1b-380e-cf44-749e-a69105572b70"},"effectiveDateTime":"2020-10-19T16:04:39-07:00"}
{"resourceType":"MedicationAdministration","id":"d2d58324-87ba-e6e0-af24-5ea50102506c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c6728850-6f5f-4012-3fec-472a4bbb0bb4"},"effectiveDateTime":"2013-04-24T08:16:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bcb854d3-a601-91c0-3a74-6cec14b65308","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1234995","display":"Rocuronium bromide 10 MG/ML Injectable Solution"}],"text":"Rocuronium bromide 10 MG/ML Injectable Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/c94a2f1b-380e-cf44-749e-a69105572b70"},"effectiveDateTime":"2020-10-19T16:04:39-07:00"}
{"resourceType":"MedicationAdministration","id":"2cdb2bfc-f8a0-9d94-d3dc-1e8bcc112491","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c6728850-6f5f-4012-3fec-472a4bbb0bb4"},"effectiveDateTime":"2013-04-25T10:08:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c4b1d345-156b-0a71-53ad-4b75464873f4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"542347","display":"isoflurane 99.9 % Inhalation Solution"}],"text":"isoflurane 99.9 % Inhalation Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/c94a2f1b-380e-cf44-749e-a69105572b70"},"effectiveDateTime":"2020-10-19T16:04:39-07:00"}
{"resourceType":"MedicationAdministration","id":"13b4fd34-4083-e2fc-177f-3882029fd998","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c6728850-6f5f-4012-3fec-472a4bbb0bb4"},"effectiveDateTime":"2013-04-25T10:08:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"af85d7dc-6d7c-d719-1e8b-ddf81aad28f9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1809104","display":"5 ML SUFentanil 0.05 MG/ML Injection"}],"text":"5 ML SUFentanil 0.05 MG/ML Injection"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/c94a2f1b-380e-cf44-749e-a69105572b70"},"effectiveDateTime":"2020-10-19T16:04:39-07:00"}
{"resourceType":"MedicationAdministration","id":"3cf87a85-d013-1e40-5b4a-54fedd72d520","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c6728850-6f5f-4012-3fec-472a4bbb0bb4"},"effectiveDateTime":"2013-04-26T11:44:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ffc2f22c-90d4-f5fb-7e9e-72a5d83eda31","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c6728850-6f5f-4012-3fec-472a4bbb0bb4"},"effectiveDateTime":"2013-04-26T11:44:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c3fa8167-122e-337a-15d5-0551d1251399","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c6728850-6f5f-4012-3fec-472a4bbb0bb4"},"effectiveDateTime":"2013-04-27T13:03:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b735c39f-7eaf-a493-8cb3-ad5fbb53599b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c6728850-6f5f-4012-3fec-472a4bbb0bb4"},"effectiveDateTime":"2013-04-27T13:03:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f8112da5-ce83-b4d1-b982-8815ddaca219","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c6728850-6f5f-4012-3fec-472a4bbb0bb4"},"effectiveDateTime":"2013-04-28T16:04:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"8b05a772-c547-f7d0-2ee6-60207d4f8c47","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/c6728850-6f5f-4012-3fec-472a4bbb0bb4"},"effectiveDateTime":"2013-04-28T16:04:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"004c418d-c814-c0d1-ca87-b778ce1b9cd4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6989ebe5-1915-4117-7b65-d5ff4f3420a0"},"effectiveDateTime":"2013-05-26T14:46:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b4fc7855-b1ca-4030-4973-642bbdd7f838","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6989ebe5-1915-4117-7b65-d5ff4f3420a0"},"effectiveDateTime":"2013-05-26T14:46:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3ebfa474-edae-5538-cc77-ac09649d28a5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6989ebe5-1915-4117-7b65-d5ff4f3420a0"},"effectiveDateTime":"2013-05-27T18:38:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4c508a93-1aea-c0fc-e0c7-796688787903","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6989ebe5-1915-4117-7b65-d5ff4f3420a0"},"effectiveDateTime":"2013-05-27T18:38:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2ba08d50-7b4a-c03b-c017-7f12a4587842","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6989ebe5-1915-4117-7b65-d5ff4f3420a0"},"effectiveDateTime":"2013-05-28T21:58:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a8e14dfd-8195-00bf-731c-c6de961bdcc3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6989ebe5-1915-4117-7b65-d5ff4f3420a0"},"effectiveDateTime":"2013-05-28T21:58:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1dd84df7-c578-d0ab-1eca-dcdd2d269e52","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/17c8cf06-3bac-a5b4-cffd-0e5cc0e1e9f5"},"effectiveDateTime":"2013-06-20T05:44:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fd68ea49-7d5d-633b-0133-25df1c1499d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/17c8cf06-3bac-a5b4-cffd-0e5cc0e1e9f5"},"effectiveDateTime":"2013-06-20T05:44:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0767a855-b7a8-39bc-fed5-aa3ad573b6b2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/17c8cf06-3bac-a5b4-cffd-0e5cc0e1e9f5"},"effectiveDateTime":"2013-06-21T07:01:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"49ba5c82-99de-53a8-b7bc-41a0655b4a9f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/17c8cf06-3bac-a5b4-cffd-0e5cc0e1e9f5"},"effectiveDateTime":"2013-06-21T07:01:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b4fd8322-183c-35c0-c87a-5ea29183a8ce","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/17c8cf06-3bac-a5b4-cffd-0e5cc0e1e9f5"},"effectiveDateTime":"2013-06-22T10:18:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"41a73e9b-668f-76ce-5dce-3842678205b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/17c8cf06-3bac-a5b4-cffd-0e5cc0e1e9f5"},"effectiveDateTime":"2013-06-22T10:18:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"517e94e9-021c-30eb-eb3e-bb3fde1ffb26","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/17c8cf06-3bac-a5b4-cffd-0e5cc0e1e9f5"},"effectiveDateTime":"2013-06-23T10:44:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4102568c-1da9-5d05-2f69-572578196c2e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/17c8cf06-3bac-a5b4-cffd-0e5cc0e1e9f5"},"effectiveDateTime":"2013-06-23T10:44:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"56d325b5-6ac9-66b9-5e67-9cebeb36b471","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/17c8cf06-3bac-a5b4-cffd-0e5cc0e1e9f5"},"effectiveDateTime":"2013-06-24T14:42:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"57679372-386b-37f5-aad5-95575638d810","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/17c8cf06-3bac-a5b4-cffd-0e5cc0e1e9f5"},"effectiveDateTime":"2013-06-24T14:42:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"28067488-90ca-4012-bc7d-eca87627f819","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f29294af-6a63-30cb-01fa-d33752c79641"},"effectiveDateTime":"2013-07-20T02:21:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c616d6ac-9f01-0da1-d53f-c59cdecbc811","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f29294af-6a63-30cb-01fa-d33752c79641"},"effectiveDateTime":"2013-07-20T02:21:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9ebee4cb-cdaf-0fb8-4c76-ec60452a0f3e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f29294af-6a63-30cb-01fa-d33752c79641"},"effectiveDateTime":"2013-07-21T05:08:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"03733fde-47cf-3a20-def3-b925bf7f327a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f29294af-6a63-30cb-01fa-d33752c79641"},"effectiveDateTime":"2013-07-21T05:08:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"008f9025-f59b-b80e-8f7f-4bd01d42b900","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f29294af-6a63-30cb-01fa-d33752c79641"},"effectiveDateTime":"2013-07-22T07:51:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fceedf0e-b0ae-3662-4ecc-d683f5a51681","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f29294af-6a63-30cb-01fa-d33752c79641"},"effectiveDateTime":"2013-07-22T07:51:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5e8dad4c-6739-c33c-6257-e90cb83181d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f29294af-6a63-30cb-01fa-d33752c79641"},"effectiveDateTime":"2013-07-23T09:39:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7653417d-adab-a928-0543-55bb9d52aa1b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f29294af-6a63-30cb-01fa-d33752c79641"},"effectiveDateTime":"2013-07-23T09:39:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9ec78732-c587-074e-221d-25007d8e9bc6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f29294af-6a63-30cb-01fa-d33752c79641"},"effectiveDateTime":"2013-07-24T10:50:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"947660b7-0353-a370-0cab-ba93ded41cb8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f29294af-6a63-30cb-01fa-d33752c79641"},"effectiveDateTime":"2013-07-24T10:50:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"40d1cba4-91f0-5e23-010e-6f62de72a50d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6a783afa-1ad4-6f87-56c3-9d1ec719da58"},"effectiveDateTime":"2013-08-20T17:25:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"14cefa00-ddaa-c6c4-0462-1a92981ad5ed","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6a783afa-1ad4-6f87-56c3-9d1ec719da58"},"effectiveDateTime":"2013-08-20T17:25:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"dcf69464-2d60-830a-563e-11286cd35e8b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6a783afa-1ad4-6f87-56c3-9d1ec719da58"},"effectiveDateTime":"2013-08-21T18:36:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0b6cad34-6a3c-abda-e6ed-267be700eb4c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6a783afa-1ad4-6f87-56c3-9d1ec719da58"},"effectiveDateTime":"2013-08-21T18:36:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"868cbf96-8f5e-dac8-c03b-a956cc029940","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6a783afa-1ad4-6f87-56c3-9d1ec719da58"},"effectiveDateTime":"2013-08-22T20:21:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ffbb0b15-bb0f-6783-e97b-47b97987a132","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6a783afa-1ad4-6f87-56c3-9d1ec719da58"},"effectiveDateTime":"2013-08-22T20:21:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7983f046-83c1-433c-7d4e-2c2f54d749d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6a783afa-1ad4-6f87-56c3-9d1ec719da58"},"effectiveDateTime":"2013-08-23T20:38:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a1675e48-d69a-cee7-2a17-9528f4ecae2e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/6a783afa-1ad4-6f87-56c3-9d1ec719da58"},"effectiveDateTime":"2013-08-23T20:38:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fdaeab95-6ce3-dfb2-b81e-babe5d129cb1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d92cca17-cf5c-2eaf-ef16-77e46cab13c2"},"effectiveDateTime":"2013-09-19T22:37:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d031a8f7-009a-685c-b54f-aecea071d65e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d92cca17-cf5c-2eaf-ef16-77e46cab13c2"},"effectiveDateTime":"2013-09-19T22:37:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"db5d9532-e6e5-12fc-df27-d13ff48fc998","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d92cca17-cf5c-2eaf-ef16-77e46cab13c2"},"effectiveDateTime":"2013-09-21T00:08:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"bdac85a6-e4d4-957e-981c-94cfd508cc29","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d92cca17-cf5c-2eaf-ef16-77e46cab13c2"},"effectiveDateTime":"2013-09-21T00:08:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cc67c29f-532b-20da-b1fc-d3891367c49b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d92cca17-cf5c-2eaf-ef16-77e46cab13c2"},"effectiveDateTime":"2013-09-22T00:17:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"69e37e9f-240b-6550-d7e5-63bd2b380dd7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/d92cca17-cf5c-2eaf-ef16-77e46cab13c2"},"effectiveDateTime":"2013-09-22T00:17:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1e3ea44e-9883-2320-2bf6-abe310dfee4c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f8673f52-eebc-f9fb-f8c6-e9d600736e12"},"effectiveDateTime":"2013-10-16T21:42:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"762248df-0352-a1e7-fbee-fb9fded31b2e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f8673f52-eebc-f9fb-f8c6-e9d600736e12"},"effectiveDateTime":"2013-10-16T21:42:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d7678fcc-ba21-9a80-a2d5-91b1d8398c69","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f8673f52-eebc-f9fb-f8c6-e9d600736e12"},"effectiveDateTime":"2013-10-18T01:32:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b2dc3fe9-1327-829c-f288-99d72b9ac539","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/65dddfdc-297e-978a-d0ad-d9e1aed8021a"},"context":{"reference":"Encounter/add55570-b766-bd75-4d0a-84ea392fef51"},"effectiveDateTime":"2024-03-15T23:43:22-07:00","reasonReference":[{"reference":"Condition/4fa0c31d-5a89-b9d3-e8be-e162891202c4","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"feff9b75-0b39-c064-959b-9f3f4769a436","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f8673f52-eebc-f9fb-f8c6-e9d600736e12"},"effectiveDateTime":"2013-10-18T01:32:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c79bf58f-48ce-75a6-4f42-f681d7dace73","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f8673f52-eebc-f9fb-f8c6-e9d600736e12"},"effectiveDateTime":"2013-10-19T05:27:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"09b54965-97c0-21d1-cf42-11e007cf4ac1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f8673f52-eebc-f9fb-f8c6-e9d600736e12"},"effectiveDateTime":"2013-10-19T05:27:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a8114dcc-2cf6-7ec9-3e27-5ec30d14d0ab","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f8673f52-eebc-f9fb-f8c6-e9d600736e12"},"effectiveDateTime":"2013-10-20T07:03:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"22db0815-51ef-280c-02f9-59f6e8053903","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f8673f52-eebc-f9fb-f8c6-e9d600736e12"},"effectiveDateTime":"2013-10-20T07:03:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7648ad4a-9fa1-f088-fc93-a326201b380e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f8673f52-eebc-f9fb-f8c6-e9d600736e12"},"effectiveDateTime":"2013-10-21T09:49:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a3abd1d8-d4f8-a4f8-8f52-d2cb6405b18e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/f8673f52-eebc-f9fb-f8c6-e9d600736e12"},"effectiveDateTime":"2013-10-21T09:49:19-07:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"15fce7b9-ca2e-b31c-86ad-3999394217e7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/f94e2d6f-aff8-c778-1760-032c23c126a3"},"effectiveDateTime":"2021-04-03T19:47:47-07:00"}
{"resourceType":"MedicationAdministration","id":"b594d51f-0353-17b9-4075-686dded39101","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-17T09:56:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"004a3d52-cf61-d8ab-013c-cc6890887652","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-17T09:56:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f8f11b20-1da9-43f7-ea52-ee9f58195320","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-18T12:45:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b1a9de28-c22d-5e8b-0a1e-bdf79e3128c8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-18T12:45:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7097c319-4cca-c009-0510-76b0c7487811","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-19T13:43:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c2271912-c496-5677-75be-93907c9deaf0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-19T13:43:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"fe5e490f-ceea-3044-353e-6761b1c330f6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-20T14:30:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ffb59615-6a6f-5e10-6975-d2b930215f73","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-20T14:30:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4a703f85-94f6-1ccb-0c4c-6fa638b4fb0f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/d846e87a-661d-6c1a-615c-091782f852c1"},"effectiveDateTime":"2021-09-30T20:05:14-07:00"}
{"resourceType":"MedicationAdministration","id":"ffb4a85a-fb06-7bc8-e974-e4fec0cdacc0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-21T15:11:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c5cfbf99-a72b-b391-f6c7-a959e3cf7958","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-21T15:11:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"beac7f7a-9f7d-67c6-991c-8ea390f4e2ca","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-22T17:40:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"309f8a3d-b1f8-22fc-3469-c69b90b91998","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-22T17:40:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a1c2eb4b-aeb5-66db-109e-6bc4f64151da","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-23T21:08:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"25152d36-bb3f-dd8e-0533-7f19b5ff7945","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-23T21:08:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"478dd64f-5ea6-d542-ff95-6ac82038a66f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-25T00:00:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4c83a679-fb78-830c-c5cb-3293188b5e8c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-25T00:00:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ebe7ebf8-a091-1c1b-de77-04820eeec31c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-26T01:24:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f4eec247-b367-0119-131f-d5246ed502ff","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-26T01:24:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4e319603-ff50-bd1f-0e6e-39ca37671309","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-27T02:43:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"01de3e28-f73e-98d1-3e41-bf8e55da9c9b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-27T02:43:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"248160fb-b822-0da1-33aa-528f31e56811","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-28T04:08:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"74f87af7-83a8-1c5e-3b46-6204ed685902","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/996168e4-bd0a-716c-2692-d92a75d1e59b"},"effectiveDateTime":"2013-11-28T04:08:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"03638046-35c9-7a9e-dee3-f98dc6f0b0c0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/36f838eb-53d6-de78-f5bf-9fd481a8416f"},"effectiveDateTime":"2013-12-26T09:52:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"34e7659f-5ecb-024a-c882-77091f07a612","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/36f838eb-53d6-de78-f5bf-9fd481a8416f"},"effectiveDateTime":"2013-12-26T09:52:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0500b236-6fbc-1e42-2352-968b1e4d9522","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/36f838eb-53d6-de78-f5bf-9fd481a8416f"},"effectiveDateTime":"2013-12-27T11:13:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1266da0f-dcc0-209b-1359-69328234ac42","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/36f838eb-53d6-de78-f5bf-9fd481a8416f"},"effectiveDateTime":"2013-12-27T11:13:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0d6e9b3d-3c51-0759-f1cf-0113333125aa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/36f838eb-53d6-de78-f5bf-9fd481a8416f"},"effectiveDateTime":"2013-12-28T14:31:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"68f8d2bc-c4c6-eb3e-03f7-d54d16a65a76","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/bc9a8605-3436-450d-dee7-79938d308c59"},"effectiveDateTime":"2022-06-27T20:21:50-07:00"}
{"resourceType":"MedicationAdministration","id":"47fc015d-eeca-d03b-8f8d-82f546a650b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/36f838eb-53d6-de78-f5bf-9fd481a8416f"},"effectiveDateTime":"2013-12-28T14:31:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1cc938f4-1028-f9ac-c3ca-2b8333853153","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/36f838eb-53d6-de78-f5bf-9fd481a8416f"},"effectiveDateTime":"2013-12-29T16:27:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"69482ea5-403a-6923-2cc2-a9154f635b59","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/36f838eb-53d6-de78-f5bf-9fd481a8416f"},"effectiveDateTime":"2013-12-29T16:27:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7d70a3a3-5af1-d1e4-69a6-d00d1b2e75ad","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/36f838eb-53d6-de78-f5bf-9fd481a8416f"},"effectiveDateTime":"2013-12-30T17:06:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b7031aa8-d3cb-32fc-bacd-5737972df998","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/36f838eb-53d6-de78-f5bf-9fd481a8416f"},"effectiveDateTime":"2013-12-30T17:06:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f65d8cd0-682c-32d8-4842-0e9d44a312f7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/36f838eb-53d6-de78-f5bf-9fd481a8416f"},"effectiveDateTime":"2013-12-31T20:21:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"10a9d17a-1c83-4375-34b8-385dc3843604","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/36f838eb-53d6-de78-f5bf-9fd481a8416f"},"effectiveDateTime":"2013-12-31T20:21:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c5381180-12e1-2c10-b7c7-35ecf256d311","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1736854","display":"Cisplatin 50 MG Injection"}],"text":"Cisplatin 50 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/36f838eb-53d6-de78-f5bf-9fd481a8416f"},"effectiveDateTime":"2014-01-01T23:52:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"557bcf76-05c4-632f-fe2d-fa8d9ba091d5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/ede20e28-8b49-5a2f-225b-5bff3efdf26e"},"context":{"reference":"Encounter/41c71670-56ad-84be-e8e3-7c462fca8cba"},"effectiveDateTime":"2021-12-02T15:18:36-08:00","reasonReference":[{"reference":"Condition/ffc5a935-cb2a-e478-257c-86c6f15ecd8b","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7542e621-bc55-9bc5-59d0-82107335ba17","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"226719","display":"Etoposide 100 MG Injection"}],"text":"Etoposide 100 MG Injection"},"subject":{"reference":"Patient/2fb8cfa2-bd8b-2c0a-1b88-84b73157e0d9"},"context":{"reference":"Encounter/36f838eb-53d6-de78-f5bf-9fd481a8416f"},"effectiveDateTime":"2014-01-01T23:52:19-08:00","reasonReference":[{"reference":"Condition/96e65488-95d5-593e-9d0a-f73d619961c9","display":"Primary small cell malignant neoplasm of lung, TNM stage 1 (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d7d85010-36f5-ac0d-62a0-13233941563a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/ede20e28-8b49-5a2f-225b-5bff3efdf26e"},"context":{"reference":"Encounter/e46fb140-1b17-6b31-83de-4e402210719c"},"effectiveDateTime":"2023-12-14T13:52:22-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"1d1f2311-052e-1b78-7ccc-24524cabd897","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/7cb52915-3945-84ad-6cce-cf222ccbd039"},"effectiveDateTime":"2023-01-15T14:31:48-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"23c5bb5e-e209-2f7c-6456-33970af8e720","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/564d4f85-19af-8538-568f-165378548a9b"},"effectiveDateTime":"2023-01-23T19:40:25-08:00"}
{"resourceType":"MedicationAdministration","id":"a2aad3bf-a496-1920-54cc-475b9d3570cd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/9569e80a-955b-b943-47ff-ba54fe072205"},"context":{"reference":"Encounter/0873efd2-33d3-61d1-ada7-0e1e474bcfe4"},"effectiveDateTime":"2018-04-01T16:14:27-07:00","reasonReference":[{"reference":"Condition/d431ce13-0f7f-4864-8b8c-90f998ff536d","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"64d40e47-c721-7269-3970-da689f591155","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/24f82792-b567-c41e-76aa-2d5e7d75ff48"},"context":{"reference":"Encounter/32aea5ac-8497-79ab-bfea-e95023fa8183"},"effectiveDateTime":"2021-09-19T20:06:01-07:00","reasonReference":[{"reference":"Condition/6253c2c3-8ec2-f9ef-f284-79a49665c865","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"810f180b-ab92-f6a9-494c-1d29a2889d8e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/6dd73602-7b06-d239-3530-77d894cb4c1b"},"effectiveDateTime":"2023-09-03T15:26:40-07:00","reasonReference":[{"reference":"Condition/b454214f-1cb4-01e5-1b1f-1e6b89950b69","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d0d5eed6-d953-d05a-91db-0ccdcf84c2d9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/d617a0f0-f88c-9ff6-2e41-cd3358f59222"},"effectiveDateTime":"2023-12-19T19:56:58-08:00"}
{"resourceType":"MedicationAdministration","id":"01b7a3ee-952a-babf-6a77-0ddeb713bfbb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/f87c4838-e4c6-a5cc-89a2-6b1aee66f09b"},"context":{"reference":"Encounter/05b6d21b-1338-07e9-28ac-10e091c329c7"},"effectiveDateTime":"2021-09-11T11:10:42-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"e1f83e51-17d8-b092-d79f-b900022a9444","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/723098d9-9ebf-3c52-9fe8-d47ca2f05eff"},"context":{"reference":"Encounter/381ca65d-9b81-bc27-cc4e-339ba4159089"},"effectiveDateTime":"2015-09-29T18:49:43-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"80d6b71a-7cef-6db2-71db-d51174b2e2a4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"313521","display":"tropicamide 5 MG/ML Ophthalmic Solution"}],"text":"tropicamide 5 MG/ML Ophthalmic Solution"},"subject":{"reference":"Patient/2f54c9fc-e679-a83a-a6e5-e2287a8990a0"},"context":{"reference":"Encounter/882bbf95-cba1-ec5d-8d10-510b3d59cc89"},"effectiveDateTime":"2024-10-27T12:16:18-07:00"}
{"resourceType":"MedicationAdministration","id":"e92c5f4a-c3b6-726c-3f26-f3599bf1275c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/723098d9-9ebf-3c52-9fe8-d47ca2f05eff"},"context":{"reference":"Encounter/8244e763-0a96-0f2c-de9d-2ddaf491760d"},"effectiveDateTime":"2016-09-27T18:25:27-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"139efe7b-0a82-4b7c-eb65-b2a786556c68","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/eaa4d11e-2483-f587-62c7-b73e2e33fa8d"},"context":{"reference":"Encounter/988fe57e-383f-845a-e90b-e4b1830c23f3"},"effectiveDateTime":"2024-05-08T13:43:33-07:00","reasonReference":[{"reference":"Condition/54feacbe-2354-b02b-3816-025aef410de4","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"aacc0d77-7847-658c-15dc-de3cde893f3e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/eaa4d11e-2483-f587-62c7-b73e2e33fa8d"},"context":{"reference":"Encounter/3c38a8de-9a39-cd87-fe90-a19fedda6696"},"effectiveDateTime":"2025-05-14T13:55:04-07:00","reasonReference":[{"reference":"Condition/54feacbe-2354-b02b-3816-025aef410de4","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b58f2d28-72f1-94b1-5ee3-b53731797998","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/a261bbf0-9d17-1bb2-e260-d1350c5664a4"},"context":{"reference":"Encounter/fd75b45b-9618-92ca-9eae-7f7ee00667e7"},"effectiveDateTime":"2021-02-18T20:26:12-08:00","reasonReference":[{"reference":"Condition/899ff42d-eccd-2a7a-708f-faed740fa3b3","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"357ed132-03a4-e435-b678-f76e286b797d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyPROGESTERone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/a261bbf0-9d17-1bb2-e260-d1350c5664a4"},"context":{"reference":"Encounter/a45f0e80-1d58-44f8-aea7-18fbd3f39764"},"effectiveDateTime":"2025-01-04T17:12:39-08:00"}
{"resourceType":"MedicationAdministration","id":"d29da75e-a66d-0523-e24b-01f98f9659ab","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/a261bbf0-9d17-1bb2-e260-d1350c5664a4"},"context":{"reference":"Encounter/6438ca6a-66ec-b938-8962-74f34c20a704"},"effectiveDateTime":"2025-03-13T21:19:02-07:00","reasonReference":[{"reference":"Condition/899ff42d-eccd-2a7a-708f-faed740fa3b3","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a802e61a-51b3-a40c-7ea0-d0ee04aeb7ac","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/723098d9-9ebf-3c52-9fe8-d47ca2f05eff"},"context":{"reference":"Encounter/42392113-1f34-44de-b71f-42f4aef2e70d"},"effectiveDateTime":"2022-04-15T15:28:53-07:00"}
{"resourceType":"MedicationAdministration","id":"a7e5dd41-2f69-d30c-7e83-c816e5a0d57c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/723098d9-9ebf-3c52-9fe8-d47ca2f05eff"},"context":{"reference":"Encounter/777a9129-9155-abdd-a1eb-0cb609bf9c2c"},"effectiveDateTime":"2022-11-01T17:48:41-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"e1e13ffd-4a31-acf2-d788-bab3a6aa86f9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/723098d9-9ebf-3c52-9fe8-d47ca2f05eff"},"context":{"reference":"Encounter/2d6a4ab8-8ece-bcdc-2e8d-3b74751e3f96"},"effectiveDateTime":"2023-11-07T20:20:00-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"e6ec0ff1-96b3-6c2a-aaaa-a328e13c3257","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/eee57822-acf1-417b-dad5-0859ca30f007"},"context":{"reference":"Encounter/b76d7b8a-0b8e-9586-fdf7-d14300e4bf12"},"effectiveDateTime":"2019-12-05T07:09:56-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"306be24b-5bdd-2900-1c1f-3a08c9f57677","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/147e90dc-6196-17c9-4b05-22db6e79c743"},"context":{"reference":"Encounter/cb550d2a-dcc5-c78c-d6a4-06ecd38121a8"},"effectiveDateTime":"2017-12-04T12:34:38-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"afe4d8dc-6ffd-7612-c0b3-063b5334c09b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/eee57822-acf1-417b-dad5-0859ca30f007"},"context":{"reference":"Encounter/c43360b9-a4de-018a-9b24-a63d64f920d9"},"effectiveDateTime":"2025-01-02T06:00:13-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"20fcb74e-f460-35f2-00a3-ce6406eb7834","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/4780c470-59f9-3cc3-4f56-3c8f9ee80fee"},"context":{"reference":"Encounter/7463ae2d-9be3-d509-880a-50c5ed4baca3"},"effectiveDateTime":"2016-06-19T00:10:06-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"6f86eb6d-06ba-6a54-14db-e18614333c17","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0b01cb66-3910-2285-469e-adde38b0ca2c"},"context":{"reference":"Encounter/8a857b02-83bc-2aae-955a-37b98c4007ad"},"effectiveDateTime":"2016-02-23T01:48:48-08:00","reasonReference":[{"reference":"Condition/51edfd9a-dcc0-ae9e-a1b0-a8e211add58c","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1a3bf312-e9e6-5897-04db-f3386b127c67","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1856546","display":"Kyleena 19.5 MG Intrauterine System"}],"text":"Kyleena 19.5 MG Intrauterine System"},"subject":{"reference":"Patient/18f57ff4-344b-7419-8395-e71035968ed5"},"context":{"reference":"Encounter/4d186905-4416-2ed5-2359-8dc33b4975a8"},"effectiveDateTime":"2017-12-20T23:12:18-08:00"}
{"resourceType":"MedicationAdministration","id":"19f122a9-2217-90b9-b913-6e568a444ad8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1856546","display":"Kyleena 19.5 MG Intrauterine System"}],"text":"Kyleena 19.5 MG Intrauterine System"},"subject":{"reference":"Patient/241927c8-7257-9699-2f97-be9882f24d0d"},"context":{"reference":"Encounter/99bb4794-050f-eb53-fbe3-7687c84a49d9"},"effectiveDateTime":"2016-06-27T15:24:40-07:00"}
{"resourceType":"MedicationAdministration","id":"0e46014d-0c63-4cb3-ba75-d0de34f3822d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/241927c8-7257-9699-2f97-be9882f24d0d"},"context":{"reference":"Encounter/5ade00bd-c749-d997-7c64-a1bfa19db96d"},"effectiveDateTime":"2019-06-16T04:17:55-07:00"}
{"resourceType":"MedicationAdministration","id":"13e25f31-9b9c-16c2-676e-6503a383df56","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/241927c8-7257-9699-2f97-be9882f24d0d"},"context":{"reference":"Encounter/ba8eaefe-da3f-78b6-9245-ce404019861c"},"effectiveDateTime":"2019-07-21T17:30:51-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"2ed4f8b8-075b-b1aa-03fe-f98ba6cb3e0b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/af048e84-05b3-3c01-0f14-101538971b8c"},"context":{"reference":"Encounter/0ac59e52-607b-99e3-2785-506d993c26b5"},"effectiveDateTime":"1973-10-03T10:25:20-07:00","reasonReference":[{"reference":"Condition/1b73ebed-cc47-97ad-ed1c-5fc9d9621969","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d2d3ac1c-54ba-bdb4-0ec8-8f943b32737d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/4780c470-59f9-3cc3-4f56-3c8f9ee80fee"},"context":{"reference":"Encounter/d1d60276-19af-e386-a8dd-94d77ee80f02"},"effectiveDateTime":"2021-07-18T00:32:58-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"fd1492ea-011a-b4b4-17b9-d304e5acdd8b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/af048e84-05b3-3c01-0f14-101538971b8c"},"context":{"reference":"Encounter/bbf39a03-a1cb-18ef-c1c2-4ec1940546d8"},"effectiveDateTime":"1974-03-27T10:00:02-07:00","reasonReference":[{"reference":"Condition/1b73ebed-cc47-97ad-ed1c-5fc9d9621969","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9e5b9afa-3e01-3695-cd38-010631e58136","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/241927c8-7257-9699-2f97-be9882f24d0d"},"context":{"reference":"Encounter/ee099e90-2c7c-3cc5-cf8b-cfca028205aa"},"effectiveDateTime":"2021-08-01T17:09:35-07:00","reasonReference":[{"reference":"Condition/05fa68ec-72f7-7f43-b14c-46eeb1563de2","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"98578457-f63e-f4f4-a6db-43a6320c8d7a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1659131","display":"piperacillin 2000 MG / tazobactam 250 MG Injection"}],"text":"piperacillin 2000 MG / tazobactam 250 MG Injection"},"subject":{"reference":"Patient/4780c470-59f9-3cc3-4f56-3c8f9ee80fee"},"context":{"reference":"Encounter/c2d13f82-84a7-98f6-0f5b-a0e48b7e1658"},"effectiveDateTime":"2023-11-21T20:31:51-08:00","reasonReference":[{"reference":"Condition/7b0d506e-66ae-c751-7da5-214a6724cf69","display":"Sepsis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"96feb62c-06e5-c7b8-a7c0-86a3f0ad416b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1807510","display":"150 ML vancomycin 5 MG/ML Injection"}],"text":"150 ML vancomycin 5 MG/ML Injection"},"subject":{"reference":"Patient/4780c470-59f9-3cc3-4f56-3c8f9ee80fee"},"context":{"reference":"Encounter/c2d13f82-84a7-98f6-0f5b-a0e48b7e1658"},"effectiveDateTime":"2023-11-21T20:31:51-08:00","reasonReference":[{"reference":"Condition/7b0d506e-66ae-c751-7da5-214a6724cf69","display":"Sepsis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6daef3d8-aaed-d7d6-7112-4872cc912c7e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/af048e84-05b3-3c01-0f14-101538971b8c"},"context":{"reference":"Encounter/d23b0217-0bf0-d798-316d-68e19fc12990"},"effectiveDateTime":"1974-06-19T09:59:01-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"6a5afe13-b2d0-8b41-c34c-0d10ebc4e888","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/4780c470-59f9-3cc3-4f56-3c8f9ee80fee"},"context":{"reference":"Encounter/10997f19-8a12-7689-474a-2c7773883de6"},"effectiveDateTime":"2024-08-04T00:01:46-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"ecd51f8c-0a7c-8dce-ed42-3e5aeaed7863","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/af048e84-05b3-3c01-0f14-101538971b8c"},"context":{"reference":"Encounter/5916c9b6-ccf3-dae0-d76b-3393ca0eaf57"},"effectiveDateTime":"1974-08-28T09:52:32-07:00","reasonReference":[{"reference":"Condition/1b73ebed-cc47-97ad-ed1c-5fc9d9621969","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"b77e4e57-9862-bd49-a17e-50b049ea1d30","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/18f57ff4-344b-7419-8395-e71035968ed5"},"context":{"reference":"Encounter/b94c86ff-80b1-6004-b355-04ade4a50330"},"effectiveDateTime":"2023-05-17T03:13:16-07:00","reasonReference":[{"reference":"Condition/b168be5f-00c3-0a4c-8261-1394b384fc81","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ab597a59-e74a-8f44-2678-8a34574aa20b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/18f57ff4-344b-7419-8395-e71035968ed5"},"context":{"reference":"Encounter/335f01ab-5dae-ce0a-ec6c-72d428816687"},"effectiveDateTime":"2024-05-22T05:43:07-07:00","reasonReference":[{"reference":"Condition/b168be5f-00c3-0a4c-8261-1394b384fc81","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"27c8c04d-c3ae-7b33-7453-df4c885879b2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1fa6a2a7-b76a-e46a-4eb8-544fc2799eb0"},"context":{"reference":"Encounter/20c28413-f1ff-fbc9-a3a1-e5c47ceb9f83"},"effectiveDateTime":"2015-11-29T06:42:27-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"b567038c-b6e0-3dc3-24ae-769909887155","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/9225d84a-8136-edce-efe6-844111cb158a"},"context":{"reference":"Encounter/964c6667-552d-6f83-3b2e-2f26d841c91f"},"effectiveDateTime":"2016-08-26T08:14:59-07:00","reasonReference":[{"reference":"Condition/6f7c4e39-d92c-deda-09af-d42646614c40","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"29a066dc-40c8-e02e-c882-fc1dde433595","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/9225d84a-8136-edce-efe6-844111cb158a"},"context":{"reference":"Encounter/dc29549f-56b7-bc71-faa4-27f9f278a027"},"effectiveDateTime":"2018-09-07T10:39:16-07:00","reasonReference":[{"reference":"Condition/6f7c4e39-d92c-deda-09af-d42646614c40","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f17da544-d1f5-cae8-8413-52ae3bf44a35","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1fa6a2a7-b76a-e46a-4eb8-544fc2799eb0"},"context":{"reference":"Encounter/bfa36f82-8489-1922-e523-e13bd2c7e2b8"},"effectiveDateTime":"2017-12-10T07:33:23-08:00","reasonReference":[{"reference":"Condition/afdd4892-0121-9bb7-60ef-3fe2f028d62a","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"937ab69c-0439-9514-7e0f-b70c3c275c81","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/af048e84-05b3-3c01-0f14-101538971b8c"},"context":{"reference":"Encounter/ec493fac-5088-761d-e731-9ac58a240566"},"effectiveDateTime":"1975-07-02T10:17:47-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"2c67dbe4-34ce-ce73-81a6-6f0ebcdff959","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/b10731e2-87e4-c0a8-2095-061b8e8bbde1"},"context":{"reference":"Encounter/4c631879-e1f5-4ba4-817b-5fba54cbf94d"},"effectiveDateTime":"2018-03-26T07:39:10-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"8e16e104-e86c-c5ff-4d91-2099c4c31caa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/fafd12a3-7a1d-7388-b744-d5aff1a432c1"},"context":{"reference":"Encounter/960fe011-07d2-741e-34c5-bacef9e3eed5"},"effectiveDateTime":"2017-10-02T21:01:40-07:00","reasonReference":[{"reference":"Condition/e802cd6d-c270-5ee1-0649-016e62c244b2","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"3ef4d2d9-5c5f-81d6-3ce4-5d2e62ddf903","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/9225d84a-8136-edce-efe6-844111cb158a"},"context":{"reference":"Encounter/57984a86-4a06-bacf-dc00-549aeae38138"},"effectiveDateTime":"2023-05-05T08:15:18-07:00","reasonReference":[{"reference":"Condition/6f7c4e39-d92c-deda-09af-d42646614c40","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"17b03e76-93e6-35ae-d09d-9baed3b61f41","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1fa6a2a7-b76a-e46a-4eb8-544fc2799eb0"},"context":{"reference":"Encounter/9b133494-ed28-238b-934e-1d2f72ffc16b"},"effectiveDateTime":"2020-12-27T06:11:29-08:00","reasonReference":[{"reference":"Condition/afdd4892-0121-9bb7-60ef-3fe2f028d62a","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c22ba6c7-02cf-c2c0-2c46-48b6a384ee85","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/99f14d01-3b7a-6c17-2743-21272ad8afae"},"context":{"reference":"Encounter/6b8ca860-1e4a-8037-11a1-359fb726e830"},"effectiveDateTime":"2016-03-11T15:11:18-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"ea1b50b6-322e-ea3c-1862-d98a67ea42fb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/99f14d01-3b7a-6c17-2743-21272ad8afae"},"context":{"reference":"Encounter/7aa5334f-9e35-f703-feb6-2770042d576e"},"effectiveDateTime":"2017-03-17T20:51:26-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"c23baece-d1fb-ead6-7e82-507d62dc4c99","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/99f14d01-3b7a-6c17-2743-21272ad8afae"},"context":{"reference":"Encounter/6f8f4110-1e5a-8232-237d-5735c2ea0839"},"effectiveDateTime":"2017-05-27T14:10:58-07:00"}
{"resourceType":"MedicationAdministration","id":"a443130f-185e-b48c-8b89-a4996d653728","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1000126","display":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"}],"text":"1 ML medroxyprogesterone acetate 150 MG/ML Injection"},"subject":{"reference":"Patient/9225d84a-8136-edce-efe6-844111cb158a"},"context":{"reference":"Encounter/891e1f73-1f61-e081-accb-a4a33d0e18c6"},"effectiveDateTime":"2025-08-06T05:39:07-07:00"}
{"resourceType":"MedicationAdministration","id":"905b3468-b88d-623f-f5ac-5bdeea894211","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/b10731e2-87e4-c0a8-2095-061b8e8bbde1"},"context":{"reference":"Encounter/befbc3c5-41cc-eaad-3931-ff6b3a66e083"},"effectiveDateTime":"2023-04-24T07:04:49-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"48c13499-5fac-c3cd-f7d2-dd06b3e68450","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/99f14d01-3b7a-6c17-2743-21272ad8afae"},"context":{"reference":"Encounter/0829c29c-7eb5-b562-781f-f4f242d5fede"},"effectiveDateTime":"2019-03-29T16:33:05-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"58aa9eb2-336f-1d12-2894-3448c574cbd2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1fa6a2a7-b76a-e46a-4eb8-544fc2799eb0"},"context":{"reference":"Encounter/e479495f-37ad-3262-7999-21d2574dbd57"},"effectiveDateTime":"2025-01-19T05:50:58-08:00","reasonReference":[{"reference":"Condition/afdd4892-0121-9bb7-60ef-3fe2f028d62a","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c9fb7682-968c-f12e-f3f5-c32cbd597aef","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/b10731e2-87e4-c0a8-2095-061b8e8bbde1"},"context":{"reference":"Encounter/35d3a638-3ccf-3355-a5cb-526b789a9578"},"effectiveDateTime":"2025-05-05T11:24:07-07:00","reasonReference":[{"reference":"Condition/2d58b59b-d2bb-3dad-f91b-22f57c96a303","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c2775f7a-2937-ec27-1bca-915c5e45d48e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/99f14d01-3b7a-6c17-2743-21272ad8afae"},"context":{"reference":"Encounter/b94e6d71-6678-e47a-01ab-58f28c560c5d"},"effectiveDateTime":"2021-05-06T14:28:31-07:00"}
{"resourceType":"MedicationAdministration","id":"c01cc91b-d062-c807-0a77-21ebe27874af","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0f4b8c2b-d721-5b17-492b-b43997cf66ee"},"context":{"reference":"Encounter/09d219c1-c0a9-3373-4399-b043dd392eda"},"effectiveDateTime":"2016-03-10T13:45:12-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"7c2a698e-8ca0-9249-f83a-6d7b052dd5d1","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/99f14d01-3b7a-6c17-2743-21272ad8afae"},"context":{"reference":"Encounter/ce295912-82d4-580b-7d35-b8c63844132c"},"effectiveDateTime":"2023-04-21T16:03:15-07:00","reasonReference":[{"reference":"Condition/2ac1c50f-1c57-2dad-0b62-29ad98d195f5","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"48ce2fee-5a8a-658d-3bbd-1d1ac2954e09","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0f4b8c2b-d721-5b17-492b-b43997cf66ee"},"context":{"reference":"Encounter/20bd5a91-d478-7829-6c16-c0ba629be3f2"},"effectiveDateTime":"2017-03-16T14:44:17-07:00","reasonReference":[{"reference":"Condition/8cfa328d-c1b2-3455-8a85-9ff0f5027614","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"86dd661e-6d23-feb9-d116-56fb0a20f303","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/00c7fab1-07f8-ad1e-3491-eb29d0b1b4fd"},"context":{"reference":"Encounter/c0f1aa09-fe65-c445-6af2-a52b13f93fb2"},"effectiveDateTime":"2017-05-26T04:03:42-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"ef94c831-ad10-c3ea-1bfc-d3cbbd6618d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/0f4b8c2b-d721-5b17-492b-b43997cf66ee"},"context":{"reference":"Encounter/3b5aeea1-d60f-a916-6d5d-da23e31c720f"},"effectiveDateTime":"2017-08-01T13:03:44-07:00"}
{"resourceType":"MedicationAdministration","id":"349f17dc-6569-3f69-f83e-96d2be131366","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/af2ac42c-8276-04b0-ee17-3ae16af25b61"},"context":{"reference":"Encounter/2756e583-55a1-b7bd-d1f1-35b03c670ae8"},"effectiveDateTime":"2023-12-14T13:33:54-08:00","reasonReference":[{"reference":"Condition/55a9055d-b7c0-ccf8-e604-8de02cea870b","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d15d6c93-b213-1479-d62b-96462606e653","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/00c7fab1-07f8-ad1e-3491-eb29d0b1b4fd"},"context":{"reference":"Encounter/71f039da-f778-4b2b-72ec-d47721aee9ef"},"effectiveDateTime":"2020-05-29T03:11:39-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"11401844-c3fa-331f-1228-22a6467b0849","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/af048e84-05b3-3c01-0f14-101538971b8c"},"context":{"reference":"Encounter/5108ef3c-d1d8-4bd1-95c4-bd7702e06ff1"},"effectiveDateTime":"1976-07-14T09:45:08-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"bd2faa2f-6ba4-c9fd-5363-b270264b2074","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0f4b8c2b-d721-5b17-492b-b43997cf66ee"},"context":{"reference":"Encounter/62cef929-ea3e-ae57-ee2f-19ec070ae3e6"},"effectiveDateTime":"2020-04-02T15:18:36-07:00","reasonReference":[{"reference":"Condition/8cfa328d-c1b2-3455-8a85-9ff0f5027614","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2553a7b1-81cd-b404-7fac-77d392e2b1a2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/0f4b8c2b-d721-5b17-492b-b43997cf66ee"},"context":{"reference":"Encounter/9e467e63-fce2-c6cb-17a1-7b90156bb6c5"},"effectiveDateTime":"2020-07-16T13:26:09-07:00"}
{"resourceType":"MedicationAdministration","id":"cbff0547-54c4-1e2a-981c-36527c035b56","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1605257","display":"Liletta 52 MG Intrauterine System"}],"text":"Liletta 52 MG Intrauterine System"},"subject":{"reference":"Patient/00c7fab1-07f8-ad1e-3491-eb29d0b1b4fd"},"context":{"reference":"Encounter/fd948b18-db92-a8f1-aa9c-643b6364667f"},"effectiveDateTime":"2024-04-07T00:52:07-07:00"}
{"resourceType":"MedicationAdministration","id":"7ffdfd79-ef04-6a93-8d64-e47add69defc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0f53c9f3-6c2f-325a-dd77-a95c6fc14385"},"context":{"reference":"Encounter/b63df0ce-4f2f-8329-1a4e-9134cf789e4e"},"effectiveDateTime":"2018-05-12T10:52:06-07:00","reasonReference":[{"reference":"Condition/0c66fcda-6cd2-8ad8-7958-a233877a25a2","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"963cb485-d97a-ffd9-ca46-208be733766f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1605257","display":"Liletta 52 MG Intrauterine System"}],"text":"Liletta 52 MG Intrauterine System"},"subject":{"reference":"Patient/0f4b8c2b-d721-5b17-492b-b43997cf66ee"},"context":{"reference":"Encounter/ff8c42f6-7a36-1a71-c574-96a18884280b"},"effectiveDateTime":"2021-07-11T13:49:10-07:00"}
{"resourceType":"MedicationAdministration","id":"19507338-a94f-f005-d6ac-0c95c39ac032","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0f53c9f3-6c2f-325a-dd77-a95c6fc14385"},"context":{"reference":"Encounter/649cf1a1-d721-41ca-b139-fece8dd317b2"},"effectiveDateTime":"2019-05-18T10:13:30-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"1b540a37-c015-bb17-d2d4-c729f1328390","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"807283","display":"Mirena 52 MG Intrauterine System"}],"text":"Mirena 52 MG Intrauterine System"},"subject":{"reference":"Patient/f6b8388d-c908-db8e-b57e-5385ad2c7253"},"context":{"reference":"Encounter/cc702973-0349-9658-2234-568dff75ca2d"},"effectiveDateTime":"2014-08-30T12:59:29-07:00"}
{"resourceType":"MedicationAdministration","id":"0218f415-98a6-1d01-ddcf-7f959e563ff5","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/096ef7ec-76b9-2cf7-31a8-a44e15df7099"},"context":{"reference":"Encounter/7b50e3fe-5395-c071-f1af-9dff7c78000e"},"effectiveDateTime":"2016-09-29T18:39:18-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"4dfc5672-e465-b5e5-0400-b51aba7b56a6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/096ef7ec-76b9-2cf7-31a8-a44e15df7099"},"context":{"reference":"Encounter/e3c2f20f-78ee-b912-f5d8-861257c0387f"},"effectiveDateTime":"2016-12-15T14:43:17-08:00","reasonReference":[{"reference":"Condition/60913571-25ef-0619-327d-68f424ed1ccb","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"cec48c47-19b8-d3d0-1333-1482e8f56018","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"807283","display":"Mirena 52 MG Intrauterine System"}],"text":"Mirena 52 MG Intrauterine System"},"subject":{"reference":"Patient/f6b8388d-c908-db8e-b57e-5385ad2c7253"},"context":{"reference":"Encounter/5254a43e-1c24-83b8-16c3-f40e23483aca"},"effectiveDateTime":"2019-08-25T05:16:41-07:00"}
{"resourceType":"MedicationAdministration","id":"6ace5d52-f09b-3465-997a-04affaf58d35","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0f4b8c2b-d721-5b17-492b-b43997cf66ee"},"context":{"reference":"Encounter/be05c1a4-384c-c560-c0f7-34f0d94212d7"},"effectiveDateTime":"2023-12-21T14:15:52-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"5e8632c3-e45b-cc66-22e0-f43b29064272","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/4313376d-a1f5-a397-3d10-2ea1dc70a843"},"context":{"reference":"Encounter/47eb9078-554c-58c0-2928-129d440e3f3b"},"effectiveDateTime":"2016-06-10T08:13:22-07:00","reasonReference":[{"reference":"Condition/cfc34db4-74c8-9da4-2fa0-aa442f866c9d","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e040c0b1-ba14-635f-17c9-763597519edb","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/4313376d-a1f5-a397-3d10-2ea1dc70a843"},"context":{"reference":"Encounter/701a8bb3-2786-47fe-186a-85229f59c88f"},"effectiveDateTime":"2017-06-16T03:42:21-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"fcce67d4-4039-7f99-fa65-bdd9f05c7893","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/096ef7ec-76b9-2cf7-31a8-a44e15df7099"},"context":{"reference":"Encounter/7a2d4885-3e8d-1c6e-8f26-88f9630e9584"},"effectiveDateTime":"2018-12-27T14:48:45-08:00","reasonReference":[{"reference":"Condition/60913571-25ef-0619-327d-68f424ed1ccb","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f71871f5-7f27-9951-4f60-f97c388911dd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/4313376d-a1f5-a397-3d10-2ea1dc70a843"},"context":{"reference":"Encounter/68a035ca-9716-6103-fee8-0c1e958e2fc3"},"effectiveDateTime":"2018-03-09T02:40:04-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"84fd6671-9785-9fe1-6ab2-ec9f334f8cd7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/245970c8-ba8d-2bbf-3e88-1a53ece405bf"},"context":{"reference":"Encounter/590b6c7d-148e-fbbd-dc38-0243eb488f77"},"effectiveDateTime":"2024-05-07T06:28:35-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"2c4bdf5a-ac84-d126-9c5e-0fc9999ae9dc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/245970c8-ba8d-2bbf-3e88-1a53ece405bf"},"context":{"reference":"Encounter/a2b1e22d-d41a-f0e6-43fa-fbdd2d631333"},"effectiveDateTime":"2024-11-05T08:37:30-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"68633092-a5ea-fec2-73ab-ebf86c1a102d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/4313376d-a1f5-a397-3d10-2ea1dc70a843"},"context":{"reference":"Encounter/5ce457b8-896c-a393-ae02-13a0e19c4c1a"},"effectiveDateTime":"2019-05-24T04:03:49-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"650f2f21-1835-79a0-953c-b0390cce9c59","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/096ef7ec-76b9-2cf7-31a8-a44e15df7099"},"context":{"reference":"Encounter/15d78c78-e0cb-ecdc-a306-bd5432a27005"},"effectiveDateTime":"2022-01-13T18:41:25-08:00","reasonReference":[{"reference":"Condition/60913571-25ef-0619-327d-68f424ed1ccb","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a20a7405-e487-e9e8-4a95-80611d06188a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/245970c8-ba8d-2bbf-3e88-1a53ece405bf"},"context":{"reference":"Encounter/f3feb3f4-b4ab-22d0-812a-05e5ee74f06b"},"effectiveDateTime":"2025-05-06T06:57:56-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"e14e81c9-309c-e763-3c11-5f3c7c837328","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/4313376d-a1f5-a397-3d10-2ea1dc70a843"},"context":{"reference":"Encounter/a8373fb4-cf09-68e8-2d1b-046d1252bc8c"},"effectiveDateTime":"2019-06-28T04:13:11-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"5bedfd4c-e0e2-0551-077d-71e76ec432b3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/4313376d-a1f5-a397-3d10-2ea1dc70a843"},"context":{"reference":"Encounter/8df8aba7-baf4-f473-3c8e-1d4ed9af771e"},"effectiveDateTime":"2020-07-10T04:37:12-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"69b9dff9-bafd-cb75-f140-64673815542a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/4313376d-a1f5-a397-3d10-2ea1dc70a843"},"context":{"reference":"Encounter/1e5c357a-4520-ea61-542f-958c01c00ef2"},"effectiveDateTime":"2021-06-11T03:57:59-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f282453a-41d2-6f02-7498-37bebfd54714","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/096ef7ec-76b9-2cf7-31a8-a44e15df7099"},"context":{"reference":"Encounter/63e63009-2e1c-21be-62d6-ecc3ad4e2ce1"},"effectiveDateTime":"2025-01-30T15:08:12-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"3238f948-745e-c337-e109-48fc9e76099d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/55ef60fe-e6d4-6080-ceac-7d7f7eda9e82"},"context":{"reference":"Encounter/61716bba-85ac-6ded-5abe-ecf4a5293654"},"effectiveDateTime":"2020-06-22T19:27:57-07:00"}
{"resourceType":"MedicationAdministration","id":"11f2019a-5a5f-448c-4eb6-603e031b8a38","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/4313376d-a1f5-a397-3d10-2ea1dc70a843"},"context":{"reference":"Encounter/5509c229-0e92-79d8-83ec-64af2809b7b9"},"effectiveDateTime":"2021-07-09T04:07:59-07:00","reasonReference":[{"reference":"Condition/cfc34db4-74c8-9da4-2fa0-aa442f866c9d","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"c9ad0d2d-6b32-c0f8-3216-e6a5b30eae62","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/b15d9c67-d201-3ce7-5cff-aa56a5306386"},"context":{"reference":"Encounter/9be1f1df-b5a1-878a-cd01-8d0c3a67f54c"},"effectiveDateTime":"2018-02-16T02:53:59-08:00"}
{"resourceType":"MedicationAdministration","id":"86d742be-129e-2350-261d-a96ced5a1dae","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/55ef60fe-e6d4-6080-ceac-7d7f7eda9e82"},"context":{"reference":"Encounter/7300de47-f434-723d-791e-562553072e94"},"effectiveDateTime":"2021-11-22T21:31:30-08:00","reasonReference":[{"reference":"Condition/6e713af5-16c7-91e5-116b-381519278ba6","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5a5b8016-d6e4-187a-20d9-b5d905ed140f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/b15d9c67-d201-3ce7-5cff-aa56a5306386"},"context":{"reference":"Encounter/c0d0624f-dd7a-3e0a-4c2e-0778f477bcca"},"effectiveDateTime":"2021-04-09T09:57:16-07:00","reasonReference":[{"reference":"Condition/addfc3af-4ebd-2843-1435-49bfd69fb0b7","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"0c92d093-2c4a-f803-0058-ae30964bd8a9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/2123c47a-1158-d4cd-e2bc-de86ba4b05eb"},"context":{"reference":"Encounter/ddf7f72a-a479-e20e-81e5-a844d9c2c7b0"},"effectiveDateTime":"2024-03-22T04:49:25-07:00"}
{"resourceType":"MedicationAdministration","id":"9c341916-179c-1bac-dd3f-edb6317a06cc","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/6d24b04c-f44c-5d0a-5bfd-b277ee049eb2"},"effectiveDateTime":"2019-06-04T15:45:17-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"25c571e9-2e39-0fce-02f6-8b545332f2bd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"389221","display":"Etonogestrel 68 MG Drug Implant"}],"text":"Etonogestrel 68 MG Drug Implant"},"subject":{"reference":"Patient/2123c47a-1158-d4cd-e2bc-de86ba4b05eb"},"context":{"reference":"Encounter/d086a570-bd91-dd0f-c1c3-a7fdb71de2ed"},"effectiveDateTime":"2025-03-17T05:19:02-07:00"}
{"resourceType":"MedicationAdministration","id":"ddd1041e-7dde-c25c-8cc0-4f1ebc2608c3","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/55ef60fe-e6d4-6080-ceac-7d7f7eda9e82"},"context":{"reference":"Encounter/f61a8368-f477-7698-b481-52ba3104a513"},"effectiveDateTime":"2024-09-09T21:59:23-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"53fab33d-21c1-58ca-d07d-7370dd9998b4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/6a094244-6853-7594-b354-1d93f94c98e6"},"effectiveDateTime":"2023-10-10T13:05:00-07:00","reasonReference":[{"reference":"Condition/7e654be5-9d8e-46fe-f837-8641bf45b0f6","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"af7f38c2-f8b6-4e66-8d6b-717d7d4cee80","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/d22a9586-8f7d-4cc8-63e7-2a1746c78b59"},"effectiveDateTime":"2024-03-12T11:08:37-07:00","reasonReference":[{"reference":"Condition/03276836-7126-19d6-7d43-16ae9493e448","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1ed21941-c6e3-6c0f-1fa1-08a38d5c5c44","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/d22a9586-8f7d-4cc8-63e7-2a1746c78b59"},"effectiveDateTime":"2024-03-12T23:08:37-07:00","reasonReference":[{"reference":"Condition/03276836-7126-19d6-7d43-16ae9493e448","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"afe7e5e3-cd6d-6b00-5383-782143535c60","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/42a0bfb6-109d-c192-8327-9934446d07e7"},"context":{"reference":"Encounter/24d35dd9-6387-58a1-b796-21487e9464cc"},"effectiveDateTime":"2017-08-16T06:54:01-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"b7bc9d85-a85e-8710-f37a-24a21f4d5b13","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/d22a9586-8f7d-4cc8-63e7-2a1746c78b59"},"effectiveDateTime":"2024-03-13T11:08:37-07:00","reasonReference":[{"reference":"Condition/03276836-7126-19d6-7d43-16ae9493e448","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"327f5e04-d172-8f1c-a9fa-6c42e5ac3722","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/d22a9586-8f7d-4cc8-63e7-2a1746c78b59"},"effectiveDateTime":"2024-03-13T23:08:37-07:00","reasonReference":[{"reference":"Condition/03276836-7126-19d6-7d43-16ae9493e448","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"80411740-6631-8aa1-efbe-7daff3842ab0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/af048e84-05b3-3c01-0f14-101538971b8c"},"context":{"reference":"Encounter/d18dbdb4-9a9a-3d0f-58cd-c1df3ec0203c"},"effectiveDateTime":"1978-07-26T11:01:51-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"325ff6c3-dfae-156e-cbd8-a745f736caf6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/4313376d-a1f5-a397-3d10-2ea1dc70a843"},"context":{"reference":"Encounter/cc02288e-f8af-185a-9c8c-bbb2fa09fbaa"},"effectiveDateTime":"2022-08-12T07:00:00-07:00","reasonReference":[{"reference":"Condition/cfc34db4-74c8-9da4-2fa0-aa442f866c9d","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f89e3370-03cf-3122-1f78-e76853dd87dd","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/1d992897-9b52-2517-6701-318d9447d290"},"context":{"reference":"Encounter/6cde975a-04cd-8ce8-a095-02a57136b06b"},"effectiveDateTime":"2021-11-16T16:11:54-08:00","reasonReference":[{"reference":"Condition/0b77c52d-a085-98b9-7db7-ae800b819985","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"4e7550e0-5b99-00da-bef5-b8580cc4ae83","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/b3dbcdf4-82ec-fa72-64c5-a5b41a00bce1"},"effectiveDateTime":"2024-07-03T11:58:59-07:00","reasonReference":[{"reference":"Condition/03276836-7126-19d6-7d43-16ae9493e448","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"76a889de-e508-a304-3281-1fdeeca0e338","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/b3dbcdf4-82ec-fa72-64c5-a5b41a00bce1"},"effectiveDateTime":"2024-07-03T23:58:59-07:00","reasonReference":[{"reference":"Condition/03276836-7126-19d6-7d43-16ae9493e448","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"6eee08cb-972c-c154-1672-0c0754b623e8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/b3dbcdf4-82ec-fa72-64c5-a5b41a00bce1"},"effectiveDateTime":"2024-07-04T11:58:59-07:00","reasonReference":[{"reference":"Condition/03276836-7126-19d6-7d43-16ae9493e448","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e9eb39ec-4a71-6615-03c9-263773a81236","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/b3dbcdf4-82ec-fa72-64c5-a5b41a00bce1"},"effectiveDateTime":"2024-07-04T23:58:59-07:00","reasonReference":[{"reference":"Condition/03276836-7126-19d6-7d43-16ae9493e448","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ff32f22a-e0ff-04fe-026e-afb448b90882","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/b3dbcdf4-82ec-fa72-64c5-a5b41a00bce1"},"effectiveDateTime":"2024-07-05T11:58:59-07:00","reasonReference":[{"reference":"Condition/03276836-7126-19d6-7d43-16ae9493e448","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a7602ec8-fd23-1c1a-96c2-895c49841ce9","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/b3dbcdf4-82ec-fa72-64c5-a5b41a00bce1"},"effectiveDateTime":"2024-07-05T23:58:59-07:00","reasonReference":[{"reference":"Condition/03276836-7126-19d6-7d43-16ae9493e448","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9cc5eec9-d615-a0ea-2632-cf295a18dca8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/b3dbcdf4-82ec-fa72-64c5-a5b41a00bce1"},"effectiveDateTime":"2024-07-06T11:58:59-07:00","reasonReference":[{"reference":"Condition/03276836-7126-19d6-7d43-16ae9493e448","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"a8a6b32a-344b-d898-e17e-f35df0246f8f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/b3dbcdf4-82ec-fa72-64c5-a5b41a00bce1"},"effectiveDateTime":"2024-07-06T23:58:59-07:00","reasonReference":[{"reference":"Condition/03276836-7126-19d6-7d43-16ae9493e448","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"708d528f-1d45-1782-66b3-1aaa0b552471","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/b3dbcdf4-82ec-fa72-64c5-a5b41a00bce1"},"effectiveDateTime":"2024-07-07T11:58:59-07:00","reasonReference":[{"reference":"Condition/03276836-7126-19d6-7d43-16ae9493e448","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"57e6a3b7-5d31-3332-b50d-1e185e002294","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/b3dbcdf4-82ec-fa72-64c5-a5b41a00bce1"},"effectiveDateTime":"2024-07-07T23:58:59-07:00","reasonReference":[{"reference":"Condition/03276836-7126-19d6-7d43-16ae9493e448","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"67ad7647-3a56-163f-0a9d-f6aeb2074525","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/b3dbcdf4-82ec-fa72-64c5-a5b41a00bce1"},"effectiveDateTime":"2024-07-08T11:58:59-07:00","reasonReference":[{"reference":"Condition/03276836-7126-19d6-7d43-16ae9493e448","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"162b1d15-e3a1-36b7-278c-1de4d3039527","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/3da764a0-2e5e-0266-cda1-5eca33162878"},"context":{"reference":"Encounter/b3dbcdf4-82ec-fa72-64c5-a5b41a00bce1"},"effectiveDateTime":"2024-07-08T23:58:59-07:00","reasonReference":[{"reference":"Condition/03276836-7126-19d6-7d43-16ae9493e448","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2c785293-cb86-7769-01a2-538db83343f2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/af048e84-05b3-3c01-0f14-101538971b8c"},"context":{"reference":"Encounter/8ec65508-c058-4556-fca2-9ab49fd53a5c"},"effectiveDateTime":"1978-12-20T09:08:57-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"a08bae68-567d-56bb-e0af-71596d2ea35c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/4313376d-a1f5-a397-3d10-2ea1dc70a843"},"context":{"reference":"Encounter/39680dff-2a4d-15f1-2c6f-e3709f76a476"},"effectiveDateTime":"2024-07-26T04:55:24-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"5a96c681-b7e4-0066-1ef1-8c00d8e75d72","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/4313376d-a1f5-a397-3d10-2ea1dc70a843"},"context":{"reference":"Encounter/083fe13e-3fe8-9b81-8527-f34ec20e92fd"},"effectiveDateTime":"2025-03-21T05:20:08-07:00","reasonReference":[{"reference":"Condition/cfc34db4-74c8-9da4-2fa0-aa442f866c9d","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"13e52a0f-8ccd-9604-a907-ae85cd31ae8c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/3359966e-9744-ffeb-ea72-5b7c25768f5d"},"context":{"reference":"Encounter/adf89fd9-27e7-68ef-8c0c-6b78f34af71e"},"effectiveDateTime":"2017-05-23T12:20:36-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"c6c55990-6858-5486-9290-1dd5116e5613","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/3359966e-9744-ffeb-ea72-5b7c25768f5d"},"context":{"reference":"Encounter/9b95ff3d-37b7-a45e-551d-741ddaa8190d"},"effectiveDateTime":"2018-05-29T16:11:57-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"cc7f8c1b-e763-705a-0aeb-f109bf15069a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/758fbe1a-998b-ceab-95a6-fcab124f7368"},"effectiveDateTime":"2001-11-04T07:32:37-08:00","reasonReference":[{"reference":"Condition/deb82646-69d9-aabd-ba59-68f397b41b96","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"67184c6c-810e-a022-43ea-fc770730c56b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/3359966e-9744-ffeb-ea72-5b7c25768f5d"},"context":{"reference":"Encounter/d35b0086-91b4-2ad1-5cf0-9dd563555763"},"effectiveDateTime":"2021-06-15T13:15:56-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"05af25e3-d8ac-b933-941d-8c27198cd1a2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/982034ad-be41-7582-2d26-718b1b0ba386"},"context":{"reference":"Encounter/347e5629-fa89-64ee-f39e-61acbb2f5efa"},"effectiveDateTime":"2017-03-27T02:51:27-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"433f1465-df9c-2f93-2e76-7c025e190ab2","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/10ae453d-519b-9716-2ca7-f7ab5a4f2baa"},"effectiveDateTime":"2006-12-03T07:36:50-08:00","reasonReference":[{"reference":"Condition/deb82646-69d9-aabd-ba59-68f397b41b96","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"62403281-5048-1bea-95f7-65a2f92b3352","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/982034ad-be41-7582-2d26-718b1b0ba386"},"context":{"reference":"Encounter/0f9be60d-768e-a650-ea4e-a643e8f152a5"},"effectiveDateTime":"2019-07-15T03:53:10-07:00","reasonReference":[{"reference":"Condition/5832ca7b-ce48-c60b-4b81-c6ca2353ccdb","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"884c3e13-9bad-6c77-d506-319a75670584","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/982034ad-be41-7582-2d26-718b1b0ba386"},"context":{"reference":"Encounter/688ea451-6884-29b5-4f5d-9c042117d636"},"effectiveDateTime":"2019-09-23T03:01:44-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"ceb43de9-7785-b50d-c29b-27c8a8511271","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/c1aabcd3-e70c-26d9-9f4d-0a91899e369f"},"effectiveDateTime":"2011-07-11T03:00:26-07:00","reasonReference":[{"reference":"Condition/3ddbb55a-1203-8bc7-a8db-bcee1abf560f","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ee56ec65-cb8f-88b0-fda3-38024a0c65ec","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/c1aabcd3-e70c-26d9-9f4d-0a91899e369f"},"effectiveDateTime":"2011-07-11T15:00:26-07:00","reasonReference":[{"reference":"Condition/3ddbb55a-1203-8bc7-a8db-bcee1abf560f","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9108edd7-ada8-024a-ffa7-0a17437e4188","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/c1aabcd3-e70c-26d9-9f4d-0a91899e369f"},"effectiveDateTime":"2011-07-12T03:00:26-07:00","reasonReference":[{"reference":"Condition/3ddbb55a-1203-8bc7-a8db-bcee1abf560f","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9612464c-a91b-17f0-b6cc-0e3476eede0b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/c1aabcd3-e70c-26d9-9f4d-0a91899e369f"},"effectiveDateTime":"2011-07-12T15:00:26-07:00","reasonReference":[{"reference":"Condition/3ddbb55a-1203-8bc7-a8db-bcee1abf560f","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"78e1bd79-d682-f699-f5be-fa04bb6e9317","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/c1aabcd3-e70c-26d9-9f4d-0a91899e369f"},"effectiveDateTime":"2011-07-13T03:00:26-07:00","reasonReference":[{"reference":"Condition/3ddbb55a-1203-8bc7-a8db-bcee1abf560f","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1e92d6d0-2fe0-7cfc-578f-d08aa948ac93","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/c1aabcd3-e70c-26d9-9f4d-0a91899e369f"},"effectiveDateTime":"2011-07-13T15:00:26-07:00","reasonReference":[{"reference":"Condition/3ddbb55a-1203-8bc7-a8db-bcee1abf560f","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ad400263-dd68-ba66-a733-7757529368d8","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/c1aabcd3-e70c-26d9-9f4d-0a91899e369f"},"effectiveDateTime":"2011-07-14T03:00:26-07:00","reasonReference":[{"reference":"Condition/3ddbb55a-1203-8bc7-a8db-bcee1abf560f","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"56f87076-323c-fce3-95be-46b570ab9b66","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/c1aabcd3-e70c-26d9-9f4d-0a91899e369f"},"effectiveDateTime":"2011-07-14T15:00:26-07:00","reasonReference":[{"reference":"Condition/3ddbb55a-1203-8bc7-a8db-bcee1abf560f","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7400323a-062f-2c41-601b-1959a5667b8d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/c1aabcd3-e70c-26d9-9f4d-0a91899e369f"},"effectiveDateTime":"2011-07-15T03:00:26-07:00","reasonReference":[{"reference":"Condition/3ddbb55a-1203-8bc7-a8db-bcee1abf560f","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"ff69a6ec-af50-aa48-e737-7ac23d856410","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/c1aabcd3-e70c-26d9-9f4d-0a91899e369f"},"effectiveDateTime":"2011-07-15T15:00:26-07:00","reasonReference":[{"reference":"Condition/3ddbb55a-1203-8bc7-a8db-bcee1abf560f","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1ec7a8d0-ade1-61c4-57c4-a28b28e58e1b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/c1aabcd3-e70c-26d9-9f4d-0a91899e369f"},"effectiveDateTime":"2011-07-16T03:00:26-07:00","reasonReference":[{"reference":"Condition/3ddbb55a-1203-8bc7-a8db-bcee1abf560f","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"2e561e72-712f-4562-713d-3e11a87eb034","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/c1aabcd3-e70c-26d9-9f4d-0a91899e369f"},"effectiveDateTime":"2011-07-16T15:00:26-07:00","reasonReference":[{"reference":"Condition/3ddbb55a-1203-8bc7-a8db-bcee1abf560f","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"99823f8f-f730-9bb1-d756-bb7b93af188e","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/c1aabcd3-e70c-26d9-9f4d-0a91899e369f"},"effectiveDateTime":"2011-07-17T03:00:26-07:00","reasonReference":[{"reference":"Condition/3ddbb55a-1203-8bc7-a8db-bcee1abf560f","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"1e8daa88-3028-e27c-578a-a442ac244013","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/c1aabcd3-e70c-26d9-9f4d-0a91899e369f"},"effectiveDateTime":"2011-07-17T15:00:26-07:00","reasonReference":[{"reference":"Condition/3ddbb55a-1203-8bc7-a8db-bcee1abf560f","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"111dbcb2-a95c-2afd-0492-b54e300a9cf7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/c1aabcd3-e70c-26d9-9f4d-0a91899e369f"},"effectiveDateTime":"2011-07-18T03:00:26-07:00","reasonReference":[{"reference":"Condition/3ddbb55a-1203-8bc7-a8db-bcee1abf560f","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f82e8875-f963-603b-4843-141277e03d7a","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1719286","display":"10 ML Furosemide 10 MG/ML Injection"}],"text":"10 ML Furosemide 10 MG/ML Injection"},"subject":{"reference":"Patient/0536e430-89bb-4933-cb56-ea33c3b2bd41"},"context":{"reference":"Encounter/c1aabcd3-e70c-26d9-9f4d-0a91899e369f"},"effectiveDateTime":"2011-07-18T15:00:26-07:00","reasonReference":[{"reference":"Condition/3ddbb55a-1203-8bc7-a8db-bcee1abf560f","display":"Chronic congestive heart failure (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"76d9cceb-0fd5-3d44-877d-f373f8e28fe4","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/af048e84-05b3-3c01-0f14-101538971b8c"},"context":{"reference":"Encounter/e43915d3-c7bb-5c5f-9f96-f287ad948e88"},"effectiveDateTime":"1981-03-11T09:26:22-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"ab993874-a2a9-7f81-c822-0d9ea3b42d84","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/af048e84-05b3-3c01-0f14-101538971b8c"},"context":{"reference":"Encounter/a79dc508-a4f5-d123-1bb5-95ea5e17fb9a"},"effectiveDateTime":"1981-04-01T06:54:33-08:00","reasonReference":[{"reference":"Condition/a45ecd94-f6b9-d52e-e12f-ab77547b9357","display":"Awaiting transplantation of kidney (situation)"}]}
{"resourceType":"MedicationAdministration","id":"da3748e0-e716-fbc6-1a58-9f519601166c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/af048e84-05b3-3c01-0f14-101538971b8c"},"context":{"reference":"Encounter/a79dc508-a4f5-d123-1bb5-95ea5e17fb9a"},"effectiveDateTime":"1981-04-02T08:35:02-08:00","reasonReference":[{"reference":"Condition/cf0dc07d-f3ce-26a5-33f3-7f66a521482e","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"c4fafc50-b2c8-cf04-aba2-16f5f2ea3fcf","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/af048e84-05b3-3c01-0f14-101538971b8c"},"context":{"reference":"Encounter/0d21da2b-5bb8-7d80-5384-0ea0b09f04b0"},"effectiveDateTime":"1981-05-13T08:04:23-07:00","reasonReference":[{"reference":"Condition/cf0dc07d-f3ce-26a5-33f3-7f66a521482e","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"ef1b9961-e928-9342-d9c8-3ba21e731385","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/af048e84-05b3-3c01-0f14-101538971b8c"},"context":{"reference":"Encounter/e1a780cf-08f8-578d-ae46-a7c5dbf2ae92"},"effectiveDateTime":"1981-05-20T09:30:28-07:00","reasonReference":[{"reference":"Condition/cf0dc07d-f3ce-26a5-33f3-7f66a521482e","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"66b92888-6c43-c12a-ef7e-417301444711","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/af048e84-05b3-3c01-0f14-101538971b8c"},"context":{"reference":"Encounter/0a8d06c9-51e3-b92e-3fd7-cd55ad8a8e9f"},"effectiveDateTime":"1981-05-27T11:00:34-07:00","reasonReference":[{"reference":"Condition/cf0dc07d-f3ce-26a5-33f3-7f66a521482e","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"bbe18397-0576-fbce-fc03-020553ec1673","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/af048e84-05b3-3c01-0f14-101538971b8c"},"context":{"reference":"Encounter/60fd7d83-2e81-e3a8-8d11-d2223ed486b3"},"effectiveDateTime":"1981-06-03T12:32:45-07:00","reasonReference":[{"reference":"Condition/cf0dc07d-f3ce-26a5-33f3-7f66a521482e","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"588e1758-3dd9-80d7-02e2-19706d556a29","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"108515","display":"1 ML tacrolimus 5 MG/ML Injection"}],"text":"1 ML tacrolimus 5 MG/ML Injection"},"subject":{"reference":"Patient/af048e84-05b3-3c01-0f14-101538971b8c"},"context":{"reference":"Encounter/8e8b6eea-e21a-e6dc-b936-143e139ad723"},"effectiveDateTime":"1981-06-10T13:41:33-07:00","reasonReference":[{"reference":"Condition/cf0dc07d-f3ce-26a5-33f3-7f66a521482e","display":"History of renal transplant (situation)"}]}
{"resourceType":"MedicationAdministration","id":"0c95582a-be72-69f3-28e0-fd6af2f72f14","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/53426bf1-d17a-7e01-c50a-c9c6e17f9299"},"context":{"reference":"Encounter/8b17ce04-16c1-a164-17ce-0179be9f8b07"},"effectiveDateTime":"2019-08-28T10:12:25-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"b6f352e0-854a-5208-9950-8bcf30164b11","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/53426bf1-d17a-7e01-c50a-c9c6e17f9299"},"context":{"reference":"Encounter/f5db8bff-0ea3-104f-72b0-0c593f5fc2a8"},"effectiveDateTime":"2021-09-08T09:28:43-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"7aecb50f-599b-4724-ff5d-e3af8c663004","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/53426bf1-d17a-7e01-c50a-c9c6e17f9299"},"context":{"reference":"Encounter/82bc5c81-0b5f-e3c1-1848-296f91747ddb"},"effectiveDateTime":"2022-09-14T11:00:08-07:00","reasonReference":[{"reference":"Condition/deb7ac3f-7723-7980-8b92-ef3acca9308f","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"5e4ab7f0-89d9-ffb9-bb9a-0a8aa7da089b","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/53426bf1-d17a-7e01-c50a-c9c6e17f9299"},"context":{"reference":"Encounter/3df6fd66-9d04-0087-c0cc-49add194e0c5"},"effectiveDateTime":"2024-09-25T10:13:52-07:00","reasonReference":[{"reference":"Condition/deb7ac3f-7723-7980-8b92-ef3acca9308f","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d106b8e2-669b-cf2b-aba6-195ea7bd712d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8439bdac-40bb-855a-0c87-d4b8244c376b"},"context":{"reference":"Encounter/6f1b599c-eb76-4869-5ddb-8622ed876245"},"effectiveDateTime":"2015-10-18T05:36:18-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"f4d8bdee-d1d6-b171-e279-3a2ff37dc4b6","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8439bdac-40bb-855a-0c87-d4b8244c376b"},"context":{"reference":"Encounter/a59c297c-d610-0f1a-e140-09ae81b68492"},"effectiveDateTime":"2015-12-20T04:12:12-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"432de2e0-baf4-25ce-2093-e4727b32465f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8439bdac-40bb-855a-0c87-d4b8244c376b"},"context":{"reference":"Encounter/078f27ab-5b70-6233-d6eb-57a3cd604ef7"},"effectiveDateTime":"2016-08-21T07:24:55-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"d80a1fe9-1dfb-ac7e-49b1-c034c51abcc7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8439bdac-40bb-855a-0c87-d4b8244c376b"},"context":{"reference":"Encounter/de4a88db-5a14-20cf-f982-e4cd336a9d0a"},"effectiveDateTime":"2017-01-15T04:32:04-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"fe4934cc-cccf-3c0f-1b88-57ad0aefcd01","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8439bdac-40bb-855a-0c87-d4b8244c376b"},"context":{"reference":"Encounter/cfb1c888-ec7a-e827-05cc-77656f2d57c0"},"effectiveDateTime":"2017-12-24T07:20:17-08:00","reasonReference":[{"reference":"Condition/845ca251-c33e-0561-c19a-ed0aea2915fa","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e659da7b-2221-0135-eae1-bfbc0a1d0326","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8439bdac-40bb-855a-0c87-d4b8244c376b"},"context":{"reference":"Encounter/d7406f59-f034-b505-52ce-bc3f8336aef2"},"effectiveDateTime":"2018-10-07T05:40:35-07:00","reasonReference":[{"reference":"Condition/845ca251-c33e-0561-c19a-ed0aea2915fa","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"e132aa1d-a70b-edc4-0042-f2a2bd808f4c","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8439bdac-40bb-855a-0c87-d4b8244c376b"},"context":{"reference":"Encounter/61a952e4-27a6-c747-8da0-9ea4faa6829e"},"effectiveDateTime":"2019-09-08T05:55:12-07:00","reasonReference":[{"reference":"Condition/845ca251-c33e-0561-c19a-ed0aea2915fa","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"eea3b974-bd6d-4b01-fe2b-ddb8c3208a2d","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8439bdac-40bb-855a-0c87-d4b8244c376b"},"context":{"reference":"Encounter/fe33c5da-42e2-554c-9b2f-e6a9454b4c59"},"effectiveDateTime":"2020-02-02T04:32:18-08:00","reasonReference":[{"reference":"Condition/845ca251-c33e-0561-c19a-ed0aea2915fa","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7fa221aa-c59c-85a6-01e6-6c284a55c69f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8439bdac-40bb-855a-0c87-d4b8244c376b"},"context":{"reference":"Encounter/22164627-e5e8-e53e-127a-738bf20196e5"},"effectiveDateTime":"2020-04-05T04:50:12-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"2dc6b766-bc9e-3490-1ecb-40190674f012","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8439bdac-40bb-855a-0c87-d4b8244c376b"},"context":{"reference":"Encounter/2f033b52-434b-0c5a-99b3-57885f9d0020"},"effectiveDateTime":"2020-07-05T06:11:10-07:00","reasonReference":[{"reference":"Condition/845ca251-c33e-0561-c19a-ed0aea2915fa","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"186cddef-1934-9091-ac7d-1c0faa4d19f0","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8439bdac-40bb-855a-0c87-d4b8244c376b"},"context":{"reference":"Encounter/22fddad8-2a4b-971c-7121-766e1555da5e"},"effectiveDateTime":"2020-08-30T04:41:52-07:00","reasonReference":[{"reference":"Condition/845ca251-c33e-0561-c19a-ed0aea2915fa","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"d67cd559-4c9b-9706-481c-dd1d5ebfb69f","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8439bdac-40bb-855a-0c87-d4b8244c376b"},"context":{"reference":"Encounter/be1ebe80-ad95-583a-d0af-c82d58ff4ee4"},"effectiveDateTime":"2021-03-28T05:45:47-07:00","reasonReference":[{"reference":"Condition/845ca251-c33e-0561-c19a-ed0aea2915fa","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"f307fa51-ee01-415f-a93f-f0e9fd8965aa","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8439bdac-40bb-855a-0c87-d4b8244c376b"},"context":{"reference":"Encounter/1ba60736-3515-fbce-6101-9ff8e8d242e4"},"effectiveDateTime":"2021-11-28T06:22:01-08:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
{"resourceType":"MedicationAdministration","id":"cc4560f3-8218-859e-4e8a-2cfedff90697","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8439bdac-40bb-855a-0c87-d4b8244c376b"},"context":{"reference":"Encounter/54cb91de-2568-f553-d071-472fe2c80ba3"},"effectiveDateTime":"2022-06-19T05:20:37-07:00","reasonReference":[{"reference":"Condition/845ca251-c33e-0561-c19a-ed0aea2915fa","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"9e868f45-2a9f-1c00-eab7-a84623216177","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8439bdac-40bb-855a-0c87-d4b8244c376b"},"context":{"reference":"Encounter/172c75d8-1d37-5a5f-ec26-aaab6aef8d30"},"effectiveDateTime":"2025-05-18T08:28:31-07:00","reasonReference":[{"reference":"Condition/845ca251-c33e-0561-c19a-ed0aea2915fa","display":"Gingivitis (disorder)"}]}
{"resourceType":"MedicationAdministration","id":"7dfec475-de69-b9d7-251d-d4be8e4ed4d7","status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1535362","display":"sodium fluoride 0.0272 MG/MG Oral Gel"}],"text":"sodium fluoride 0.0272 MG/MG Oral Gel"},"subject":{"reference":"Patient/8439bdac-40bb-855a-0c87-d4b8244c376b"},"context":{"reference":"Encounter/68c16d3d-2edd-304c-a74b-07fd015f5011"},"effectiveDateTime":"2025-07-06T04:55:48-07:00","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"103697008","display":"Patient referral for dental care (procedure)"}],"text":"Patient referral for dental care (procedure)"}]}
